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1. Introduction and taxonomy 
Members of the family of the Chlamydiaceae are obligate intracellular Gram-negative 
bacteria that cause a variety of diseases in humans, other mammals and birds. They have a 
serious impact on both human and animal health and are therefore of major economic 
importance worldwide. The primary sites of replication are mucosal epithelial cells of the 
respiratory, urogenital and gastrointestinal tract, the conjunctival epithelium, as well as 
monocytes and macrophages (Pospischil et al., 2010). Currently, eleven Chlamydia species 
have been identified (Table 1.1) and the pylogenetic classification of the Chlamydiaceae is 
shown in Figure 1.1 (Sachse et al., 2015).  
Table 1.1: The family Chlamydiaceae. Adapted from Kerr et al. (2005), Longbottom and 
Livingstone (2006), and Sachse et al. (2015). 
Species Natural host Other hosts Clinical signs 
C. trachomatis Human  
Chronic conjunctivitis and blindness 
(trachoma), infection of urogenital tract, 
infertility 
C. pneumoniae Human,horse, koala 
Amphibians, 
reptiles 
Pneumonia, bronchitis, 
encephalomyelitis, laryngitis, 
atherosclerosis, reactive arthritis 
C. abortus a Sheep, goat Cattle, swine Reproductive disorders, abortion and bad semen quality 
C. psittaci a Birds Mammals Respiratory tract infection, rhinitis, conjunctivitis, diarrhoea 
C. caviae b Guinea pig Horse Ocular and urogenital tract infection 
C. felis b Cat  
Conjunctivitis, rhinitis and respiratory 
tract infection 
C. muridarum Rodents  Respiratory and genital tract infection 
C. pecorum Cattle, koala Sheep, goat, swine 
Reproductive disorders, infertility, 
infection of the urine tract (koala) and 
abortion, enteritis, polyarthritis, 
encephomyelitis, metritis, mastitis, 
conjunctivitis and pneumonia (other 
animals) 
C. suis b Swine Ruminants Diarrhea, pneumonia, conjunctivitis, reproductive disorders 
C. gallinacea b Chicken Other poultry Respiratory tract infection 
C. avium b Pigeon, parrot  
Enteritis, respiratory tract infection, 
diarrhea 
a Zoonotic pathogen, b Potential zoonotic pathogen 
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Figure 1.1: Phylogenetic tree of the family of Chlamydiaceae. The construction of the tree 
was based on an alignment of almost complete 16S rRNA genes from the type strains of all 
established Chlamydiaceae species. RaxML generated the tree starting from that alignment. 
Bootstrap values indicate the stability of the branches based on 100 replicates. The bar 
indicates 1% sequence divergence (Sachse et al., 2015). 
2. Chlamydia psittaci 
C. psittaci infections have been reported in over 500 species of birds, where infection is either 
latent or can become systemic and clinically overt in the respiratory tract (Stewardson and 
Grayson, 2010). The symptoms include conjunctivitis, anorexia, nasal discharge, rhinitis, 
diarrhea, polyuria, dyspnea and dullness (Vanrompay et al., 1995a). C. psittaci is an important 
zoonotic pathogen. In humans, C. psittaci infections can vary from mild flu-like symptoms to 
a life-threatening pneumonia (Beeckman and Vanrompay, 2009; Smith et al., 2011). 
Symptoms commonly reported are high fever, difficulty breathing and a non-productive 
cough, low pulse, chills, headache, and myalgia. Transmission of C. psittaci occurs horizontal 
via inhalation of infected aerosols of pharyngeal or nasal secretions or dried feces and vertical 
via the eggshell (Ahmed et al., 2015). Sequencing of the C. psittaci major outer membrane 
protein (ompA) gene identified 9 genotypes (A to F, E/B, M56, and WC) (Geens et al., 2005). 
The genotypes cluster with host species (Pannekoek et al., 2008). Genotype A and B are 
associated with psittacine birds (cockatoos, parrots, parakeets and lories) and pigeons, 
respectively. Genotype C has been isolated from ducks and geese, whereas genotype D was 
found mainly in turkeys. The host range of genotype E is more diverse, since it has been 
isolated from pigeons, ratites, ducks, turkeys and occasionally humans. Genotype F was 
isolated from psittacine birds and turkeys. Genotype E/B has been isolated mainly from ducks 
(Geens et al., 2005; Pannekoek et al., 2010). Genotypes WC and M56 represent isolates from 
epizootics in cattle and muskrats, respectively (Spalatin et al., 1966; Everett et al., 1999).  
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2.1 Treatment 
Chlamydial infections in animals are currently mainly treated by tetracycline and its 
derivatives (chlortetracycline, oxytetracycline, doxycycline), because it is a cheap, broad 
spectrum antibiotic with an excellent tissue distribution and low toxicity, which easily 
resolves the infection (Sandoz and Rockey, 2011). However, the extensive use of the 
antibiotic also for other bacterial infections in animals, both as therapy and in the past also as 
a prophylaxis, led to the fast spread of tetracycline resistant Gram-positive and Gram-negative 
bacteria (Michalova et al., 2004). Chlamydia suis is the first intracellular bacterium in which a 
horizontally acquired resistance gene was observed (Dugan et al., 2004). Pigs are the natural 
host of C. suis, but also C. abortus, C. pecorum and C. psittaci occur in pigs (Schautteet and 
Vanrompay, 2011). This might suggest that transfer of the tetracycline resistence, tet(C), gene 
to other Chlamydia species is feasible. However, intuitively we would expect that the 
Chlamydia species should be present at the same site of infection and that the inclusion of two 
different species should fuse before horizontal gene transfer might occur.  
Chlamydiaceae replicate in mucosal epithelial cells of  the conjunctivae, the respiratory, 
urogenital and gastrointestinal tract (Schautteet and Vanrompay, 2011), thus if a host is 
infected by multiple Chlamydia species, the different species can be present simultaneously at 
the same infection site. However, different fusogenic properties were observed. Multiple C. 
trachomatis inclusions present in the same infected cell mostly fuse (Matsumoto et al., 1991; 
Rockey et al., 2002), while many C. psittaci strains are non-fusogenic (Rockey et al., 1996). 
The tet(C) gene recombined in the C. trachomatis genome when cocultured with a 
tetracycline-resistent C. suis strain in vitro, while the resistence gene was not succesfully 
transferred to C. caviae (Suchland et al., 2009). This might either be due to the non-
recombigenic activity of C. caviae, or the sequences at potential recombination sites might 
differ too much between these species or it might be that the C. suis inclusion could not fuse 
with the C. caviae inclusions and that this event is essential for recombination. All latter 
hypotheses are possible, as it is currently unknown how an intracellular bacteria acquired a 
resistance gene through horizontal gene transfer. Unexpectedly, preliminary results by 
Suchland et al. (unpublished data) suggested that fusion of inclusions is not required for 
recombination, which favors the other two possible explanations. C. caviae clusters 
phylogenetically together with C. psittaci, and therefore C. psittaci might show similar results 
as C. caviae in recombination experiments. However, up to now no experiments on the 
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possible transfer of the tet(C) gene from C. suis to C. psittaci have been performed neither in 
vitro nor in vivo. Further research is needed to unravel the horizontal gene transfer mechanism 
in Chlamydia spp., to find out whether or not the tet(C) could be transferred to C. psittaci. 
However, the presence of the tet(C) gene in C. suis is not always associated with a 
tetracycline-resistant phenotype, so MIC-values for tetracycline should be determined for 
strains containing the tet(C) gene to confirm that the resistant gene is functional (Di Francesco 
et al., 2008).  
The occurence of the tet(C) gene in one Chlamydia species should warn us that the wide use 
of antibiotics in veterinary medicine creates an environment in which pathogens acquire and 
maintain antibiotic resistance genes (Dugan et al., 2004). Antibiotics are widespread in the 
poultry industry and spreading of the tet(C) gene is possible, as tetracycline resistant 
Salmonella (Kidie et al., 2013; Chotinun et al., 2014), Campylobacter jejuni (Deckert et al., 
2010; Thibodeau et al., 2011) and Staphylococcus aureus isolates (Yucel et al., 2011; 
Argudín et al., 2013; Nemeghaire et al., 2013) have been observed in a high proportion in 
poultry. These observations, together with the systemic infection capacity of C. psittaci, 
highlight the possiblity that C. psittaci might acquire tetracycline resistence. Therefore, 
vaccination is regarded the best option to prevent chlamydial infections (Longbottom and 
Livingstone, 2006).  
3. Developmental cycle 
Chlamydiaceae are obligate intracellular bacteria, which means that they are completely 
dependent on eukaryotic host cells to replicate. The chlamydial developmental cycle is a 
unique biphasic developmental cycle, which involves predominantly two distinct 
morphological forms: the extracellular, infectious elementary bodies (EBs) and the 
intracellular, non-infectious, metabolically active reticulate bodies (RBs) (Figure 1.2). In 
addition, intermediate bodies (IBs) can be formed during the maturation from RBs to EBs 
(Vanrompay et al., 1996). 
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Figure 1.2: Schematic representation of the developmental cycle of the Chlamydiaceae. 
Numbers refer to hours post infection, however, the timing of the different stages varies 
depending on the chlamydial species and the host cell. The cycle starts when the infectious 
elementary bodies (EBs) attach to the host cell. Upon binding, EBs are internalized in tight, 
endocytic vesicles, called inclusions. The EBs differentiate to the metabolically active 
reticulate bodies (RBs), which divide by binary fission. The normal developmental cycle can 
be interrupted by different conditions and agents, which lead to persistence. During the 
persistent infection, no growth of the chlamydial organisms can be observed. Once the stress-
induced factor is removed, the normal developmental cycle can be completed. The RBs 
continue to replicate until they detach from the inclusion membrane and consequently revert 
into EBs again. The EBs are released from the host cell through lysis or inclusion extrusion 
(Geens, 2005).  
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The EBs are small (diameter 0.2-0.3 µm), coccoid shaped particles that have a highly 
condensed chromosome and an unusual rigid ultrastructure due to disulfide cross-linking of 
cysteine-rich proteins in the envelope (Raulston, 1995; Hatch, 1996). That cell envelope 
makes the EBs osmotically stable and poorly permeable and protects the particles to survive 
up to several months in the hostile extracelullar environment (Longbottom and Coulter, 2003). 
The EBs initiate infection by attachment to a eukaryotic host cell, by which the EBs are 
endocytosed and in which they reside within a membrane-bound vacuole, called an inclusion. 
The EBs convert to the much larger (0.5-1.6 µm) RBs, which are also coccoid shaped, but 
have a low electron density and their cell envelope is less rigid and more permeable because 
the disulfide bonds are reduced and some cysteine-rich proteins are absent (Raulston, 1995). 
In addition, the major outer membrane protein (MOMP) is predominantly present in a 
monomeric form in RBs, while in EBs the protein has been identified as dimers, trimers and 
multimeric complexes (Newhall and Jones, 1983; Hatch et al., 1984). The RBs divide by 
binary fission and the inclusion expands (Moulder, 1991). After 20-48h, depending on the 
species, RBs differentiate asynchronously into EBs (Moulder, 1991; Hatch, 1996), which are 
then released from the infected host cell through cell lysis or inclusion extrusion, thereby 
closing the developmental cycle (Hybiske and Stephens, 2007b).  
4. Persistence 
A recurrent chlamydial infection might either be the result of a repeated infection or of a 
persistent infection that manifests after an unresolved primary infection (Hogan et al., 2004). 
The detection of chlamydial macromolecules in the absence of cultivability, recurrences that 
occur when reinfection is unlikely and clinical antibiotic resistance are evidences for 
persistence in vivo. Holland et al. (1992) detected C. trachomatis by either tissue culture or 
direct fluorescence cytology for a shorter period after a primary and secondary infection of 
primates than they detected chlamydial RNA. Dean et al. (2000) studied seven women with 
more than three recurrent infections over two to five years. Four women had identical 
genotypes at each recurrence and plenty culture-negative samples were positive by ligase 
chain reaction. All these experiment suggest that chlamydial persistence exists in vivo.  
Chlamydial persistence has been induced in vitro through deviations of conventional cell 
culture conditions, such as amino acid deprivation (Coles et al., 1993), iron depletion 
(Raulston, 1997), antibiotic treatment (Goellner et al., 2006; Hu et al., 2015), phage infection 
(Hsia et al., 2000), co-infection with virus (Borel et al., 2010) and tryptophan depletion by 
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IFN-γ treatment (Beatty et al., 1994; Goellner et al., 2006). Small inclusions, which contain a 
smaller amount of abnormally enlarged RBs, called aberrant bodies, and loss of infectivity are 
common characteristics of the different persistent models. The aberrant bodies are formed due 
to the inability of the RBs to divide, while DNA and protein synthesis continues. Removal of 
the stressors results in septum formation, RB division and differentation to EBs (Hogan et al., 
2004). Further research is needed to determine whether the persistent state induced in vitro 
resembles the latent and chronic infections that are observed in vivo (Wyrick, 2010).  
5. A chlamydial infection from outside to inside 
Multiple membranes have a key function during the developmental cycle of the 
Chlamydiaceae (Figure 1.3). In a first step, the EB attaches to the host plasma membrane 
and invades the host cell (Figure 1.3, a). Subsequently, the EB differentiates to RB, which 
divide inside the inclusion. The inclusion membrane is quickly modified by Chlamydia-
derived proteins (Bastidas et al., 2013). It is hypothesized that the modified inclusion 
membrane is essential to ensure the escape of the inclusion from the endolysosomal pathway, 
while selective interactions with other cellular compartments are maintained to acquire 
essential nutrients and allow intracellular survival (Valdivia, 2008; Saka and Valdivia, 2010). 
The lipids that are needed for the growing membranes (inclusion, RB and EB membranes) are 
scavenged from the host (Figure 1.3,b; Elwell et al., 2011; Scidmore, 2012). While the 
proteins present in those membranes, are Chlamydia-specific (Taraska et al., 1996). EB and 
RB membrane compositions differ significantly, which could be expected based on their 
different role during the developmental cycle (Figure 1.3, c and d; Raulston, 1995; Marques et 
al., 2010; Saka et al., 2011). In what follows, the events occuring at the plasma and inclusion 
membranes as well as the composition of inclusion, EB and RB membranes will be discussed 
in detail. There are significant species- and strain-specific differences in the way that 
Chlamydia interacts with the host cell, so results can not always be extrapolated and caution 
should be exercised (Valdivia, 2008).  
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Figure 1.3: Overview of Chlamydia and host-cellular interactions. (a) Chlamydiacea enter 
the host cell in an actin-dependent way, that involves both chlamydial and host factors. The 
EBs are enclosed by a vacuole membrane, named the inclusion membrane. Chlamydiacea 
modify the inclusion membrane by inserting chlamydial proteins and thereby they prevent the 
fusion with lysosomes. The inclusion migrates across microtubuli toward the microtubule 
organizing center (MTOC). (b) The EBs differentiate to RBs that divide by binary fission, 
leading to an expansion of the inclusion. The inclusion interacts with multiple host-cell 
organelles such as fragmented Golgi ministacks, the ER, lipid droplets and multivesicular 
bodies (MVBs). (c, d) Eventually, most of the cytoplasmic space is filled by the inclusion, in 
which RBs differentiate back to EBs, which are released from the host cell and are ready to 
infect neighbouring host cells. Adapted from Bastidas et al. (2013). 
5.1 Plasma membrane 
5.1.1 Attachment 
Bacterial attachment to a host cell is characterized by a two-step process in which primary, 
reversible, electrostatic interactions (Heckels et al., 1976; Hatch et al., 1981) are followed by 
a stronger, more specific binding of adhesins to their cognate receptors present on the surface 
of the host cell (Boyle and Finlay, 2003; Elwell et al., 2008; Lambert and Smith, 2009). The 
primary interaction of Chlamydia species to their host cells is mediated through electrostatic 
interaction of EBs with host heparan sulfate containing glycosaminoglycans (Zhang and 
Stephens, 1992; Su et al., 1996). Different bacterial adhesins: MOMP (Caldwell and Perry, 
1982; Su et al., 1996), OmcB (Fadel and Eley, 2007; Moelleken and Hegemann, 2008), 
Chlamydial infection biology                                                                                                    11 
Hsp70 (Mamelak et al., 2001), Polymorphic membrane protein 6 (Pmp), Pmp20 and Pmp21 
(orthologs of PmpG, PmpB and PmpD of C.trachomatis, respectively) of C. pneumoniae 
(Mölleken et al., 2010), all Pmps of C. trachomatis (Becker and Hegemann, 2014) and host 
receptors: mannose receptor, mannose 6-phosphate receptor and estrogen receptor (reviewed 
in Campbell and Kuo, 2006; Cocchiaro and Valdivia, 2011) have been suggested. Protein 
disulfide isomerase (PDI) is structurally required for EB attachment and PDI-mediated 
reduction at the cell surface is essential for invasion (Abromaitis and Stephens, 2009). In 
addition, growth factors and their receptors, such as the platelet-derived growth factor 
receptor (PDGFR) and Abelson (Abl) kinase are essential host factors for chlamydial binding 
(Elwell et al., 2008). Most likely, adhesion will be mediated by multiple cell surface proteins 
(Cocchiaro and Valdivia, 2009). 
5.1.2 Internalization 
Chlamydia species carry a functional type III secretion (T3S) system, through which the 
pathogen translocates effector proteins directly into the host cell (Peters et al., 2007). The 
translocated actin recruitment protein (Tarp) is an early effector protein that mediates actin 
remodelling by either direct contact with actin (Jewett et al., 2006) or through a Rac1-
dependent actin remodelling at the attachment sites (Carabeo et al., 2004; Clifton et al., 2004). 
Host Src (Jewett et al., 2008), Syk (Mehlitz et al., 2008) and Abl (Elwell et al., 2008) kinases 
phosphorylate the N-terminal tyrosine-rich tandem repeats of Tarp from C. trachomatis, 
which leads to the recruitment of guanine nucleotide exhange factors (GEFs), Sos1 and Vav2, 
which activate Rac1 (Lane et al., 2008). The activated Rac1 subsequently leads to the 
activation of the Arp2/3 complex and actin reorganization (Carabeo et al., 2007). Tarp from 
other Chlamydia species cannot be targeted for tyrosine phosphorylation, which highlights the 
differences in the pathogenesis of different Chlamydia species. Clathrin is an additional host 
factors that contributes to invasion in nonphagocytic cells (Hybiske and Stephens, 2007a). 
The actin rearrangement induced by Tarp is transient and it is hypothesized that other 
effectors, such as CT166 (Thalmann et al., 2010) and CT694 (Hower et al., 2009) in C. 
trachomatis might regulate the actin depolymerization. The EBs are immediately after entry 
sequestered in a membrane-bound vacuole, called the inclusion. The inclusion quickly 
dissociates from the endosomal pathway, avoiding lysosomal fusion, through remodelling of 
the inclusion membrane by insertion of bacterial proteins (Scidmore et al., 1996; Scidmore et 
al., 2003). The remodelled membrane subsequently promotes migration of the inclusion along 
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microtubuli to the MTOC, nearby the peri-Golgi region (Scidmore et al., 1996; Grieshaber et 
al., 2003). This transport is dynein-dependent but dynactin-independent. It is suggested that 
chlamydial effector proteins in the inclusion membrane mimic dynactin (Scidmore, 2011).  
5.2 Inclusion membrane 
Chlamydiacea acquire most of their metabolic needs from the host cell. These essential 
factors include nutrients, such as amino acids and iron, and lipids. The arginin transporter ArtJ, 
the metal transporter zntA, the ATP-ADP transporter Ntp1 and the cytochrome oxidase 
subunit I CydA may be present in the inclusion membrane (Saka et al., 2011). In addition, the 
inclusion selectively interacts with organelles in the peri-Golgi niche to sequester essential 
factors for chlamydial development (Figure 1.3, b). Sphingolipids (Hackstadt et al., 1996), 
cholesterol (Carabeo et al., 2003) and glycerophospholipids (Wylie et al., 1997) are essential 
eukaryotic lipids for chlamydial development. Chlamydiae interact with various host 
pathways to acquire those lipids and nutrients, which will be discussed below.  
5.2.1 Vesicular pathway 
Several endosome and Golgi-related Rab GTPases, which regulate organelle identity and 
vesicular trafficking (Seabra and Wasmeier, 2004), associate with the inclusion membrane 
(Rzomp et al., 2003). Rab proteins were observed in association with the inclusion membrane 
in both a species-dependent and species-independent manner (Rzomp et al., 2003; Scidmore, 
2011). Rab1 and 14 are required in C. trachomatis development (Elwell et al., 2008), while 
Rab11 is required for C. caviae development (Derré et al., 2007). Rab1, 4 and 11 are recruited 
to C. trachomatis, C. pneumoniae and C. muridarum inclusions. Rab6 is associated with the C. 
trachomatis inclusion and not with C. pneumoniae and C. muridarum inclusions, while for 
Rab10 the opposite was observed (Rzomp et al., 2003). Rab GTPases function in different 
pathways and the recruitment of different Rabs is suggested to promote selective 
interaction/fusion with host vesicles containing essential nutrients (Bastidas et al., 2013): 
Rab4, 11 and 14 are endocytic, while Rab6 and 10 are endoplasmatic reticulum (ER) - Golgi 
related (Rzomp et al., 2003). Rab6 and 11 mediate fragmentation of the Golgi into ministacks 
(Heuer et al., 2009; Rejman Lipinski et al., 2009) and Rab14 mediates delivery of Golgi-
derived sphingomyelin to the inclusion (Capmany and Damiani, 2010). In contrast, Rab4 and 
11 may participate in iron acquisition (Ouellette and Carabeo, 2010).  
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It is suggested that chlamydial proteins which differ between species, may be involved in Rab 
recruitment (Rzomp et al., 2003). The C. trachomatis CT229 interacts with Rab4 (Rzomp et 
al., 2006), while the C. pneumoniae Cpn0585 interacts with Rab1, 10 and 11 (Cortes et al., 
2007). CT229 and Cpn0585 are both inclusion membrane proteins (Inc). Incs are identified 
by a large hydrophobic region, which encodes two transmembrane domains and by a type III 
secretion signal, that allows the secretion and subsequent insertion of the protein in the 
inclusion membrane. Bioinformatic studies have predicted that the amount of inc genes in 
chlamydial genomes varies between 50 and 90 genes in C. trachomatis and C. pneumoniae 
respectively (Lutter et al., 2012). This high amount of genes in the highly reduced chlamydial 
genomes suggests that Inc proteins mediate an important function in the chlamydial 
developmental cycle (Moore and Ouellette, 2014). Inc proteins are expressed at different time 
points during the developmental cycle (early and mid-cycle) (Nicholson et al., 2003). In 
addition to recruiting Rab GTPases, the fusion of vesicles might also be regulated by 
recruiting host soluble NSF-sensitive attachment receptor (SNARE) proteins, which are key 
components of the intracellular fusion machinery (Südhof and Rothman, 2009). Multiple Inc 
proteins, such as IncA, CT813 and CT223, contain SNARE-like motifs. IncA interacts with 
host endocytic SNARE proteins Vamp3, Vamp7 and Vamp8, through its SNARE motif.  
The Brefeldin A (BFA)-sensitive vesicular-trafficking pathway is another vesicular pathway 
that is mediated by Chlamydiaceae to intercept cholesterol and sphingomyelin from the Golgi 
apparatus. Chlamydiacea use GBF1, a BFA-sensitive GEF that activates ADP ribosylation 
factors (Arfs) to acquire sphingomyelin. The activated Arfs recruit namely coat proteins 
necessary for vesicle formation. The sphingomyelin acquired through this vesicle-mediated 
pathway is essential for inclusion growth and stability, but not for bacterial replication (Elwell 
et al., 2011).  
5.2.2 Non-Vesicular pathway 
Host-sphingomyelin is essential for progeny production and inclusion biogenesis (Van Ooij et 
al., 2000; Robertson et al., 2009), however, BFA-mediated inhibition of vesicular transport 
had no effect on the production of infectious progeny (Hackstadt et al., 1996). That paradox is 
solved by the observation that the ceramide transfer protein (CERT) is recruited to the 
inclusion by C. trachomatis, possibly through interaction with IncD (Derré et al., 2011). 
CERT is a cytosolic lipid transfer protein that transports ceramide, the precursor of 
sphingomyelin, from the ER to the trans-Golgi region, where it is converted to sphingomyelin 
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by sphingomyelin synthases 1 or 2 (Hanada, 2010). C. trachomatis creates a sphingomyelin 
synthesis factory at the inclusion membrane by recruiting both CERT and at least one 
sphingomyelin synthase to the inclusion membrane. It is suggested that the CERT-recruitment 
leads to the formation of an ER-inclusion membrane contact site (Derré et al., 2011). 
Sphingomyelin acquired through this vesicle-independent pathway is essential for C. 
trachomatis replication. Phosphatidylinositol (PI) and phosphatidylcholine (PC), two 
eukaryotic glycerophospholipids which are present in purified EBs, are also acquired from the 
host cell through the non-vesicular transport pathway, which is mediated by ERK and the 
cytosolic phospholipase A2 (PLA2). Chlamydia modifies the sequestered 
glycerophospholipids by replacing the non-branched chain fatty acids by Chlamydia-derived 
branched chain fatty-acids (Wylie et al., 1997; Su et al., 2004), which is in contrast to 
cholesterol and sphingomyelin that are not modified (Wylie et al., 1997; Su et al., 2004).  
5.2.3 Lipid droplets 
Lipid droplets (LD) are ER-derived storage organelles for neutral lipids or long chain fatty 
acids (Kumar et al., 2006; Cocchiaro et al., 2008). Lipid droplet-associated protein (Lda) 1 
and 3 are translocated to the host cytosol and localize to LDs that are adjacent to the inclusion 
membrane (Kumar et al., 2006). The captured LDs are translocated intact across the inclusion 
membrane (Cocchiaro et al., 2008). The observations that the LDs do not accumulate in the 
inclusion lumen and the presence of neutral lipids in RBs, led to the suggestion that the 
associated lipids are either directly scavenged or metabolized by RBs (Scidmore, 2011). IncA 
cofractionated with LDs and partially colocalized with intraluminal LDs. Therefore, it was 
suggested that IncA might mark entry sites for LDs at the inclusion membrane (Cocchiaro et 
al., 2008).  
5.2.4 Multivesicular bodies 
Multivescular bodies (MVB) are part of the endolysosomal pathway (Beatty, 2006). MVB are 
important for the sorting and processing of proteins and lipids that are destined for lysosomal 
degradation or recycling to the Golgi or plasma membrane exocytosis (Denzer et al., 2000; 
Piper and Luzio, 2001; Woodman and Futter, 2008). Chlamydiacea might use the MVBs as 
an additional lipid (sphingolipids, phospholipids and cholesterol) source (Beatty, 2006; 
Gambarte Tudela et al., 2015). MVBs migrate along microtubuli to the inclusion. Different 
MVB markers, such as CD63 and LBPA, reside within the C. trachomatis inclusion lumen. 
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Rab39a, which labels a subset of late endosomal vesicles – mainly MVB - , participates in the 
delivery of the MVBs to the inclusion (Gambarte Tudela et al., 2015). However, the 
chlamydial effectors involved in the transport of MVB into the inclusion lumen are unknown 
(Gambarte Tudela et al., 2015; Dumoux and Hayward, 2016).  
5.2.5 Mitochondria 
Mitochondria were found in close association with C. psittaci and C. caviae inclusions, but 
this assocation was not observed in C. trachomatis and C. pneumoniae-infected cells 
(Matsumoto et al., 1991; Derré et al., 2011). The mitochondrial transporter inner/outer 
membrane (TIM-TOM) complex, which is involved in the recognition and transport of host 
mitochondrial proteins into the mitochondria, is essential for C. caviae inclusion biogenesis 
and the production of infectious progeny. Consequently, depletion of the complex affected C. 
caviae replication and differentiation, but the C. trachomatis development was unaffected 
(Derré et al., 2011). The functional significance of the association of C. caviae and C. psittaci 
inclusions with mitochondria is currently unknown (Knittler et al., 2014) . It might be related 
to acquire energy. Although Chlamydia species have the capacity to produce ATP (Iliffe-Lee 
and McClarty, 1999), mimic-ATP/ADP transporters Npt1 and Npt2 are observed in EBs and 
RBs (Tjaden et al., 1999; Saka et al., 2011) and the ATP/ADP transporters might also be 
present in the inclusion membrane (Saka et al., 2011), it might be that C. caviae and C. 
psittaci have an additional, redundant pathway to acquire energy, as the genes required for 
ATP production are only transcribed starting from 6 hpi. Therefore, energy needed for the 
early differentation of EBs to RBs might either come from chlamydial ATP reserves, but also 
from the host (Iliffe-Lee and McClarty, 1999).  
Prevention of apoptosis could be a second reason for the observed association of the inclusion 
with the mitochondria. The release of mitochondrial cytochrome c into the cytoplasm is 
essential to induce apoptosis (Yang, 1997). One of the observed effects of chlamydial 
effectors is the prevention of mitochondrial cytochrome c release into the host cytoplasm, 
which is normally induded by pro-apoptotic factors (Fan et al., 1998).  
5.2.6 Lysosomes 
Although Chlamydiaceae modify the inclusion membrane to prevent fusion with the 
endolysosomal pathway, lysosomes reside in close approximation to the inclusion membrane. 
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Ouellette et al. (2011) suggested that the lysosomes might be a source of essential amino 
acids early in the developmental cycle of C. trachomatis, while free amino acids are used later 
in the cycle. However, C. pneumoniae requires lysosomal degradation products throughout 
the developmental cycle (Ouellette et al., 2011).  
5.3 EB and RB membranes 
The functions of the two predominant morphological forms, EBs and RBs, differ significantly 
(paragraph 3). So it is not surprising that the lipid and protein composition of their membranes 
differ significantly and knowledge regarding their membrane compositions will give insight in 
their different functions (Stephens and Lammel, 2001). In what follows, a detailed description 
of the proteins and lipids present in membranes of both EB and RB will be discussed. If a 
protein or lipid is specific for one developmental form, it will be mentioned in the text.  
Like all Gram-negative bacteria, Chlamydiaceae are surrounded by an outer membrane (OM) 
and a cytoplasmatic inner membrane (IM) (Tamura et al., 1971), which is separated by a 
periplasmatic space (Figure 1.4).The inner and outer membrane differ morphologically and 
chemically (Glauert and Thornley, 1969). Both membranes contain phospolipids and proteins 
and the outer membrane contains on top of that also lipopolysaccharides (LPS) (Filip et al., 
1973). The phospholipids present in the inner and outer membrane of EBs and RBs is a 
mixture of lipids typically found in prokaryotes (phosphatidylethanolamine [PE], 
phosphatidylglycerol [PG] and phosphatidylserine [PS] and eukaryotes (PC, PI, 
sphingomyelin and cholesterol) (Wylie et al., 1997). C. trachomatis can synthesize the PE, 
PG and PS de novo and the eukaryotic lipids are acquired from the host cell (Wylie et al., 
1997). The host-derived straight-chain unsaturated fatty acids are replaced by chlamydial 
branched-chain fatty acids (Wylie et al., 1997). Hatch and Mcclarty (1998) suggested that 
chlamydiae do not regulate the types of phospholipids trafficked and Wylie et al. (1997) 
showed that the host phospholipid synthesis did not alter following an infection with 
chlamydiae. Another remarkable observation by Wylie et al. (1997) is that C. trachomatis 
does not require de novo host phospholipids synthesis nor exogenous phospholipids to 
replicate. However, as mentioned in paragraph 5.2.2, sphingomyelin is essential for 
chlamydial replication. The ratio of PC to PE differs in EBs and RBs and the number of 
branched-chained phospholipids is lower in RBs. In general, EBs have a higher phospholipid 
content and membrane fluidity is greater in RBs (Manire and Tamura, 1967; Raulston, 1995). 
Chlamydial LPS is composed of a pentasaccharide containing a lipid A core and it contains 
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multiple cross-reacting epitopes with LPS of enterobacterial Re mutants (Ingalls et al., 1995; 
Vanrompay et al., 1995a). However, chlamydial LPS contains also a genus-specific epitope, 
which is composed of a 3-deoxy-D-mannose-oct-2 ulopyranosonic acids (Kdo) trisaccharide 
with the sequence αKdo-(2-8)- αKdo-(2-4)-αKdo (Caldwell and Hitchcock, 1984; Brade et al., 
1987; Vanrompay et al., 1995a). Chlamydial LPS is immunogenic, however, it is at least 10 
times less immunogenic than typical endobacterial LPS, such as Salmonella and Neisseria (Birkelund et al., 1989; Ingalls et al., 1995; Heine et al., 2003). The strength of the Gram-
negative cell wall is usually provided by peptidoglycan in the periplasmic space, which is 
critical for cell division, maintaining cell shape and hydrostatic pressure (Egan and Vollmer, 
2013). However, presence of peptidoglycan in the chlamydial cell envelope was a matter of 
debate for a long time. Although the chlamydial genomes encode the genes for peptidoglycan 
biosynthesis (Hesse et al., 2003; McCoy et al., 2003; McCoy and Maurelli, 2005; McCoy et 
al., 2006; Patin et al., 2009; Patin et al., 2012) and chlamydial growth is affected by 
antibiotics targetting peptidoglycan biosynthesis (Moulder et al., 1963; Tamura and Manire, 
1968), attempts to detect peptidoglycan were unsuccessful. The latter was called ‘the 
chlamydial anomaly’ (Moulder, 1993). However, Liechti et al. (2014) were able to detect 
chlamydial peptidoglycan by the use of a new labeling approach, which uses D-amino acid 
dipeptide probes and click chemistry. So the rigidity of the chlamydial cell wall is mediated 
both by highly cross-linked proteins and peptidoglycan. 
 
Figure 1.4: Model of the envelope of chlamydial EBs. In the outer membrane, MOMP, 
Omp3 and Pmps are shown. Omp 2 is the major constituent of the periplasmic space. 
Peptidoglycan is also a component of the periplasmic space. Specific proteins of the inner 
membrane are not yet identified. Adapted from Hatch (1996). 
Outer
membrane
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5.3.1 Chlamydial outer membrane complex 
The location of proteins in the inner or outer membrane in Gram-negative bacteria was 
previously determined by separation of those membranes on density gradients (Ito et al., 
1977). However, that method and variations of that method were for unknown reasons not 
succesfully applied to chlamydiae (Hatch, unpublished data). Therefore, an alternative method 
has been used to characterize the location of proteins in the chlamydial cell envelope. That 
method is based on the principle that hydrophobic outer membrane proteins can be separated 
from many soluble EB proteins by the use of mild detergents, such as Triton X-114 (Everett 
and Hatch, 1995; Bini et al., 1996; Nally et al., 2007; Aistleitner et al., 2014), Sarkosyl 
(Caldwell et al., 1981; Bavoil et al., 1984; Bini et al., 1996; Liu et al., 2010; Aistleitner et al., 
2014) and octylglucoside (Bavoil et al., 1984; Kawa and Stephens, 2002; Yeung et al., 2008). 
The Sarkosyl-insoluble fraction isolated from purified EBs was called the chlamydial outer 
membrane complex (COMC) by Caldwell et al. (1981). This protein complex consists 
predominantly of MOMP, two cysteine rich proteins (CRP), which both have been given 
different names EnvA/OmcA/small CRP/Omp3 and EnvB/OmcB/large CRP/Omp2, and some 
Pmps (Figure 1.4) (Hatch et al., 1984; Stephens et al., 1987; Sardinia et al., 1988; Liu et al., 
2010). Other proteins present in the COMC are PorB, Omp85, YscC, CTL0887, CTL0541, 
CTL0645, OprB and Pal (Liu et al., 2010).  
5.3.1.1 Major outer membrane protein 
Caldwell et al. (1981) identified a 39 500-dalton outer membrane protein in the Sarkosyl-
insoluble fraction of purified C. trachomatis EBs. The insolubility is due to the extensive 
disulphide cross-linking (Caldwell et al., 1981; Newhall and Jones, 1983; Hatch et al., 1986). 
The protein was called MOMP and it accounts for 60% of total envelope proteins in both EBs 
and RBs (Caldwell et al., 1981; Bavoil et al., 1984). MOMP is cross-linked to itself in the 
chlamydial EB and is therefore essential for the structure and morphology of the chlamydial 
EB (Caldwell et al., 1981; Newhall and Jones, 1983), it functions as a porin which is only 
active in the chlamydial RB (Bavoil et al., 1984) and has a potential function as adhesin (Su et 
al., 1990; Su and Caldwell, 1991). The protein consists of five conserved (CS1-CS5) and four 
variable sequence (VS1-VS4) regions, which are exposed in the periplasmic and extracellular 
space, respectively (Figure 1.5) (Baehr et al., 1988; Kim and DeMars, 2001). MOMP plays an 
important role in eliciting an immune response. Monoclonal as well as polyclonal antibodies 
against MOMP, C. pneumoniae MOMP is an exception as it is not immunodominant probably 
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because it is not surface exposed (Campbell et al., 1990), are able to neutralize the infectivity 
of Chlamydiacea in vitro and in vivo (Caldwell and Perry, 1982; Zhang, Watkins, et al., 1987; 
Zhang et al., 1989). MOMP contains genus-, species- and serovar-specific epitopes (Caldwell 
et al., 1981). Protective epitopes locate in VS1 and VS2 (Baehr et al., 1988), serovar specific 
epitopes are also present in those domains and in VS4, while genus- and species specific-
epitopes are located in the CSs and some species-specific epitopes are found in the most 
conserved regions of VS4 (Baehr et al., 1988; Yuan et al., 1989; Batteiger, 1996). The surface 
exposure (Baehr et al., 1988; Collett et al., 1989; Wang et al., 2006), high immunogenicity 
(Caldwell et al., 1981), and the observation that MOMP elicits both neutralizing antibodies 
and T-cell responses (Su and Caldwell, 1992) prompted the suggestion that MOMP would be 
an ideal vaccine candidate (Stephens et al., 1987; Baehr et al., 1988). However, experimental 
vaccines based on native MOMP (Pal et al., 2005; Kari et al., 2009), purified recombinant 
MOMP (Tuffrey et al., 1992; Shaw et al., 2002), synthetic peptides corresponding to B- and 
T-cell epitopes (Su et al., 1995) or DNA based immunogens (Pal et al., 1999) have not 
achieved complete nor consistent protection in none of the various animal models (Shaw et al., 
2002). Therefore, further research for more efficacious vaccine candidates is necessary 
(Vasilevsky et al., 2016). 
 
Figure 1.5: Schematic representation of MOMP in the outer membrane of the 
chlamydial cell wall. Full lines represent the conserved regions (CS1-CS5) and alternating 
lines represent the variable domains (VS1-VS4). Adapted from Baehr et al. (1988) and Kim 
and DeMars (2001). 
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5.3.1.2 OmcA and OmcB 
OmcA and OmcB, which have previously also been called EnvA/small CRP/Omp3 and 
EnvB/large CRP/Omp2 respectively, are two other, besides MOMP, abundant proteins 
present in the COMC (Liu et al., 2010). The genes encoding these two proteins are tandemly 
arranged in a bicistronic operon, that is only transcribed late in the infectious cycle (Lambden 
et al., 1990), while MOMP is located separately and the transcription starts earlier (Raulston, 
1995). Both proteins are cysteine-rich and are only present in chlamydial EBs and in RBs 
when they start to asynchronously differentiate to EBs (around 21-24 hpi) (Hatch et al., 1984). 
The cysteine-rich proteins form disulfide-cross-linked complexes, which are responsible for 
membrane rigidity. Whether or not the MOMP is linked by disulfide bridges to the cysteine-
rich proteins is unknown (Raulston, 1995; Hatch, 1996). The mechanism for crosslinking is 
also currently unknown. Reduction occurs very rapidly, probably simultaneously with 
internalization, and it requires chlamydial protein synthesis (Hatch et al., 1986). In addition, 
Hatch et al. (1986) observed that MOMP and the two CRPs were intracellularly 
predominantly observed in the reduced state and the proteins were spontaneously cross-linked 
after host cell lysis. However, Newhall (1987) observed that cross-linking occured late in the 
developmental cycle, but before cell lysis and therefore it was suggested disulfide bond 
formation is enzym-mediated. Membrane-associated and periplasmic protein disulfide 
isomerases, which are also present in other Gram-negative bacteria (Bardwell, 1994), might 
be involved in the cross-linking process. OmcB is a possible candidate for this function, as it 
has a potential sulfydryl-oxidoreductase active site (Hatch, 1996). Similar to MOMP, both 
proteins possess genus- and species-specific epitopes, in addition only OmcA has serovar-
specific epitopes, but none of the epitopes were accessible to antibodies on the native 
chlamydial cell surface (Batteiger et al., 1985; Zhang, Watkins, et al., 1987; Watson et al., 
1994).  
OmcA has a molecular mass of 12-15 kDa, is a  highly conserved hydrophilic lipoprotein, 
which is anchored in the outer membrane by its lipid moiety and the proteinaceous portion 
faces the periplasmic space (Figure 1.4) (Allen et al., 1990; Everett et al., 1994; Raulston, 
1995; Hatch, 1996). OmcA of C. psittaci 6BC contains 14 cysteine residues, which is 17% of 
the total amino acid content (Everett et al., 1994). 
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OmcB has a molecular mass of 57-62 kDa and it is a major immunogen in chlamydial 
infections (Mygind et al., 1998b; Sanchez-Campillo et al., 1999). The protein is highly 
conserved among Chlamydia species, with a highly variable N-terminal region (Newhall, 
1987; Allen et al., 1990; Watson et al., 1991), is involved in the conversion of the chlamydial 
RB to EB (Mygind et al., 1998a) and it is believed to be a key structural component to 
maintain cell-wall rigidity and osmotic stability via disulfide bonding of outer membrane 
proteins (Newhall, 1987; Allen and Stephens, 1989). The protein migrates as a singlet in the C. 
trachomatis trachoma biovar and as a doublet in C. psittaci, C. caviae GPIC and the C. 
trachomatis lymphogranuloma venereum (LGV) biovar by SDS-PAGE, which is due to post-
translational signal peptide cleavage sites in its amino-terminal region (Batteiger et al., 1985; 
Hatch et al., 1986; Allen and Stephens, 1989; Raulston, 1995; Ting et al., 1995). The mature 
form of the larger pair of OmcB of C. psittaci 6BC has 37 cysteine residues, which is 7.2% of 
the total amino acid content (Hatch, 1996), and has a net positive charge, which is in contrast 
to most chlamydial proteins that are neutral or acidic (Batteiger et al., 1985; Allen and 
Stephens, 1989). Although both members of the doublet were basic in the LGV biovar, the 
protein has a neutral charge in the trachoma biovar (Batteiger et al., 1985). There has been a 
controversy regarding the OmcB localization. The OmcB protein of C. psittaci is hydrophilic, 
not embedded in a lipid bilayer and susceptible to digestion with trypsin after incubation in 
Tris–EDTA, which all together suggest a periplasmic localization of the protein in C. psittaci 
(Everett and Hatch, 1995). However, Ting et al. (1995) observed that the larger of the CRP 
doublet proteins of C. caviae GPIC was degraded by trypsin, without incubation in Tris-
EDTA, to peptides of approximately the same size as the short doublet of the protein. They 
therefore suggested that at least the N-terminal portion of the larger doublet protein is surface 
exposed and they observed that the protein plays a role in adhesion of C. caviae to host cells. 
Stephens et al. (2001) confirmed that OmcB of C. trachomatis LGV is surface exposed and 
accessible to antibodies and identified a heparin-binding motif in the N-terminal region of 
OmcB in both C. trachomatis LGV and trachoma (serovar B) biovars and in C. pneumoniae 
and C. psittaci. Synthetic peptides of this regions in the different Chlamydia species and 
strains bound to heparin (Stephens et al., 2001). However, the OmcB of C. trachomatis LGV 
was shown to function as an heparin-dependent adhesin which can be neutralized by anti-
OmcB antibodies (Fadel and Eley, 2007), while C. trachomatis serovar E (trachoma biovar) 
was shown not to be dependent on heparin for adhesion (Fadel and Eley, 2008). Further 
research is needed to elucidate whether the heparin-binding motifs identified by Stephens et al. 
(2001) are surface exposed and functional in different C. trachomatis serovars and to decide 
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whether differences in OmcB binding properties might be related to the different invasiveness 
observed for those biovars (Allen et al., 1990). Moelleken and Hegemann (2008) confirmed 
that OmcB is a heparin-dependent adhesin in C. pneumoniae. No research has been done on 
adhesion capacities of C. psittaci OmcB.  
5.3.1.3 Polymorphic membrane proteins 
Whole-genome sequencing has revealed the polymorphic membrane protein (Pmp) gene 
family. This is the largest protein family of Chlamydia species and it is a unique feature of the 
genus (Horn et al., 2004; Vandahl et al., 2004). The Pmp proteins were first identified in C. 
abortus through their immunogenicity (Longbottom et al., 1996; Longbottom et al., 1998b) 
and later it was noticed that the family is present in all currently sequenced chlamydial 
genomes (Read et al., 2000; Read, 2003; Thomson et al., 2005; Azuma et al., 2006; Voigt et 
al., 2012). The Pmps have been identified as autotransporter (type V secretion system) 
proteins, based on their cleavable N-terminal signal sequence (type II secretion) for 
translocation across the inner membrane, a central passenger domain which is responsible for 
the protein’s function and a C-terminal transporter domain that forms a β-barrel and with a 
phenylalanine at the end, which is suggestive for outer membrane localization, for 
translocation across the outer membrane (Struyve et al., 1991; Henderson and Lam, 2001; 
Dautin and Bernstein, 2007). Experimental evidence for several Pmps confirmed this in silico 
prediction (Longbottom et al., 1998a; Vandahl et al., 2002; Wehrl et al., 2004; Kiselev et al., 
2007; Liu et al., 2010). Most autotransported proteins contribute to the virulence of many 
Gram-negative pathogens (Henderson et al., 2004; Dautin and Bernstein, 2007; Tseng et al., 
2009). Adhesins (e.g. AIDA-I and Ag43 of Escherichia coli, Hia of Haemophilus influenzae), 
toxins (e.g. VacA of Helicobacter pylori) and proteases (e.g. IgA protease of Neisseria 
gonorrheae) are some functions of the autotransported proteins (Henderson et al., 2001; 
Tseng et al., 2009). The autotransported Pmp proteins account for 3.15% and 5.1% of the 
total coding capacity of C. trachomatis and C. pneumoniae, respectively (Grimwood and 
Stephens, 1999). This is a relatively high proportion of the highly reduced genome and 
therefore it is suggested that the Pmps might play an important function in chlamydial biology.  
The size and amino acid sequences of the Pmp proteins are highly variable, but grouping of 
those proteins in one family is based on the conserved motifs FxxN and GGA (with I, L or V 
in the 4th position). The C. trachomatis and C. muridarum genomes encode nine pmp genes, 
named pmpA to pmpI (Stephens, 1998; Read et al., 2000). They have been divided in six 
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phylogenetically related subtypes (PmpA, B/C, D, E/F, G/I and H), which may be able to 
substitute structurally and functionally for one another (Grimwood and Stephens, 1999). The 
number of pmp genes is variable, ranging from 9 to 16 full length genes in the Chlamydia 
reference strains C. abortus S26/3 (Thomson et al., 2005), C. avium 10DC88 (Sachse et al., 
2014), C. caviae GPIC (Read, 2003), C. felis FE/C-56 (Azuma et al., 2006), C. gallinacea 08-
1274/3 (Sachse et al., 2014), C. muridarum Nigg (Read et al., 2000), C. pecorum DBDeUG 
(Bachmann et al., 2014), C. pneumoniae CWL029 (Kalman et al., 1999), C. psittaci ATCC 
VR-125/6BC (Voigt et al., 2011) and C. trachomatis D/UW-3/Cx (Stephens, 1998) (Figure 
1.6). In addition, truncated and frame shifted pmp genes have also been observed in several 
chlamydia genomes.  
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Figure 1.6: Schematic overview of putative Pmp proteins in Chlamydia reference strains. 
FxxN motifs (yellow), GGA (I,L,V) motifs (blue), central PMP_M region (green) and 
autotransporter domain (red) are shown. The passenger domain is located in between the N-
terminal secretion signal (not shown, it is predicted to comprise around 20 amino acids at the 
N-terminus) and the C-terminal autotransporter domain. The passenger domain is transported 
across the outer membrane through the autotransporter domain. Frame shifted pmp genes are 
not shown. For each Chlamydia species it should be tested experimentally whether the 
truncated, putative proteins are produced and functional (Vasilevsky et al., 2016).  
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Figure 1.6: continued 
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Figure 1.6: continued 
Different functions are proposed for members of the Pmp family. The first suggested function 
was that of adhesin, as the conserved motifs GGA (I,L,V) and FxxN were also found in 
adhesins of Anaplasma phagocytophilum (Girard and Mourez, 2006). Mölleken et al. (2010) 
showed that yeast cells, which expressed Pmp6, Pmp20 and Pmp21 (orthologs of PmpG, 
PmpB and PmpD of C. trachomatis, respectively) on their surface, and beads coated with 
recombinant proteins of these three Pmp proteins adhere to human epithelial cells. The 
observation that pre-incubation of epithelial cells with these three proteins reduced the 
binding significantly, confirmed the adhesive capacities of Pmp6, Pmp20 and Pmp21 of C. 
pneumoniae. Mölleken et al. (2010) analyzed Pmp21 in more detail and noticed that at least 
two motifs (FxxN + GGA I/L/V or FxxN + FxxN) are required for adhesion and anti-Pmp21 
antibodies can neutralize a C. pneumoniae infection in vitro. This neutralizing activity of anti-
Pmp21 antibodies was previously also observed by Wehrl et al. (2004). Moreover, the 
epidermal growth factor receptor has been identified as the receptor for Pmp21 (Mölleken et 
al., 2013). Crane et al. (2006) observed that C. trachomatis PmpD is surface localized and 
that anti-PmpD antibodies neutralize C. trachomatis, but not C. pneumoniae, C. muridarum 
and C. caviae infections, indicating that PmpD is a species-specific antigen. In addition, they 
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noticed that preexisting anti-MOMP and anti-LPS antibodies blocked significantly the 
neutralizing activity of anti-PmpD serum in vitro. MOMP and LPS are highly abundant and 
immunodominant antigens on the EB surface (Su et al., 1990) and therefore they suggested 
that MOMP and LPS might act as decoys for the immune system, as binding of neutralizing 
antibodies to both structures blocks the binding of neutralizing anti-PmpD antibodies (Crane 
et al., 2006). However, anti-MOMP and anti-LPS antibodies do not block anti-PmpD 
neutralization in vitro when anti-PmpD antibodies were preexisting. It is therefore suggested 
that a vaccine that generates PmpD neutralizing antibodies might be effective (Crane et al., 
2006). Recently, Becker and Hegemann (2014) showed that all Pmps of C. trachomatis, 
although in a varying degree, mediate adhesion to human epithelial and endothelial cells. In 
addition, all nine recombinant Pmp proteins can neutralize C. trachomatis infections, which 
suggests that all of the Pmp adhesins are important in the infection process. It was also 
observed that the Pmp proteins inhibit chlamydial infections in a species-specific manner, as 
incubation of human epithelial and endothelial cells with C. trachomatis Pmp proteins was 
not effective to block a subsequent C. pneumoniae infection and vice versa. The latter 
experiment and the different levels of adhesion of Pmp proteins to different cell types 
confirmed the previously suggested hypothesis that Pmp proteins are involved in host and 
tissue tropism (Becker and Hegemann, 2014). All nine Pmp proteins of C. trachomatis have 
been shown to be surface localized (Tan et al., 2010). A different surface localization of 
PmpD on EBs and RBs of C. trachomatis has been observed by different research groups. 
Crane et al. (2006) and Swanson et al. (2009) observed PmpD on EBs, while Kiselev et al. 
(2007, 2009) observed PmpD on RBs but not on EBs. This difference may be attributed to 
different epitopes that may be recognized by the different anti-sera (Crane et al., 2006). 
Pmp21 (ortholog of PmpD of C. trachomatis) was also observed to be surface localized on C. 
pneumoniae EBs and RBs (Vandahl et al., 2002; Wehrl et al., 2004; Mölleken et al., 2010). In 
addition, Pmp6, Pmp8, Pmp10, Pmp11 (all orthologs of PmpG of C. trachomatis) were also 
observed at the surface of C. pneumoniae EBs (Knudsen et al., 1999; Vandahl et al., 2002). 
Other Pmp proteins might also be present at the surface, but the epitopes recognized by their 
antibodies were either unable to be detected, which might be due to destruction of those 
epitopes by the fixation method used or it might be due to the inaccessibility of the epitopes 
(Vandahl et al., 2002). The 90kDa Pmps (orthologs of pmpG of C. trachomatis) were 
observed at the surface of both C. abortus RBs and EBs (Longbottom et al., 1998a). At least 
some Pmp proteins are surface localized antigens on EBs and have been shown to neutralize 
infectivity in vitro. However, vaccine candidates should also be highly immunogenic in vivo. 
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Longbottom et al. (1998b) observed that the 90kDa Pmps of C. abortus were highly 
immunogenic components of COMC, although they are only minor components of COMC. 
In addition, Knudsen et al. (1999) observed that conformational epitopes of C. pneumoniae 
Pmp10 (PmpG ortholog of C. trachomatis) were dominant antigens in experimentally infected 
mice and Bunk et al. (2008) found that Pmp6 (also a PmpG orthologs of C. trachomatis) is 
immunodominant. Up to now, only sera from patients infected with C. trachomatis have been 
tested for their immunogenicity against a panel of recombinant Pmp proteins. Tan et al. (2009) 
observed that patients infected with C. trachomatis elicited high titer antibodies against a 
subset of Pmp proteins, that varies between infected individuals. It is suggested that the 
variable antibody profiles may reflect the variation in transcription and protein production 
profiles along the developmental cycle (Grimwood and Olinger, 2001; Vandahl et al., 2002; 
Tan et al., 2009; Wheelhouse et al., 2009; Carrasco et al., 2011; Wheelhouse et al., 2012b), 
which suggests that the Pmp may be involved in antigenic variation and contribute to 
immune evasion in the infected host (Carrasco et al., 2011; Tan et al., 2009). Other, minor 
investigated potential functions of the Pmp proteins are: induction of apoptosis in 
neighbouring uninfected cells and suppression of T-cells  (Swanson et al., 2009). The Pmps 
have also been shown to be involved in the induction of cytokine production (Niessner et al., 
2003) in infected cells and in pelvic inflammatory disease and infertility (Taylor et al., 2011).  
Previous studies have mainly focused on the Pmp proteins of C. trachomatis (Belland et al., 
2003b; Crane et al., 2006; Kiselev et al., 2007; Tan et al., 2009; Kiselev et al., 2009; 
Swanson et al., 2009; Tan et al., 2010; Carrasco et al., 2011; Saka et al., 2011; Humphrys et 
al., 2013; Becker and Hegemann, 2014) and C. pneumoniae (Knudsen et al., 1999; Vandahl et 
al., 2002; Wehrl et al., 2004; Mölleken et al., 2010; Mölleken et al., 2013), both human 
pathogens, and on the zoonotic C. abortus (Longbottom et al., 1998a,b; Wheelhouse et al., 
2009; Wheelhouse et al., 2012a,b; Forsbach-Birk et al., 2013). Up to now, the Pmp proteins 
of C. psittaci have not been molecularly analyzed. C. psittaci infects pet birds and poultry and 
infections lead to financial losses, particularly in duck, turkey (Vanrompay et al., 1997) and 
more recently also chicken production (Dickx et al., 2010), as they cause mortality, reduced 
feed conversion, reduced egg production, high expenses for antibiotic treatment and carcass 
condemnation at slaughter (Vanrompay et al., 1997). In addition, C. psittaci is the most 
common zoonotic animal chlamydiosis, which can cause a life-threatening pneumonia 
(Vanrompay et al., 1997; Longbottom and Livingstone, 2006; Grinblat-Huse et al., 2011). A 
thorough molecular characterization of the Pmp proteins of C. psittaci is an essential step to 
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further unravel the host-pathogen interaction. Generated knowledge might indicate whether 
one or more members of this family might be potential vaccine candidates for C. psittaci or 
not. 
5.3.1.4 PorB 
PorB, also called OmpB, is a protein of 38 kDa that was not readily detected by biochemical 
methods, as it has approximately the same molecular weight as well as the same isoelectric 
point as the abundant MOMP (Kubo and Stephens, 2000). The protein is, although in lower 
amounts than MOMP, present in the COMC of EBs and is surface accessible by PorB-specific 
antisera (Sanchez-campillo et al., 1999; Kubo and Stephens, 2000; Kubo and Stephens, 2001; 
Kawa and Stephens, 2002). Anti-PorB antibodies neutralized C. trachomatis infectivity in 
vitro (Kawa and Stephens, 2002). The sequence of PorB is highly conserved among 
Chlamydia species (Kubo and Stephens, 2000; Kawa and Stephens, 2002). It has been 
suggested that PorB is a substrate-specific porin, which is responsible for the diffusion of 
some specific metabolites like dicarboxylic acids such as 2-oxoglytarate to complete the 
tricarboxylic adic cycle and as such to provide carbon and energy production intermediates to 
chlamydiae (Iliffe-Lee and McClarty, 1999; Kubo and Stephens, 2001). This is in contract to 
MOMP, that functions as a general porin and permits the diffusion of a wide variety of 
compounds, such as polysaccharides and amino acids (Kubo and Stephens, 2001). 
5.3.1.5 Omp85 
Omp85 is an outer membrane protein that is conserved in Gram-negative bacteria and 
organelles of bacterial origin, such as mitochondria (Gentle et al., 2005). Omp85 proteins 
have an N-terminal periplasmic domain and a C-terminal β-barrel domain, which is embedded 
in the outer membrane (Gentle et al., 2005). Omp85 is essential for the assembly of protein in 
the outer membrane (Voulhoux et al., 2003) and it might also be involved in lipid assembly in 
the outer membrane (Gentle et al., 2005). Chlamydial Omp85 has been shown to be part of 
the C. trachomatis COMC (Liu et al., 2010). Omp85 is surface-accessible and anti-Omp85 
antibodies neutralize chlamydial infectivity in vitro (Kubo and Stephens, unpublished data). 
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5.3.1.6 YscC 
YscC is the only T3S system protein that is clearly localized in the outer membrane. For C. 
trachomatis YstC has been shown to be membrane localized (Fields et al., 2003) and to be 
part of the COMC (Liu et al., 2010).  
5.3.1.7 OprB 
OprB is a porin with a carbohydrate-selective porin motif in its C-terminal part. The protein is 
well conserved in Chlamydia species. Anti-OprB antibodies reacted with ring-shaped 
structures, similar to anti-MOMP stainings, which indicated that the protein is located in a 
membrane. More specifically, OprB is part of the C. trachomatis COMC (Birkelund et al., 
2009; Liu et al., 2010). It is currently unknown whether OprB is surface localized (Birkelund 
et al., 2009).  
5.3.1.8 Pal 
Peptidoglycan-associated lipoprotein (Pal) is an outer membrane lipoprotein (Parsons et al., 
2006), which is a component of the C. trachomatis outer membrane complex (Liu et al., 
2010). Orthologs of Pal anchor the outer membrane to peptidoglycan (Parsons et al., 2006) 
and are part of the Tol complex, which connects the inner and outer membranes in other 
Gram-negative bacteria. Pal is essential for the survival and pathogenesis of certain Gram-
negative bacteria (Godlewska et al., 2009). 
5.3.2 Heat shock proteins 
Three chamydial heat shock proteins (Hsp) have been identified: Hsp10, Hsp60 and Hsp70, 
which are chlamydial homologues of Escherichia coli GroES, GroEL and DnaK (Danilition et 
al., 1990; Cerrone et al., 1991; LaVerda et al., 1999). Hsp are among the most abundant 
proteins in nature and are highly conserved among both eukaryotes and prokaryotes (Peeling 
and Mabey, 1999). Hsp are highly conserved chlamydial proteins (>95% amino-acid identity) 
and share approximately 50% homology with human Hsps (Peeling and Mabey, 1999). The 
proteins are constitutively expressed throughout the chlamydial developmental cycle and the 
expression is up-regulated during stress (Peeling and Mabey, 1999). Hsp are suggested to 
function as chaperones (Zugel and Kaufmann, 1999). Antibodies against Hsp10 and Hsp60 
have been shown to contribute to immunopathologic manifestations of the severe upper 
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genital tract complications of chlamydial disease in women (LaVerda et al., 1999). Hsp70 is 
associated with isolated COMC of C. trachomatis (Raulston et al., 2002). However, not all 
proteins associated with COMC are component of the COMC. Liu et al. (2010) elucidated 
which proteins are enriched in the COMC and in the sarkosyl-soluble phase compared to 
whole EB protein lysates. Hsp70 and Hsp60 are overrepresented in the sarkosyl-soluble 
fraction, which suggest that they are not components of the COMC (Liu et al., 2010). 
Raulston et al. (2002) showed that chlamydial Hsp70 is not surface exposed on purified EBs. 
The results of their experiments suggested that the structural integrity of the outer membrane 
of C. trachomatis EBs, which is maintained by protein disulfide bonds, is essential for 
attachment to the host epithelial cell, but after the first initial attachment, reduction of the 
disulfide-cross-linked outer membrane proteins leads to the exposure of the chlamydial Hsp70 
substrate-binding domain, which is suggested to be essential for chlamydial infectivity 
(Raulston et al., 2002). 
5.3.3 Nutrient transporters 
Saka et al. (2011) quantified the proteome of C. trachomatis EBs and RBs. Transporters, 
permeases and translocators account for 7% and 2.5% of the RB and EB proteome of C. 
trachomatis, respectively. Npt1 and Npt2, two integral membrane ATP/ADP antiporters, were 
more abundant in the RB . Npt1 mediates the import of host cell ATP, through the export of 
chlamydial ADP. Npt2 transports ATP, CTP, GTP and UTP in a proton-dependent manner 
(Stephens, 1998; Tjaden et al., 1999). Oligopeptide, amino acid and sugar transporters were 
also more abundant in the RB. Components of the ABC-type oligopeptides transport system, 
Na+-linked D-alanine glycine permease DagA_2 and the hexose phosphate transport protein 
UhpC were more prominent in the RB. YtgA, which is possibly involved in iron transport 
(Miller et al., 2009), was also enriched in the RB. It is suggested that the EB uses glucose to 
cope with the high demand for energy at the early stage of the infection, while the RB 
switches to ATP synthesis by generating an ion gradient through eukaryotic like vacuolar (V)-
type ATPases (Saka et al., 2011). Six predicted V-type ATPase subunits were enriched in the 
RB. These results suggest that the RB acquires energy both by ATP synthesis and ATP 
transport from the host. Saka et al. (2011) proposed that the ATP is used both by the 
replicating RB and loaded in the EBs, to fuel early processes such as protein secretion. The 
above mentioned results are consistent with the functions of RBs, as the actively replicating 
RB has a high demand for nutrients.  
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Virulence factors account for 5% and 14% of the RB and EB proteome, respectively. Two 
components of the basal aparatus of the T3S system, the C-ring component CdsQ and the 
ATPase CdsN were largely absent in the RB. The relative abscence of these components may 
either be substituted by additional factors or the RB may have a reduced T3S capacity. This 
might prevent that an excess of T3S effectors would be secreted, as such excess could harm 
the host cell, disrupt the development of the inclusion or provide substrates for antigen 
presentation by the host (Saka et al., 2011). 
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Study objectives 
The present study aims to fundamentally characterize the polymorphic membrane protein 
(Pmp) family of Chlamydia psittaci. C. psittaci is a Gram negative obligate intracellular 
pathogen of birds and an important zoonotic agent via inhalation of infected aerosols of 
pharyngeal or nasal secretions or dried feces (Dickx and Vanrompay, 2011).  
In the last decade, the Pmp proteins have been studied intensively, particularly because the C. 
trachomatis and C. pneumoniae Pmp families represent a relatively high proportion of the 
coding capacity (3.15 to 5.1%, respectively) in the highly reduced chlamydial genome. 
Moreover the occurrence of the pmp gene family in all currently sequenced chlamydial 
genomes (Grimwood and Stephens, 1999) suggests an important function in chlamydial 
biology. Previous studies have mainly focused on the Pmps of C. trachomatis (Belland et al., 
2003b; Crane et al., 2006; Kiselev et al., 2007; Tan et al., 2009; Kiselev et al., 2009; 
Swanson et al., 2009; Tan et al., 2010; Carrasco et al., 2011; Saka et al., 2011; Humphrys et 
al., 2013; Becker and Hegemann, 2014) and C. pneumoniae (Vandahl et al., 2002; Wehrl et 
al., 2004; Mölleken et al., 2010; Mölleken et al., 2013), both human pathogens, and on the 
zoonotic C. abortus (Longbottom et al., 1998a; Longbottom et al., 1998b; Wheelhouse et al., 
2009; Wheelhouse et al., 2012a; Wheelhouse et al., 2012b; Forsbach-Birk et al., 2013). 
However, the pmp gene family of C. psittaci has not been investigated so far.  
Whole genome-sequencing of Chlamydia spp. has revealed the Pmp family, which is the 
largest membrane protein family in Chlamydia spp. and it is a unique feature of the genus 
(Horn et al., 2004; Vandahl et al., 2004). Pmps are grouped into a family based on the 
conserved repetitive motifs FxxN and GGA (with I, L or V at the 4th position). In C. 
trachomatis, they have been further divided into six phylogenetically related subtypes (PmpA, 
B/C, D, E/F, G/I, and H) which may be able to substitute structurally and functionally for one 
another (Grimwood and Stephens, 1999). The passenger domain is responsible for the 
protein’s function (Henderson and Lam, 2001). Pmp6, Pmp20 and Pmp21 of C. pneumoniae 
(orthologs of PmpG, PmpB and PmpD of C. trachomatis, respectively) and all Pmp proteins 
of C. trachomatis are proposed to function as adhesins, based on adhesion assays and specific 
neutralization of the infection by incubation of the host cells with the recombinant Pmp 
proteins (Crane et al., 2006; Mölleken et al., 2010; Becker and Hegemann, 2014). Up to now, 
anti-PmpD and anti-Pmp21 antibodies are the only Pmp-specific antibodies that are tested for 
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their possible neutralizing capacity. Specific anti-PmpD and anti-Pmp21 antibodies can 
partially neutralize C. trachomatis and C. pneumoniae infection, respectively, in vitro (Wehrl 
et al., 2004; Crane et al., 2006; Mölleken et al., 2010).  
Patients infected with C. trachomatis usually elicit high titer antibodies against a subset of the 
Pmp proteins, that varies between infected individuals (Tan et al., 2009). The different 
antibody profiles in patients may reflect different transcription and protein production profiles 
along the developmental cycle or it may be a result of strain variation or site specificity 
(Grimwood and Olinger, 2001; Vandahl et al., 2002; Tan et al., 2009; Wheelhouse et al., 
2009; Carrasco et al., 2011; Wheelhouse et al., 2012b). An attractive hypothesis is that 
variation of pmp gene expression and the resulting antigenic variation phenotype contributes 
to immune evasion in the infected host. Finally, Pmp proteins were reported to be involved in 
host and tissue tropism (Becker and Hegemann, 2014).  
The first objective of this thesis was to determine the number, organization and size of pmp 
coding sequences (CDSs) in different C. trachomatis, C. pneumoniae, C. abortus and C. 
psittaci genomes. Therefore, the pmp CDSs were annotated by a Hidden Markov Model and 
all CDSs were drawn to scale. Furthermore, conserved proteins are hypothesized to be 
indispensable for the pathogenesis of an organism. So the level of conservation of the Pmp 
proteins within and across the above-mentioned 4 Chlamydia species was determined.  
Quantitative real-time polymerase chain reaction (RT-qPCR) is a major tool to gain insight in 
the molecular pathogenesis of C. psittaci (Vandesompele et al., 2002). However, validated 
reference genes are needed to avoid biases in RT-qPCR. This normalization step is the most 
problematic and most neglected part in RT-qPCR. Up to now, stably expressed genes for 
normalization of RT-qPCR data in Chlamydia species have only been determined for C. 
trachomatis (Borges et al., 2010). Therefore, the second objective of this study was to 
validate reference genes for RT-qPCR in C. psittaci during the normal developmental cycle, 
during penicillin-induced persistence and for normal + penicillin conditions. Reference genes 
validated for normal + penicillin should be used to check whether a certain gene is up- or 
down-regulated during the persistent state compared to during normal development. The latter 
could help to further unravel the molecular mechanism of the persistent state and thus by 
preventing Chlamydia spp. to go into the persistent state, this would help to treat chlamydial 
infections.  
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Chlamydial infections can easily be resolved by treatment with antibiotics. However, C. suis 
acquired stable tetracycline resistance by horizontal gene transfer (Dugan et al., 2004; Dugan 
et al., 2007). Pigs are the natural host of C. suis, but C. abortus, C. pecorum and C. psittaci 
also occur in the pig (Schautteet and Vanrompay, 2011). Consequently, spreading of the 
tetracycline resistance gene is possible. As chlamydial infections are economically 
devastating (Everett, 2000; Harris et al., 2012; Forsbach-Birk et al., 2013; Kalmar et al., 
2015), the need for an effective vaccine is high. Vaccine development is not the aim of this 
thesis. However, as the Pmp proteins have been hypothesized to be vaccine candidates (Crane 
et al., 2006; Mölleken et al., 2010), a thorough analysis of these proteins in C. psittaci is a 
first fundamental step to unravel the host-pathogen interactions and generated knowledge can 
be applied for future vaccine research. As previous studies suggested a unique role in 
chlamydial pathogenesis for virulence genes expressed during stress (Carrasco et al., 2011), 
the third objective of this study was to determine the expression and production profile of the 
pmp CDSs and Pmp proteins during the normal developmental cycle and during penicillin-
induced persistence by RT-qPCR and immunofluorescence (IF) microscopy. In addition, as 
RT-qPCR determines the expression level in the population and IF in individual inclusions, 
immuno-electron microscopy (IEM) was used to assess the subcellular localization of the 
Pmps at late developmental times on individual chlamydiae.  
Vaccination of pregnant ewes by the C. abortus outer membrane complex conferred 
protective immunity (Tan et al., 1990). In addition, a multisubunit vaccine encompassing the 
major outer membrane protein and multiple Pmp proteins conferred better immunity than the 
single antigens (Yu et al., 2014). The Pmps present in the multisubunit vaccine are 
overrepresented in the C. trachomatis outer membrane complex (Liu et al., 2010). Overall, 
Pmp proteins present in the chlamydial outer membrane complex are suggested to be potential 
vaccine candidates. As the composition of the chlamydial outer membrane complex was 
previously only determined for C. trachomatis (Mygind et al., 2000; Birkelund et al., 2009; 
Liu et al., 2010), C. pneumoniae (Knudsen et al., 1999) and C. abortus (Tan et al., 1990; 
Cevenini et al., 1991; McCafferty et al., 1995; Longbottom et al., 1996), the fourth objective 
of this study was to determine which Pmp proteins are present in the C. psittaci outer 
membrane complex by IEM.  
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Abstract 
Variation is a central trait of the polymorphic membrane protein (Pmp) family. The number of 
pmp coding sequences differ between Chlamydia species, but it is unknown if the number of 
pmp coding sequences is constant within a Chlamydia species. The level of conservation of 
the Pmp proteins has previously only been determined for C. trachomatis. As different Pmp 
proteins might be indispensible for the pathogenesis of different Chlamydia species, this study 
investigated the conservation of the Pmp proteins both within and across C. trachomatis, C. 
pneumoniae, C. abortus and C. psittaci. The pmp coding sequences were annotated in 16 C. 
trachomatis, 6 C. pneumoniae, 2 C. abortus and 16 C. psittaci genomes by a Hidden Markov 
Model. The number and organization of polymorphic membrane coding sequences differed 
within and across the analyzed Chlamydia species. The length of coding sequences of pmpA, 
pmpB and pmpH was conserved among all analyzed genomes, while the length of the 
expanded subtypes pmpE/F and pmpG, and remarkably also of subtype pmpD differed among 
the analyzed genomes. PmpD, PmpA, PmpH and PmpA were the most conserved 
polymorphic membrane proteins in C. trachomatis, C. pneumoniae, C. abortus and C. psittaci, 
respectively. PmpB was the most conserved polymorphic membrane protein across the four 
analyzed Chlamydia species.  
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1. Introduction 
Members of the Chlamydiaceae are well known pathogens, causing a wide variety of 
infectious diseases in both animals and humans (Longbottom and Coulter, 2003). Chlamydia 
trachomatis and C. pneumoniae are the most prevalent species in humans. C. trachomatis is 
the leading cause of preventable blindness and sexually transmitted disease (Schachter and 
Dawson, 1990), while C. pneumoniae causes pneumonia, bronchitis, and sinusitis, with 
chronic infections contributing to atherosclerosis (Hanh et al., 2002; Belland et al., 2004). 
The most common chlamydial species infecting animals are C. psittaci (birds), C. abortus 
(sheep and goats), C. suis (pigs) and C. pecorum (mammals and marsupials). These infections 
can result in conjunctivitis, cardiovascular or systemic disease, abortion, infertility, enteritis, 
encephalitis, arthritis or respiratory disease (Everett, 2000). However, the molecular 
mechanisms behind this observed host tropism has not been unraveled. As variation is a 
central trait of the members of the polymorphic membrane protein (Pmp) family (Grimwood 
and Stephens, 1999), these proteins were hypothesized to play a role in host and tissue 
tropism, which is recently confirmed by Becker et al. (2014). Pmp variation is evidenced, for 
example, by a diversity in the number of Pmp coding sequences (CDSs); for example, the C. 
trachomatis genome encodes only 9 pmp CDSs, while the Pmp family is expanded in C. 
pneumoniae, C. abortus and C. psittaci. The expansion of the Pmp family can be specifically 
attributed to the expansion of the pmpE/F and pmpG subtypes. This raises the question 
whether the number of pmp CDSs varies only across species, or also within a species. 
Therefore, we re-examined the previously published number of pmp CDSs of C. trachomatis, 
C. pneumoniae, C. abortus and C. psittaci in 16, 6, 2, and 16 genomes, respectively, as those 
are the two main human Chlamydia pathogens and the two most devastating animal 
Chlamydia species with available genome sequences. More generally, conserved proteins are 
hypothesized to be indispensable for the pathogenesis of an organism. Consequently, if the 
Pmp proteins are important for host tropism, it can be hypothesized that different Pmp 
subtypes may be differentially conserved within different Chlamydia species. Until now, the 
level of conservation of the Pmp proteins had only been determined for C. trachomatis 
(Gomes et al., 2006; Carrasco et al., 2011). Adding to their possible role in adhesion to 
different host cells, we hypothesize that some Pmp subtypes may also have a redundant, 
essential function in different hosts. For this reason, in this study we have determined the 
level of conservation within and across four key Chlamydia species.  
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2. Materials and methods 
2.1 Chlamydia species and strains 
Genomes of 4 different Chlamydia species, namely C. trachomatis, C. pneumoniae, C. 
abortus and C. psittaci, were analyzed. Sixteen complete C. trachomatis genomes were 
selected. Strains belonging to the ocular serovar (A/HAR-13, A/363 and C/TW-3), urogenital 
serovar (D/13-96, E/150, E/11023, F/1-93, F/6-94, G/9301, G/9768 and J/31-98) and LGV 
biovar (L1/115, L2/25667R, L2c, L2b/8200/07 and 434/Bu) were included. All C. 
pneumoniae and C. abortus genomes available at the moment of analysis were included (B21, 
AR39, CWL029, J138, LPCoLN, TW-183 and LLG, S26/3 respectively). Sixteen C. psittaci 
genomes were selected, comprising all complete genome sequences that were available at the 
moment of analysis (01DC11, 02DC15, 08DC60, C19/98, 6BC, 84/55, CP3, GR9, M56, MN, 
NJ1, VS225, WC and WSRTE30), the previously well-characterized, prototypic C. psittaci 
strain Cal10 (Matsumoto, 1982; Hovis et al., 2013; Mojica et al., 2015) and the first 
sequenced C. psittaci genome, namely strain RD1 (Seth-Smith et al., 2011). 
2.2 Bioinformatics analyses 
A phylogenetic tree of the above-mentioned C. trachomatis, C. pneumoniae, C. abortus and C. 
psittaci genomes was constructed. Whole genome maximum likelihood trees were constructed 
as described in Sahl et al. (2011). Sequences were aligned with Mugsy v1r2.3 (Angiuoli and 
Salzberg, 2011) which generates blocks of conserved aligned sequence. Blocks were then 
joined together and converted to a concatenated multifasta alignment file with the bx-python 
toolkit (http://bitbucket.org/james_taylor/bx-python/wiki/Home). The alignment file was 
filtered using mothur filter.seqs (Schloss et al., 2009). A maximum likelihood based 
phylogenetic tree was inferred using RaxML (raxmlHPC-PTHREADS v8.2.5) (Stamatakis, 
2014), using the GTRGAMMA model, with 100 independent runs on distinct starting trees 
and rapid bootstrap analysis. 
We annotated the pmp CDSs in the above-mentioned genomes using a newly developed 
Hidden Markov Model (HMM) and an additional manual search of the NCBI database (Table 
2.1). The HMM was developed by individual clustal alignments, which were independently 
run on each pmp subfamily within the seed set, consisting of manually curated pmp genes 
from six sequenced C. psittaci genomes (6BC, RD1, 01DC11, 02DC15, 08DC60 and C19/98). 
The pmp coding and protein sequences differ within and across Chlamydia species              41 
Alignments were reviewed manually and it was determined that no trimming was necessary. 
The HMMER package (hmmbuild) was used to build a separate model for each pmp 
subfamily. All HMMs were validated using the HMMER package (hmmsearch) against a 
larger set of C. psittaci and C. caviae sequences. The protein sequences of each Pmp subtype 
were aligned with ClustalW2 and the percentage of conserved amino acids was calculated 
both within and across Chlamydia species. 
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Table 2.1: All C. trachomatis, C. pneumoniae, C. abortus and C. psittaci strains that were used for the comparative analysis of the pmp 
coding sequences.  
Species Strain Length (Mb) CDS (#) Protein (#) Pseudogene % GC Reference Accession number 
C. trachomatis L2c 1.04 949 900 5 41.3 (Somboonna et al., 2011) CP002024.1 
L2/25667R 1.04 948 899 4 41.3 (Harris et al., 2012) HE601954.1 
L2b/8200/07 1.04 949 899 5 41.3 (Harris et al., 2012) HE601795.1 
L1/115 1.04 947 895 7 41.3 (Harris et al., 2012) HE601952.1 
D/13-96 1.04 953 903 6 41.3 (Putman et al., 2013) CP006676.1 
J/31-98 1.04 955 908 3 41.3 (Putman et al., 2013) CP006680.1 
F/1-93 1.04 956 895 17 41.3 (Putman et al., 2013) CP006671.1 
F/6-94 1.04 955 905 6 41.3 (Putman et al., 2013) CP006673.1 
434/Bu 1.04 937 880 11 41.3 (Thomson et al., 2008) AM884176.1 
A/363 1.04 958 905 8 41.3 (Harris et al., 2012) HE601796.2 
A/HAR-13 1.04 958 905 8 41.3 (Harris et al., 2012) CP000051.1 
C/TW-3 1.04 957 897 16 41.3 (Borges et al., 2014) CP006945.1 
E/11023 1.04 953 902 7 41.3 (Jeffrey et al., 2010) CP001890.1 
E/150 1.04 955 904 7 41.3 (Jeffrey et al., 2010) CP001886.1 
G/9301 1.04 953 903 6 41.3 (Jeffrey et al., 2010) CP001930.1 
G/9768 1.04 953 903 6 41.3 (Jeffrey et al., 2010) CP001887.1 
C. pneumoniae B21 1.22 1219 1182 not mentioned 40.5 (Roulis et al., 2014) AZNB01000082.1 
AR39 1.23 1165 1110 not mentioned 40.6 (Read et al., 2000) AE002161.1 
CWL029 1.23 1091 1029 19 40.6 (Kalman et al., 1999) AE001363.1 
J138 1.23 1113 1060 11 40.6 
(Shirai, et al., 2000a; 
Shirai et al., 2000b) BA000008.3 
LPCoLN 1.24 1102 1006 54 40.5 (Myers et al., 2009) CP001713.1 
TW-183 1.23 1109 1059 8 40.6 (Geng, et al., 2002) AE009440.1 
C. abortus LLG 1.14 1001 936 23 39.9 (Sait et al., 2011) CM001168.1 
S26/3 1.14 1006 930 34 39.9 (Thomson et al., 2005) CR848038.1 
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C. psittaci 01DC11 1.17 1019 965 12 39.1 (Schöfl et al., 2011) CP002805.1 
02DC15 1.17 1021 972 7 39.1 (Schöfl et al., 2011) CP002806.1 
08DC60 1.17 1018 963 13 39.1 (Schöfl et al., 2011) CP002807.1 
6BC 1.17 1018 971 5 39.1 
(Grinblat-Huse et al., 
2011) CP002586.1 
C19/98 1.17 1016 968 6 39.0 (Schöfl et al., 2011) CP002804.1 
Cal10 1.18 1038 982 14 39.0 
(Grinblat-Huse et al., 
2011) AEZD00000000 
RD1 1.16 1001 943 16 39.1 (Seth-Smith et al., 2011) FQ482149.1 
84/55 1.17 1037 893 102 39.1 (Van Lent et al., 2012) CP003790.1 
CP3 1.17 1121 950 21 39.0 (Van Lent et al., 2012) CP003797.1 
GR9 1.15 1010 949 19 39.1 (Van Lent et al., 2012) CP003791.1 
M56 1.16 1008 946 20 38.8 (Van Lent et al., 2012) CP003795.1 
MN 1.17 1019 956 21 39.1 (Van Lent et al., 2012) CP003792.1 
NJ1 1.16 1015 955 18 39.0 (Van Lent et al., 2012) CP003798.1 
VS225 1.16 1025 898 85 39.0 (Van Lent et al., 2012) CP003793.1 
WC 1.17 1026 963 21 39.1 (Van Lent et al., 2012) CP003796.1 
WSRTE30 1.14 1008 934 32 39.0 (Van Lent et al., 2012) CP003794.1 
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3. Results 
3.1 The number, organization and size of pmp coding sequences (CDSs) in the genome 
varied within and across Chlamydia species 
A phylogenetic tree of all analyzed genomes was constructed (Figure 2.1). The number of 
pmp CDSs encoded in the genome varied within Chlamydia species, ranging from 17 to 28 
(including both full length and truncated genes) for C. pneumoniae, from 12 to 14 for C. 
abortus, and from 11 to 21 in C. psittaci (Figure 2.2 and Tables 2.2 and 2.3). All C. 
trachomatis genomes encoded 9 pmp CDSs, except strain F/1-93 which had 8 full length and 
1 truncated pmpE/F CDS. The number of pmpE/F CDSs ranged from 2 to 6 (including both 
full length and truncated CDSs) in C. pneumoniae, from 2 to 3 in C. abortus and from 1 to 2 
in C. psittaci genomes and the number of pmpG CDSs ranged from 9 to 18 for C. pneumoniae, 
from 6 to 7 for C. abortus, and from 5 to 15 for C. psittaci. The above-mentioned ranges 
included full length and truncated pmp CDSs. Frame shifted CDSs were only observed for 
pmpE/F CDSs, pmpG CDSs and exceptionally for pmpB CDSs in C. pneumoniae B21 draft 
genome.
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Figure 2.1: A phylogenetic tree of all analyzed C. trachomatis, C. pneumoniae, C. abortus 
and C. psittaci genomes. The genomes clustered by Chlamydia species. For C. trachomatis, 
the LGV serovars clustered together and the urogenital and ocular serovars clustered together. 
Bootstrap values are added on each branch. All branches have high bootstrap values (> 75) 
except for some C. psittaci strains (01DC11, C19/98, RD1, 84/55, Cal10 and 02DC15).  
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Figure 2.2: Genome organization of pmp CDSs in C. trachomatis, C. pneumoniae, C. abortus and 
C. psittaci. All pmp CDSs and inter-CDS regions encoded in (A) C. trachomatis, C. pneumoniae and 
C. abortus genomes, (B) in C. psittaci reference strains and (C) in C. psittaci strains are drawn to scale. 
A break (//) is added if the inter-CDS region is bigger than 5000 bp. Both full length and truncated 
CDSs are shown for all genomes, except for C. pneumoniae B21 for which only full length CDS are 
drawn, as only contigs instead of a complete genome sequence are available and the positions of the 
pmp CDSs are incorrect. If pmp CDSs were overlapping, then an additional line was added for that 
genome. 
(A) 
(B) 
(C) 
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Table 2.2: The amount of full length, truncated and frame shifted pmp CDSs in C. 
trachomatis, C. pneumoniae, C. abortus and C. psittaci genomes. 
Species Strain 
Full length pmp 
CDSs 
Truncated pmp 
CDSs 
Frame shifted pmp 
CDSs 
C. trachomatis 
 
A/HAR-13 9 / / 
  F/1-93 8 1 / 
C. pneumoniae B21 10 7 / 
AR39 16 1 4 
CWL029 16 1 8 
J138 15 6 7 
LPCoLN 18 / 1 
  TW-183 17 11 / 
C. abortus LLG 10 2 / 
  S26/3 14 / 3 
C. psittaci 84/55 12 7 / 
CP3 13 1 / 
GR9 14 4 / 
M56 13 2 / 
MN 17 3 / 
NJ1 16 / / 
VS225 13 1 / 
WC 17 4 / 
WSRTE30 14 1 / 
01DC11 16 / 2 
02DC15 16 / 3 
08DC60 14 / 3 
6BC 16 / 2 
C19/98 15 / 3 
Cal10 15 2 / 
  RD1 11 / 1 
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Table 2.3: The accession numbers of all pmp CDSs of C. trachomatis, C. pneumoniae, C. abortus and C. psittaci. Full length CDSs are written in plain, black, truncated CDSs in bold and frame shifted CDSs are underlined. 
Species Strain A B C D E/F 
C. trachomatis 
L2c ctl2c_703 ctl2c_704 ctl2c_705 ctl2c_203 ctl2c_270 ctl2c_271     
L2/25667R L2225667_428 L2225667_429 L2225667_430 L2225667_866 L2225667_933 L2225667_934     
L2b/8200/07 L2B8200_00426 L2B8200_00427 L2B8200_00428 L2B8200_00863 L2B8200_00929 L2B8200_00930     
L1/115 L1115_427 L1115_428 L1115_429 L1115_865 L1115_932 L1115_933     
D/13-96 O176_02240 O176_02245 O176_02250 O176_04535 O176_04865 O176_04870     
J/31-98 O180_02235 O180_02240 O180_02245 O180_04525 O180_04855 O180_04860     
F/1-93 O169_02250 O169_02255 O169_02260 O169_04545 O169_04875 O169_04880     
F/6-94 O172_02235 O172_02240 O172_02245 O172_04530 O172_04860 O172_04865     
434/Bu ct434bu_701 ct434bu_702 ct434bu_703 ct434bu_201 ct434bu_268 ct434bu_269     
A/363 A363_440 A363_441 A363_442 A363_878 A363_943 A363_944     
A/HAR-13 ctahar_444 ctahar_445 ctahar_446 ctahar_881 ctahar_946 ctahar_947     
C/TW-3 CTW3_02250 CTW3_02255 CTW3_02260 CTW3_04555 CTW3_04900 CTW3_04905     
E/11023 cte11023_431 cte11023_432 cte11023_433 cte11023_868 cte11023_933 cte11023_934     
E/150 cte150_432 cte150_433 cte150_434 cte150_869 cte150_935 cte150_936     
G/9301 ctg9301_431 ctg9301_432 ctg9301_433 ctg9301_870 ctg9301_935 ctg9301_936     
G/9768 ctg9768_431 ctg9768_432 ctg9768_433 ctg9768_869 ctg9768_934 ctg9768_935     
C. pneumoniae 
B21 gi|572024350|gb|ETR80440.1| 
X556_0232; 
X556_0233  
gi|572023388|gb|E
TR79739.1| 
gi|572024253|gb|ETR
80366.1| gi|572024246|gb|ETR80363.1|     
AR39 CP_0213 CP_0212  CP_0897 CP_0286 CP_0285 CP_0283 CP_0284   
CWL029 CPn_0539 CPn_0540  CPn_0963 CPn_0466 CPn_0467 CPn_0471    
J138 pmp_19 pmp_20  pmp_21 pmp_15 pmp_16 pmp_17_1 pmp_17_2 pmp_17_3 pmp_18 
LPCoLN CPK_ORF01054 CPK_ORF01055  CPK_ORF00378 CPK_ORF00981 CPK_ORF00983 CPK_ORF00982 CPK_ORF00984   
TW-183 CpB0560 CpB0561  CpB1000 CpB0484 CpB0485 CpB0486 CpB0487 CpB0488 CpB0489 
C. abortus LLG 
gi|333409995|gb|EG
K68982.1| 
gi|333409994|gb|E
GK68981.1|  
gi|333410522|gb|E
GK69509.1| 
gi|333410058|gb|EG
K69045.1| gi|333410059|gb|EGK69046.1|     
S26/3 CAB201 CAB200  CAB776 CAB265 CAB266 CAB267    
C. psittaci 
01DC11 CPS0A_0238 CPS0A_0237  CPS0A_0875 CPS0A_0303 CPS0A_0304     
02DC15 CPS0B_0234 CPS0B_0233  CPS0B_0862 CPS0B_0299 CPS0B_0300     
08DC60 CPS0D_0235 CPS0D_0234  CPS0D_0872 CPS0D_0302 CPS0D_0303     
6BC G5O_0236 G5O_0235  G5O_0845 G5O_0302 G5O_0303     
C19/98 CPS0C_0236 CPS0C_0235  CPS0C_0874 CPS0C_0302 CPS0C_0303     
Cal10 G5Q_0224 G5Q_0223  G5Q_0827 G5Q_0290 G5Q_0291     
RD1 Cpsi_2191 Cpsi_2181  Cpsi_7911 Cpsi_2811 Cpsi_2821     
84_55 B595_0240 B595_0239  B595_0921 B595_0307      
CP3 B711_0240 B711_0239  B711_0922 B711_0310 B711_0311     
GR9 B598_0235 B598_0234  B598_0860 B598_0301 B598_0302     
M56 B602_0233 B602_0232  B602_0866 B602_0299 B602_0300     
MN B599_0234 B599_0233  B599_0861 B599_0299 B599_0300     
NJ1 B712_0235 B712_0234  B712_0865 B712_0300 B712_0301     
VS225 B600_0246 B600_0245  B600_0919 B600_0317 B600_0318     
WC B603_0235 B603_0234  B603_0864 B603_0301 B603_0302     
WSRTE30 B601_0233 B601_0232  B601_0863 B601_0300 B601_0301     
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Species Strain G 
C. trachomatis 
L2c ctl2c_272          L2/25667R L2225667_935          
L2b/8200/07 L2B8200_00931          
L1/115 L1115_934          D/13-96 O176_04875          J/31-98 O180_04865          F/1-93 O169_04885          F/6-94 O172_04870          434/Bu ct434bu_270          A/363 A363_945          A/HAR-13 ctahar_948          C/TW-3 CTW3_04910          E/11023 cte11023_935          E/150 cte150_937          G/9301 ctg9301_937          G/9768 ctg9768_936          
C. pneumoniae 
B21 gi|572023612|gb|ETR79887.1| 
gi|572024215|g
b|ETR80340.1| 
gi|572023613|g
b|ETR79888.1| 
gi|572024213|g
b|ETR80338.1| 
gi|572024214|g
b|ETR80339.1| 
gi|572024223|g
b|ETR80344.1| 
gi|572024240|gb|E
TR80359.1| 
gi|572023587|gb|
ETR79873.1| 
gi|572023605|gb|
ETR79883.1| 
gi|572024220|gb|
ETR80343.1| 
AR39 CP_0306 CP_0303 CP_0308 CP_0302 CP_0307 CP_0761 CP_0757 CP_0309 CP_0770 CP_0759 
CWL029 CPn_0447 CPn_0445 CPn_0451 CPn_0446 CPn_0015 CPn_0013 CPn_0444 CPn_0005 CPn_0453 CPn_0449 
J138 pmp_1 pmp_2_1 pmp_2_2 pmp_3_1 pmp_3_2 pmp_4_1 pmp_4_1_2 pmp_4_2 pmp_5_1 pmp_5_2 
LPCoLN CPK_ORF00516 
CPK_ORF0096
0 
CPK_ORF0051
5 
CPK_ORF0096
3 
CPK_ORF0096
5 
CPK_ORF0095
8 CPK_ORF00959 CPK_ORF00514 CPK_ORF00956 CPK_ORF00506 
TW-183 CpB0464 CpB0467 CpB0462 CpB0468 CpB0463 CpB0018 CpB0460 CpB0006 CpB0470 CpB0015 
C. abortus LLG 
gi|333410066|g
b|EGK69053.1| 
gi|333410063|g
b|EGK69050.1| 
gi|333410064|g
b|EGK69051.1| 
gi|333410062|g
b|EGK69049.1| 
gi|333410067|g
b|EGK69054.1| 
gi|333410355|g
b|EGK69342.1|     
S26/3 CAB281 CAB598 CAB282 CAB277 CAB278 CAB269 CAB283    
C. psittaci 
01DC11 CPS0A_0315 CPS0A_0318 CPS0A_0317 CPS0A_0316 CPS0A_0677 CPS0A_0684 CPS0A_0307 CPS0A_0314 CPS0A_0320 CPS0A_0309 
02DC15 CPS0B_0313 CPS0B_0315 CPS0B_0314 CPS0B_0675 CPS0B_0316 CPS0B_0676 CPS0B_0304 CPS0B_0311 CPS0B_0319 CPS0B_0306 
08DC60 CPS0D_0316 CPS0D_0681 CPS0D_0317 CPS0D_0318 CPS0D_0320 CPS0D_0307 CPS0D_0314 CPS0D_0324 CPS0D_0309 CPS0D_0323 
6BC G5O_0661 G5O_0314 G5O_0316 G5O_0315 G5O_0660 G5O_0657 G5O_0317 G5O_0307 G5O_0313 G5O_0309 
C19/98 CPS0C_0317 CPS0C_0681 CPS0C_0683 CPS0C_0315 CPS0C_0318 CPS0C_0307 CPS0C_0314 CPS0C_0321 CPS0C_0309 CPS0C_0320 
Cal10 G5Q_0648 G5Q_0303 G5Q_0306 G5Q_0302 G5Q_0294 G5Q_0300 G5Q_0308 G5Q_0296 G5Q_0307 G5Q_0299 
RD1 Cpsi_6121 Cpsi_2851 Cpsi_2891 Cpsi_2911 Cpsi_2901 Cpsi_2881     84_55 B595_0726 B595_0330 B595_0722 B595_0724 B595_0332 B595_0328 B595_0326 B595_0316 B595_0324 B595_0334 
CP3 B711_0330 B711_0316 B711_0327 B711_0339 B711_0338 B711_0324 B711_0337 B711_0333   GR9 B598_0313 B598_0315 B598_0667 B598_0669 B598_0306 B598_0310 B598_0318 B598_0307 B598_0317 B598_0309 
M56 B602_0678 B602_0312 B602_0676 B602_0303 B602_0311 B602_0316 B602_0306 B602_0315 B602_0310  MN B599_0311 B599_0670 B599_0671 B599_0313 B599_0315 B599_0672 B599_0304 B599_0310 B599_0317 B599_0306 
NJ1 B712_0673 B712_0314 B712_0672 B712_0306 B712_0313 B712_0316 B712_0308 B712_0315 B712_0312 B712_0309 
VS225 B600_0332 B600_0324 B600_0331 B600_0335 B600_0326 B600_0333 B600_0330 B600_0328   WC B603_0319 B603_0680 B603_0677 B603_0318 B603_0678 B603_0316 B603_0314 B603_0306 B603_0311 B603_0321 
WSRTE30 B601_0314 B601_0671 B601_0305 B601_0310 B601_0316 B601_0306 B601_0315 B601_0308 B601_0307  
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Species Strain G Middle domain H I 
C. trachomatis 
L2c ctl2c_273 ctl2c_275 
L2/25667R L2225667_936 L2225667_938 
L2b/8200/07 L2B8200_00932 L2B8200_00934 
L1/115 L1115_935 L1115_937 
D/13-96 O176_04880 O176_04895 
J/31-98 O180_04870 O180_04885 
F/1-93 O169_04890 O169_04905 
F/6-94 O172_04875 O172_04890 
434/Bu ct434bu_271 ct434bu_273 
A/363 A363_946 A363_948 
A/HAR-13 ctahar_949 ctahar_951 
C/TW-3 CTW3_04915 CTW3_04930 
E/11023 cte11023_936 cte11023_939 
E/150 cte150_938 cte150_941 
G/9301 ctg9301_938 ctg9301_941 
G/9768 ctg9768_937 ctg9768_940 
C. pneumoniae 
B21 gi|572024239|gb|ETR80358.1| 
AR39 CP_0299 CP_0301 CP_0760 CP_0298 
CWL029 CPn_0019 CPn_0016 Cpn_0452 CPn_0454 
J138 pmp_6 pmp_7 pmp_8 pmp_9 pmp_10 pmp_11 pmp_13 pmp_12 pmp_14 
LPCoLN CPK_ORF00967 CPK_ORF00968 
TW-183 CpB0023 CpB0019 CpB_0471 CpB_0024 CpB0469 CpB0471 
C. abortus LLG gi|333410061|gb|EGK69048.1| 
S26/3 CAB268 
C. psittaci 
01DC11 CPS0A_0319 CPS0A_0313 CPS0A_0306 
02DC15 CPS0B_0318 CPS0B_0310 CPS0B_0303 
08DC60 CPS0D_0313 CPS0D_0306 
6BC G5O_0320 G5O_0312 G5O_0305 
C19/98 CPS0C_0313 CPS0C_0306 
Cal10 G5Q_0297 G5Q_0293 
RD1 Cpsi_2841 
84_55 B595_0318 B595_0333 B595_0323 B595_0320 B595_0315 
CP3 B711_0315 
GR9 B598_0308 B598_0668 B598_0305 
M56 B602_0302 
MN B599_0316 B599_0309 B599_0308 B599_0314 B599_0303 
NJ1 B712_0305 
VS225 B600_0322 
WC B603_0307 B603_0320 B603_0310 B603_0308 B603_0317 B603_0305 
WSRTE30 B601_0304 
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In addition to the different number of pmp CDSs between strains of the same Chlamydia 
species, the organization of the pmp CDSs varied within and across Chlamydia species. 
Within the species C. pneumoniae, most pmp CDSs were encoded on the sense strand, while 
in strains AR39 and LPCoLN most pmp CDSs were coded on the antisense strand. However, 
the order of the CDSs stayed identical. In all analyzed strains of the C. psittaci and C. abortus 
species, most pmp CDSs were coded on the antisense strand. The CDSs organization was the 
same in all analyzed C. trachomatis strains (only strain A/HAR-13 is shown in Figure 2.2). 
However, C. trachomatis is the only species in which a similar number of pmp CDSs were 
encoded on both strands, and the genome organization of the pmp CDSs in C. trachomatis is 
different from the organization observed in the other 3 species, as the pmpD CDS is encoded 
between the pmpB and pmpE/F CDSs and the pmpB and pmpG CDSs for C. trachomatis and 
the other 3 species, respectively.  
The pmp CDSs are drawn to scale in Figure 2.2. The size of pmpA, pmpB and pmpH CDSs 
was identical in all analyzed genomes, while C. abortus S26/3 encoded a shorter pmpE/F 
CDS compared to the other pmpE/F CDSs in that genome and all other genomes. The size of 
the CDSs of the highly expanded pmpG subtype varied within and across genomes. The most 
striking observation was the shorter pmpD CDSs in C. abortus S26/3 and in three C. psittaci 
strains (84/55, CP3 and VS225). pmpC and pmpI CDSs were only observed in C. trachomatis 
genomes, while truncated pmp middle domain CDSs were only observed in C. pneumoniae 
genomes. Moreover, C. pneumoniae is the only species that encoded truncated pmpE/F CDSs. 
3.2 Different Pmp proteins are highly conserved within and across different Chlamydia 
species 
The amino acid sequences of Pmp proteins of the same subtype were aligned and levels of 
conserved amino acids assessed within and across the C. trachomatis, C. pneumoniae, C. 
abortus and C. psittaci genomes (Tables 2.4 and 2.5). PmpD was highly conserved within all 
analyzed species (= in top 3 of most conserved Pmps), and PmpA and B in three out of four 
analyzed species. The level of conservation of PmpD in C. psittaci was analyzed across 13, 
rather than 16, PmpD amino acid sequences. Three C. psittaci strains (84/55, CP3 and VS225) 
were excluded from this analysis due to a large deletion within PmpD that skewed 
conservation analysis. It is striking that PmpH is the most conserved Pmp protein in C. 
abortus, while it is among the least conserved in the other 3 species. As the Pmps were least 
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conserved in C. psittaci (Table 2.4), the most conserved Pmps across Chlamydia species were 
determined both including and excluding C. psittaci Pmps. Remarkably, in both cases, PmpB 
is the most conserved Pmp and PmpD is only the 4th most conserved Pmp (Table 2.5).  
Table 2.4: The level of conservation of the amino acid sequence of Pmp proteins in 16 C. 
trachomatis, 6 C. pneumoniae, 2 C. abortus and 16 C. psittaci genomes. 
Species Pmp % AA conserved Range (%) 
C. trachomatis D 98.37 83.27-98.37 
A 97.64 
I 97.61 
C 95.74 
B 95.72 
G 95.36 
E 91.85 
H 90.63 
F 83.27 
C. pneumoniae A 99.37 0.34-99.37 
B 98.25 
D 98.20 
H 96.42 
E 15.99 
G 0.34 
C. abortus H 99.69 3.57-99.69 
D 99.35 
B 99.16 
A 99.14 
E 38.26 
G 3.57 
C. psittaci A 94.21 0-94.21 
D 86.13 
B 82.23 
H 81.03 
E 25.81 
G 0 
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Table 2.5: The level of conservation of Pmp proteins across C. trachomatis, C. 
pneumoniae, C. abortus and (C. psittaci). 
% AA conserved when Pmp amino acid sequences were included from:  
C. trachomatis, C. pneumoniae, 
C. abortus and C. psittaci 
C. trachomatis, C. pneumoniae and 
C. abortus  
PmpB (25.08%) PmpB (26.03%) 
PmpA (24.27%) PmpH (25.53%) 
PmpH (22.71%) PmpA (24.77%) 
PmpD (21.42%) PmpD (21.95%) 
PmpE (5.72%) PmpE (7.40%) 
PmpG (0%) PmpG (0.22%) 
4. Discussion 
As the degree of conservation of the Pmp proteins was until now only determined for C. 
trachomatis, most studies on C. trachomatis, C. pneumoniae and C. abortus Pmp proteins 
have focused mainly on PmpD (Wehrl et al., 2004; Crane et al., 2006; Kiselev et al., 2009; 
Wheelhouse et al., 2012a), due to its being highly conserved in C. trachomatis (Gomes et al., 
2006; Carrasco et al., 2011) and highly immunogenic (Caldwell et al., 1975a,b; Caldwell and 
Kuo, 1977; Crane et al., 2006; Tan et al., 2009). Gomes et al. (2006) reported PmpD as the 
second most conserved Pmp of C. trachomatis at amino acid level, while Carrasco et al. 
(2011) reported it as the third. In this study, we identified PmpD as the most conserved Pmp. 
This can be explained by the use of genomes of different C. trachomatis strains for analyses. 
However, the two previous studies and the current study have all identified PmpA, PmpD and 
PmpI as the three most conserved Pmp proteins in C. trachomatis, suggesting that these three 
Pmps are highly conserved in C. trachomatis.  
Becker et al. (2014) recently demonstrated that PmpD is the strongest adhesin of C. 
trachomatis and referred to Tan et al. (2010) to document that PmpD was the only Pmp that 
was expressed in almost all inclusions in C. trachomatis infected cells and to Gomes et al. 
(2006) to report that PmpD is the second most conserved Pmp in C. trachomatis, thereby 
arguing for a crucial function of PmpD in the infection cycle of C. trachomatis. However, 
PmpA and PmpI were equally abundantly expressed and equally highly conserved as PmpD 
(Tan et al., 2010). This might indicate equally important functions for PmpA and PmpI and 
highlights the need to analyze also Pmp proteins other than PmpD.  
54                                                                                                                                  Chapter II  
As variation is the central theme in the Pmp family, we hypothesize that the Pmp proteins 
might play a role in the observed difference in host and tissue preferences of different 
Chlamydia species. Consequently, we suggested that different Pmp proteins may be most 
conserved in different Chlamydia species. Indeed, different Pmp proteins were most 
conserved in each Chlamydia species (PmpD, PmpA, PmpH and PmpA in C. trachomatis, C. 
pneumoniae, C. abortus and C. psittaci respectively), with PmpA being most conserved Pmp 
protein in both C. pneumoniae and C. psittaci, which is different from what we suggested 
before. However, multiple proteins likely mediate adhesion and the most conserved Pmp 
proteins might still play a role for that. The different organization of the pmp CDSs within 
genomes of the same Chlamydia species (C. pneumoniae) and across Chlamydia species, 
indicate that pmp CDSs were located in regions of the genome where high levels of 
recombination have occurred. The pmp CDSs were mainly encoded on the antisense strand of 
C. pneumoniae strain AR39 and LPCoLN. These two genomes also clustered closely together 
phylogenetically, which may indicate that those genomes were subject to similar 
recombination events also on loci other than the pmp CDSs.  
The Pmp proteins were most conserved in C. abortus, which can be explained by the 
availability of only two completed C. abortus genome sequences at the time of analyses. 
Therefore, the level of conservation can only be compared for C. trachomatis and C. psittaci, 
as for those species an equal amount of genomes (16) were analyzed. The Pmp proteins were 
more conserved in C. trachomatis compared to C. psittaci, which might be explained by the 
zoonotic nature of C. psittaci. C. psittaci might have adapted to its numerous different hosts 
through expression of variation in its Pmps and through expansion of the number of pmp 
genes. However, this does not explain why C. pneumoniae encodes the largest number of pmp 
CDSs and why the number of pmpE/F and pmpG subtype CDSs is highest in C. pneumoniae, 
as it is not a zoonotic bacterium. However, previous comparative genomic analyses of human 
C. pneumoniae strains (AR39, TW-183, J138 and CWL029) and the koala C. pneumoniae 
LPCoLN strain by Myers et al. (2009) suggested that C. pneumoniae has an animal origin. 
The observed truncated pmp and inc CDSs in the human C. pneumoniae strains were assigned 
to a reductive evolution of this species after it adapted to its human host (Myers et al., 2009). 
The current study supports that hypothesis, as C. pneumoniae LPCoLN encodes the largest 
amount of full length pmp CDSs of all analyzed C. pneumoniae strains. This is in contrast to 
C. psittaci, where the strains isolated from mammals (C. psittaci MN and WC) encode the 
largest amount of full length pmp CDSs. The latter might be explained by the fact that 
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mammalian C. psittaci infection is a zoonosis. Truncated CDSs were mostly observed in C. 
pneumoniae and C. psittaci. In C. pneumoniae those truncated CDSs might be the result of 
reductive evolution processes (Myers et al., 2009), while for C. psittaci we suggest that these 
truncated pmp CDSs might recombine to another region, resulting in a full length, functional 
pmp CDS. 
In contrast to the hypothesis that different Pmp proteins might mediate adhesion in different 
Chlamydia species, some Pmp subtypes might have the same redundant, critical function in 
different hosts. Hence, we determined the level of conservation of the Pmp proteins across 
different Chlamydia species. In our analysis PmpB is the most conserved Pmp protein, with 
PmpA, PmpH and PmpD being the second, third and fourth most conserved Pmp proteins, 
respectively.  
PmpD is considered to be a vaccine candidate, however, our analysis shows that PmpD is not 
the most conserved Pmp protein across Chlamydia species. It is also not the most conserved 
Pmp protein within all Chlamydia species and in some C. abortus and C. psittaci strains, the 
PmpD protein was truncated. This raises the possibility that PmpD is not essential for the 
pathogenesis of C. psittaci and C. abortus. Our study highlights that, rather than focusing on 
PmpD, all Pmp proteins should be examined to accurately determine their utility as vaccine 
candidates. 
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Abstract 
Chlamydia psittaci is a Gram-negative obligate intracellular pathogen of birds. Infections lead 
to economic losses in the poultry industry and the infection can be transmitted to humans. No 
vaccine is available and the bacterium host-cell interaction is not completely understood. The 
replicating bacteria cause pneumonia, but they can also be present as non-replicating, 
persistent bacteria inside the cytoplasm of avian cells. Quantitative real-time polymerase 
chain reaction (RT-qPCR) is a major tool to gain a better insight into the molecular 
pathogenesis of C. psittaci in birds. However, identification of stably expressed reference 
genes is required to avoid biases in RT-qPCR, when studying active replicating and persistent 
C. psittaci. The expression stability of ten candidate reference genes was investigated for 
performing gene expression analysis in C. psittaci during normal growth and during 
penicillin-induced persistence, using geNorm. The genes tyrS, gidA, radA and 16S rRNA 
ranked among the most stably expressed genes. The final selected reference genes differed 
according to the bacterial growth status (normal growth versus persistent status), and the time 
points selected during the duration of a normal chlamydial developmental cycle.  
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1. Introduction 
Quantitative real-time PCR (RT-qPCR) has become a major tool to better understand the 
molecular pathogenesis of bacterial infections. RT-qPCR is a sensitive, efficient and accurate 
technique for gene expression studies and it is an established technique for studying bacterium 
host cell interactions (Vandesompele et al., 2002). However, the accuracy and reproducibility 
of RT-qPCR is influenced by: i) the sample amount, ii) yield of the extraction process, iii) the 
RNA quality, iv) sample to sample variation and v) reverse transcriptase efficiency (Bustin, 
2001). The expression of reference genes is affected by all sources of variation during the 
experimental workflow, in the same way as the expression of the genes of interest is 
influenced. Therefore, the use of reference genes is the preferred method to reduce the non-
biological variation. However, the normalization step is the most problematic and ignored part 
of RT-qPCR. A commonly used normalization strategy involves normalization to a single, 
non-validated bacterial reference gene, such as the 16S rRNA gene (Mannonen et al., 2011), 
which is generally regarded as the universal bacterial reference gene for data normalization. 
However, evaluation of RT-qPCR candidate reference genes for expression studies in 
Lactobacillus casei (Zhao et al., 2011), Escherichia coli (Zhou et al., 2011), Bacillus cereus 
(Reiter et al., 2011), Corynebacterium pseudotuberculosis (Carvalho et al., 2014), 
Clostridium botulinum (Kirk et al., 2014), Listeria monocytogenes (Tasara and Stephan, 
2007), and Staphylococcus aureus (Valihrach and Demnerova, 2012; Sihto et al., 2014) 
revealed that the 16S rRNA gene cannot be regarded as a universal reference gene. In fact, the 
expression stability of candidate reference genes should be validated specifically for each 
bacterial species and each experimental setting (Vandesompele et al., 2002).  
RT-qPCR analyses could help to understand the molecular pathogenesis of C. psittaci.           
C. psittaci is an obligate intracellular Gram-negative bacterium that is responsible for 
respiratory disease in birds. A C. psittaci infection leads to significant economic losses due to 
reduced feed conversion, mortality, carcass condemnation at slaughter, reduced egg 
production and/or the expense of antibiotic treatment (Vanrompay et al., 1997). Currently, no 
vaccine is available. C. psittaci is also an important zoonotic agent via inhalation of infected 
aerosols of pharyngeal or nasal secretions or dried feces. The bacterium replicates by binary 
fission inside the cytoplasm of host cells but when stressed (iron depletion, exposure to 
interferon gamma and/or penicillin), the pathogen can go into a non-replicative, persistent 
status, and once stressors are removed, replication and bacterial excretion starts again. 
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So far, stably expressed genes, i.e. genes that are expressed at the same level at all analyzed 
time points and conditions, for normalization of RT-qPCR data in Chlamydia have only been 
determined for the human pathogen C. trachomatis (Borges et al., 2010). In this study, we 
present the selection and validation of reference genes for RT-qPCR studies in C. psittaci 
during the normal developmental cycle and during penicillin-induced persistence. Reference 
genes determined for normal + penicillin should be used to check whether a certain gene is 
up- or down-regulated during the persistent state compared to during normal development. 
This is important to further understand the persistent state, which could help to prevent 
Chlamydia spp. to go into the persistent state and therewith this would help to treat 
chlamydial infections. 
2. Material and methods 
2.1 Chlamydia psittaci strain, cell culture and infection 
The previously well-characterized, prototypic strain C. psittaci Cal10 (Matsumoto, 1982; 
Hovis et al., 2013; Mojica et al., 2015), which was isolated from ferrets inoculated with throat 
washings from humans with an influenza-like respiratory infection (Francis and Magill, 1938), 
and with a complete genome sequence available (Grinblat-Huse et al., 2011) was used in this 
study. The bacterium was grown in HeLa 229 cells, the first human cell line established in 
culture (Gey et al., 1952), starting from human cervical cancer cells. The cells were seeded in 
100 mm² tissue culture dishes for 24h at 37°C with 5% CO2 in Dulbecco’s modified Eagle’s 
medium (DMEM, Mediatech, Herndon, VA) supplemented with 10% heat inactivated fetal 
bovine serum (Atlanta Biologicals, Lawrenceville, GA), gentamycin (25 µg ml-1; Quality 
Biological, Gaithersburg, MD) and fungizone (1.25 µg ml-1; Invitrogen, Carlsbad, CA). The 
medium was aspirated and cells were inoculated with C. psittaci Cal10 in SPG (0.25 M 
sucrose, 10 mM sodium phosphate and 5mM L-glutamic acid) at a multiplicity of infection 
(MOI) of 1 followed by incubation on a rocking platform for 2 h at 37°C. The unbound 
organisms were washed away with PBS and the bacterium was grown either under normal 
conditions using the above-mentioned medium, or by adding penicillin (100U ml-1) to the 
above-mentioned medium as a way to induce Chlamydia persistence (Hu et al., 2015). One ml 
SPG was added to a mock-infected dish. For all cells, addition of medium after rocking and 
washing marked time 0 hpi of the experiment. 
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2.2 Total RNA extraction and cDNA synthesis 
At 2, 6, 12, 18, 24, 32, and 48 hours post infection (hpi), total RNA was extracted from the 
monolayers according to the manufacturer’s instructions (TRIzol, Invitrogen). Total RNA was 
quantified (Nanodrop 2000, Thermo Scientific, Wilmington, DE) and the samples were 
treated with RNase-free amplification grade DNase I (Promega, Madison, WI) following the 
manufacturer’s protocol and confirmed to be DNA-free by PCR (Table 3.1) for the C. psittaci 
Cal10 16S rRNA gene. One µg of total RNA was reverse transcribed (Superscript II RT, 
Invitrogen) with random hexamer primers (Invitrogen) following the manufacturer’s protocol. 
RNA and cDNA samples were stored at -80°C and -20°C, respectively. 
Table 3.1: Primers to check the RNase-free DNase I treatment. 
Gene Primer  Primer sequence (5’ to 3’) Amplicon size (bp) 
16S rRNA 16S-QPCR-F TGTACAAGGCCCGGGAACGTA 156 
 16S-QPCR-R GGCCAGTACAGAAGGTAGCA  
2.3 Primer design and validation for RT-qPCR 
Primers for the candidate reference genes were designed using Primer3 software with the 
following settings: amplicon size of 100-200 bp, optimal melting temperature of 60°C and a 
GC content of 50-60% (Table 3.2). For each primer pair, different primer concentrations (100 
nM, 150 nM, 200 nM, 300 nM, 400 nM and 500nM) were tested in duplicate. The 
concentration resulting in the best sigmoid expression curve was chosen (Table 3.2). Melt 
curve analysis was used to ensure the specificity of the primers. The RT-qPCR efficiency was 
determined for each gene using slope analysis with a linear regression model. Standard curves 
were generated with serial dilutions of genomic DNA of purified EBs (1/5 = 8 ng µl-1, 1/25, 1/ 
125, 1/625, 1/3125, 1/15625). The corresponding RT-qPCR efficiencies (E) were calculated 
according to the equation E = (10(-1/slope)-1) x 100 (Pfaffl, 2001). Primers selected for RT-
qPCR displayed an efficiency between 90 and 110% and a coefficient of correlation greater 
than 0.98.  
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Table 3.2: Primers used to determine the stability of candidate reference genes. 
Gene Primer Primer sequence(5'-3') Amplicon size (bp) Tm (°C) GC (%) Primer concentration (nM) Efficiency (%) 
16S rRNA 16SrRNA-1 TGTACAAGGCCCGGGAACGTA 156 59,9 57,1 200 95,4 
 16SrRNA-2 GGCCAGTACAGAAGGTAGCA  58,0 55,0 200  enoA  enoA-1  AGCCGCAACTTTAGGACGA 187 60,9 52,6 500 90,1 
 enoA-2  ATCAGCACCCATACGCACAG  62,1 55,0 500  gatA gatA-1 GCGTTAGGTTCCGATACAG 165 55,9 52,6 200 94,9 
 gatA-2 GGCGACATCTTCAACAAC  54,9 50,0 200  hemN hemN-1 TTTACACATGCGGCCTGAC 170 60,7 52,6 500 101,2 
 hemN-2 CAATGGCTTGGTAACCTGCT  60,1 50,0 500  tyrS tyrS-1 TGGGACAGGCTTATGGTTTG 169 60,9 50,0 200 96,6 
 tyrS-2 CGTGCGACTTTAGGCACTTC  61,0 55,0 200  fumC fumC-1 CTTGCATACCGCCAGAGAGT 170 60,4 55,0 200 103,9 
 fumC-2 CAACCCAACGCAATGTGA  60,1 50,0 200  gidA gidA-1 GATCTCCGGGTTGTTCTTCA 100 60,1 50,0 400 97,9 
 gidA-2 GAACGTGGTTTCCCAATCAG  60,4 50,0 400  hflX hflX-1 CGTAAGGCTAAAGAG 181 57,3 55,0 500 97,8 
 hflX-2 TTGCCCACTAGGAAG  57,2 55,0 500  radA radA-1 GTCGCCGCCTAATAGGGTAA 108 61,3 55,0 500 105,6 
 radA-2 ACCATAGAGCTGCGAGAGGA  60,1 55,0 500  map map-1 AAACGCGTCTGTCAAGCATC 156 61,4 50,0 200 92,2 
  map-2 ACCCACACCGTGACCTACAA   61,3 55,0 200   
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2.4 Real-time quantitative PCR (RT-qPCR) 
The expression level of each candidate reference gene was examined by RT-qPCR on an 
Rotor-Gene Q Real-Time PCR Detection System (Qiagen, Hilden, Germany). Each reaction 
mixture contained 1 µl cDNA, the optimal primer concentration for each primer pair (Table 
3.2), 10 µl iQ SYBR Green Supermix (Bio-Rad, Richmond, CA) and ddH2O to a final volume 
of 20 µl. RT-qPCR reaction conditions were as follows: initial denaturation at 95°C for 3 min, 
40 cycles each consisting of 30 s at 95°C and 30 s at 58°C, followed by the melting curve 
program (95°C for 1 min, 55°C-95°C in steps of 0.5°C each 10 s). Two biological replicates 
of each sample (normal infection vs. penicillin-induced persistence, each at 7 different time 
points during the developmental cycle) were tested in duplicate. C. psittaci Cal10 genomic 
DNA was used as a positive control, while HeLa 229 cDNA, non-reverse-transcribed C. 
psittaci Cal10 total RNA, and ddH2O were used as negative controls. Data analyses were 
carried out with geNorm software (version 2.4, Biogazelle, Ghent, Belgium) on normal, 
penicillin and normal + penicillin samples. Expression categories were defined as early (2–6 
hpi), middle (12–18 hpi) and late (> 24 hpi). 
2.5 Selection of reference genes 
The expression level of 10 candidate reference genes (16S rRNA, map, tyrS, hemN, hflX, gidA, 
gatA, fumC, radA and enoA) was measured for the two biological replicates of each sample. 
The Cq-values were used to analyze the expression stability of candidate reference genes by 
geNorm, implemented in the qBasePLUS software. geNorm is based on the principle that the 
expression ratio of two ideal reference genes are identical in all samples tested, independent 
of the experimental conditions. Variation in those ratios indicates the non-stable expression of 
one or both reference genes. Therefore, geNorm determines the level of pairwise variation for 
each candidate reference gene with all other candidate reference genes (M-value). Genes with 
a low M-value are the most stably expressed. Sequential removal of the least stable gene 
generates a ranking of the candidate reference genes according to their stable expression. 
geNorm also calculates the pairwise variation Vn/n+1 to determine the ideal number of 
reference genes for normalization (Vandesompele et al., 2002). The cut-off value below 
which the inclusion of an additional control gene was considered not to result in a significant 
improvement of the normalization, was set at 0.15 (Vandesompele et al., 2002).  
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3. Results 
3.1 Choice and transcript profiles of candidate reference genes 
Reference genes for C. psittaci during normal and penicillin-induced persistence conditions, 
at early (2 and 6 hpi), mid (12 and 18 hpi) and late (24, 32 and 48 hpi) time points, were 
validated in this study. The candidate reference genes were chosen based on the reference 
genes tested for C. trachomatis and the housekeeping genes used for the multi locus sequence 
typing of Chlamydiales (Pannekoek et al., 2008; Borges et al., 2010). To minimize the risk of 
co-regulation, ten candidate genes were selected by the following criteria: i) widely spread on 
the chromosome, ii) involved in different pathways, and iii) not adjacent to putative outer 
membrane, secreted or hypothetical proteins that might be under diversifying selection (Table 
3.3). The gene encoding the 16S rRNA was the most abundantly expressed (only 3.97 cycles 
to reach the cycle treshold), while enoA and fumC were the least abundant transcripts (31.83 
and 31.2 cycles respectively) (Figure 3.1). radA and tyrS transcript levels showed the lowest 
and enoA and fumC transcript levels the highest variation in Cq-values (10.67, 10.59, 15.99 
and 19.84 cycles respectively). The wide range of transcript levels of the candidate reference 
genes confirmed that no single candidate reference gene was constantly expressed at the 
different conditions and time points analyzed. This implicated the need for using multiple 
reference genes.  
Table 3.3: Candidate reference genes.  
Gene symbol Function Pathways 
map Mitogen-activated protein kinase Protein phoshorylation 
tyrS Tyrosine-tRNA ligase 
Catalysation of the attachment of an amino acid 
to its cognate tRNA molecule 
16S rRNA 16S ribosomal RNA subunit Translation 
hemN Coproporphyrinogen III oxidase  Coproporphyrinogen III decarboxyation 
hflX GTPase 
May have a role during protein synthesis or 
ribosome biogenesis 
radA DNA recombination/repair protein DNA repair, homologous recombination 
enoA Component of enolase Glycolysis 
fumC Fumarase C Citric acid cycle 
gatA Belongs to the GATA transcription factor family Transcription 
gidA Glucose-inhibited division protein A Protein involved in tRNA modification 
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Figure 3.1: Transcript levels of candidate reference genes. The transcript levels for each 
reference gene in all C. psittaci samples (normal + penicillin condition at all time points) are 
shown. The data are expressed as box plots: the box represents the 25th-75th percentiles, the 
median is depicted by a bar across the box and the whiskers on each box represent minimum 
and maximum value (excluding outliers which are depicted as dots). 
 
3.2 Stability of reference genes expression 
The stability of the transcript levels of the candidate reference genes was determined using 
geNorm. The program calculated the average expression stability value (M-value) for each 
candidate reference gene during normal, penicillin and normal + penicillin conditions (Figure 
3.2). For each condition, the stability value for each candidate reference gene was determined 
for early, mid, late and all time points. In addition to the M-value, geNorm calculated also a 
Vn/n+1-value to determine the optimal number of reference genes for accurate normalization 
for each condition (Figure 3.3). A Vn/n+1 smaller than 0.15 indicates that an additional 
reference gene (Vn+1) has no significant effect (Vandesompele et al., 2002). If the pairwise 
variation was bigger than 0.15, than geNorm advised to use the number of reference genes 
with the lowest Vn/n+1 value. 
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Figure 3.2: Stability ranking of candidate reference genes during normal, penicillin and normal + penicillin conditions by geNorm. 
Candidate reference genes are ranked from left to right in order of increasing expression stability (decreasing M-value). 
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Figure 3.3: Determination of the optimal number of reference genes required for 
reliable normalization by geNorm. The pairwise variation (Vn/n+1) was calculated stepwise 
between normalization factors based on the n and (n+1) most stable expressed reference genes. 
According to the geNorm developers, a variation of <0.15 indicates no significant 
contribution of an additional control gene to the normalization factor. If Vn/n+1 is higher than 
0.15, than the lowest Vn/n+1 is the optimal number. The optimal number of control genes are 
illustrated by arrows. 
The lowest and highest M-value of the reference genes for all the samples (normal + 
penicillin) and for normal and penicillin conditions separately, as well as which reference 
genes to use for each condition, are listed in Table 3.4. gatA was excluded from the analysis, 
as it was not transcribed in all samples. In general, gidA had the lowest M-value (highest 
stability) for six conditions, while enoA had the highest M-value (lowest stability) for 6 
conditions. Genes tyrS, gidA, radA and 16S rRNA were among the reference genes suggested 
to be used in 11, 9, 8 and 8 out of the 12 tested conditions respectively, while genes map, hflX, 
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enoA, hemN and fumC were suggested to be used in 5, 4, 2, 1 and none of the tested 
conditions. enoA and hemN were unique reference genes for the normal condition. No gene 
was unique for the penicillin-induced persistence condition, although in general the reference 
genes proposed for use during the normal condition at a specific time point differed from the 
ones proposed for the penicillin-induced persistent condition at the corresponding time point. 
Including more different samples resulted in less stably expressed reference genes. For 
example, the lowest M-value of the normal + penicillin condition was higher than the one of 
normal and penicillin separately for early, mid, late and all time points. In addition, the lowest 
M-value of normal, penicillin and normal + penicillin was the highest for all time points 
together compared to early, mid and late time points separately. Late and all time point 
samples were less stable than early and mid time point samples, as late and all time points 
showed the highest M-values. Consequently, the more conditions analyzed, the more 
reference genes were needed to normalize the data accurately (2-5 reference genes for normal 
and penicillin conditions separately, while 4-5 reference genes for normal + penicillin 
conditions together). 
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Table 3.4: Overview of reference genes for three conditions: normal, penicillin and normal + penicillin. The most suitable reference genes 
for each condition are shown. Reference genes are listed from least to most stable. 
Condition Time point Lowest M-value Highest M-value Reference genes Vn/n+1 < 0.15? 
Normal 
 
early 0,432 (hemN) 2,126 (hflX) enoA, tyrS, hemN No 
mid 0,398 (16S rRNA) 2,204 (map) gidA, tyrS, hflX, 16S rRNA No 
late 0,718 (gidA) 2,832 (enoA) 16S rRNA, map, tyrS, radA, gidA No 
all  1,024 (tyrS) 3,012 (enoA) hflX, radA, gidA, tyrS No 
Penicillin 
early 0,488 (gidA) 2,243 (hemN) tyrS, map, gidA Yes 
mid 0,151(gidA) 1,169 (fumC) radA, gidA Yes 
late 0,631 (tyrS) 2,657 (enoA) radA, hflX, 16S rRNA, tyrS No 
all  0,997 (tyrS) 2,719 (enoA) map, 16S rRNA, radA, tyrS No 
Normal + 
penicillin 
early 0,817 (gidA) 2,263 (fumC) enoA, 16S rRNA, map, tyrS, gidA No 
mid 0,502 (gidA) 1,822 (fumC) 16S rRNA, tyrS, radA, gidA No 
late 1,081 (gidA) 2,745 (enoA) hflX, 16S rRNA, tyrS, radA, gidA No 
all  1,226 (tyrS) 2,846 (enoA) 16S rRNA, map, radA, gidA, tyrS No 
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4. Discussion 
RT-qPCR is an accurate and sensitive tool for studying gene expression in bacterial pathogens 
(Bustin, 2005). Unfortunately, normalization is still the most obstinate problem for real-time 
quantification. Different normalization methods are available. The use of genomic DNA is 
less suited to normalize for experimental variations, as the gDNA is determined on DNA 
samples. So, it cannot be used to correct for differences in RNA extraction and RT-PCR 
efficiencies (Borges et al., 2010). Therefore, the use of reference genes is advised 
(Vandesompele et al., 2002). However, it is essential to validate reference genes for each 
bacterial species and each specific experiment to be able to control for non-biological 
variation and therewith obtain accurate and reliable gene expression data. Selection of 
unstable, unvalidated reference genes can result in miscalculations of gene expression levels 
and lead to incorrect conclusions (Dheda et al., 2005). Several publications underlined the 
importance to use multiple reference genes, as no single, universal reference gene exists. 
Nevertheless, many recently published papers still normalized mRNA levels by a single 
reference gene (Bustin, 2005; Kiselev et al., 2009; Almeida et al., 2012; Ferreira et al., 2013), 
mostly 16S rRNA. In fact, none of the previously mentioned studies that used 16S rRNA as a 
reference gene, showed data on the stability of the gene in the experimental setting utilized. 
Other reports justified the choice of the 16S rRNA as reference gene only by referring to 
another study, usually performed under different experimental conditions with other strains.  
Borges et al. (2010), validated reference genes for performing gene expression analyses in C. 
trachomatis, but reference genes have not been validated for gene expression studies in other 
Chlamydia species. Therefore, we investigated the suitability of ten candidate reference genes 
for future gene expression analysis in C. psittaci Cal10. The expression of the 16S rRNA gene, 
extensively used as reference gene in Chlamydia spp. gene expression studies (Douglas and 
Hatch, 2000; Mathews et al., 2001; Belland et al., 2003a; Nicholson et al., 2004; Goellner et 
al., 2006; Suchland et al., 2008; Ferreira et al., 2013), and of nine other C. psittaci genes (map, 
tyrS, hemN, hflX, gidA, gatA, fumC, radA and enoA) was studied during both normal bacterial 
growth conditions and penicillin-induced persistence.  
Our data confirmed the finding that the best-suited reference genes differ among experimental 
conditions, as the most stably expressed reference gene (lowest M-value) varied for each 
experimental group. The most striking observation was that the tyrS gene was suggested as a 
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reference gene for all but one conditions, thus not for the mid time point during penicillin-
induced persistence. We have no reasonable explanation for the latter observation. 16S rRNA 
was suggested as reference gene in only 8 out of the 12 tested conditions. This result is in 
alignment with an earlier study, in which they found that 16S rRNA was the most stable 
reference gene for C. trachomatis under normal conditions, but its expression was highly 
unstable during stress conditions (Borges et al., 2010). In addition, the reference genes to be 
used for C. psittaci gene expression analyses differ from those described for C. trachomatis 
gene expression analysis (Borges et al., 2010). As also demonstrated by Vandesompele et al. 
(2002), measuring expression levels by using multiple reference genes was more accurate 
than just using one. The effect of potential regulations of single genes is decreased by the use 
of multiple reference genes, and improves the reproducibility of relative gene expression 
analysis.  
In conclusion, we successfully identified reference genes, which can be used for C. psittaci 
gene expression analysis during the normal developmental cycle and during penicillin-
induced persistence. The importance of proper reference gene evaluation for RT-qPCR data 
normalization is emphasized by our data and therewith we strongly advise to make systematic 
validation of reference genes to confirm their stability within the strains and under the 
conditions selected. 
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Adapted from: 
Van Lent S., De Vos W.H., Creasy H.H., Marques P.X., Ravel J., Vanrompay D., Bavoil 
P., Hsia R. Analysis of polymorphic membrane protein expression in cultured cells identifies 
PmpA and PmpH of Chlamydia psittaci as candidate factors in pathogenesis and immunity to 
infection. Plos One. Accepted with minor revisions. 
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Abstract 
Studies of the polymorphic membrane protein (Pmp) paralogous families of Chlamydia 
trachomatis, Chlamydia pneumoniae and Chlamydia abortus have suggested the potential of 
these proteins for the development of a Chlamydia vaccine. To determine if members of the 
Pmp family of C. psittaci are also vaccine candidates, we analyzed transcription levels, 
protein production and localization of several Pmps of C. psittaci under normal en stress 
conditions. We found that PmpA was highly produced in all inclusions as early as 12 hpi in 
all biological replicates. In addition, PmpA and PmpH appeared to be unusually accessible to 
antibodies as determined by both immunofluorescence and immuno-electron microscopy. 
These results suggest an important role for these Pmps in the pathogenesis of C. psittaci, and 
make them promising candidates in vaccine development. 
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1. Introduction 
The Chlamydiaceae are a family of Gram-negative obligate intracellular bacteria that infect 
animals and humans, causing diseases with a wide range of symptoms. Among these, a 
significant species is C. psittaci that may cause respiratory disease in poultry and pet birds, 
and may also cause zoonotic psittacosis in humans. Psittacosis, or parrot fever, is usually 
characterized by fever chills, headache, dyspnea and cough. Chest X-rays often show an 
infiltrate (Beeckman and Vanrompay, 2009). However, the disease seems to vary 
considerably in severity as the clinical features of the infection can range from none to sepsis 
with multi-organ failure requiring admission in an intensive-care-unit (Heddema et al., 2006). 
People usually contract the infection via inhalation of an aerosol from droppings of infected 
birds. Epidemics of C. psittaci infections in turkeys are economically devastating due to high 
mortality rates, carcass condemnation at slaughter, reduced egg production and/or the cost of 
antibiotic treatment to reduce mortality and allow marketing of turkeys (Vanrompay et al., 
1997). Little is known about the mechanisms by which Chlamydia species manipulate host 
cells and induce disease in different hosts. In spite of diverse infection strategies and 
symptoms, all Chlamydia spp. share a unique, conserved, biphasic developmental cycle. The 
elementary body (EB) is the infectious, metabolically dormant form of Chlamydia, which 
differentiates into the metabolically active reticulate body (RB) after internalization by the 
eukaryotic host cell. The developmental cycle takes place entirely inside a vacuole, called the 
inclusion. After several rounds of exponential growth, the RBs asynchronously differentiate 
into EBs. The infectious EBs are then released from infected host cell through cell lysis or 
inclusion extrusion, thereby closing the developmental cycle.  
Chlamydial proteins are differentially produced in EBs and RBs (Marques et al., 2010; Saka 
et al., 2011). Proteins present on the surface of EBs are of particular interest for vaccine 
development, as they are putative targets for neutralizing antibodies. For many years, 
antibodies against polymorphic membrane proteins (Pmps; previously known as 90-kDa 
protein family) have been detected during natural infections of humans, turkeys and sheep 
(Campbell et al., 1990; Cevenini et al., 1991; Souriau et al., 1994; Giannikopoulou et al., 
1997; Longbottom et al., 1998b; Knudsen et al., 1999) and during experimental infections of 
specific pathogen-free turkeys (Vanrompay et al., 1994; Verminnen et al., 2006). Longbottom 
et al., (1998b), were first to clone and sequence four genes of the 90-kDa gene family. 
Genome sequencing revealed that the pmp genes encode the largest membrane protein family 
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in Chlamydia spp., a unique feature of the genus (Horn et al., 2004; Vandahl et al., 2004). In 
the last decade, the Pmps have been studied intensively, particularly because the Chlamydia 
trachomatis and Chlamydia pneumoniae Pmp families represent a relatively high proportion 
of the coding capacity (3.15 to 5.1%, respectively) in the highly reduced chlamydial genome. 
Moreover the occurrence of the pmp gene family in all currently sequenced chlamydial 
genomes (Grimwood and Stephens, 1999) suggests an important function in chlamydial 
biology. The observed diversity in the number of alleles, gene and protein sequences, size 
(90-190 kDa), and expression levels within and across Chlamydia spp. also suggests that 
Pmps may be responsible for differences in the pathogenesis across Chlamydia species.  
Pmps were classified as autotransported (type V secretion) proteins, based on their N-terminal 
signal sequence (type II secretion), a central passenger domain and a C-terminal putative 
transporter domain, predicted to form a β-barrel through which the protein is secreted to the 
chlamydial surface (Vandahl et al., 2001; Henderson and Lam, 2001). This prediction is 
supported by experimental evidence for several Pmps (Longbottom et al., 1998a; Vandahl et 
al., 2002; Wehrl et al., 2004; Kiselev et al., 2007; Liu et al., 2010). Pmps are grouped into a 
family based on the conserved repetitive motifs FxxN and GGA (with I, L or V at the 4th 
position). In C. trachomatis, they have been further divided into six phylogenetically related 
subtypes (PmpA, B/C, D, E/F, G/I, and H) which may be able to substitute structurally and 
functionally for one another (Grimwood and Stephens, 1999). The passenger domain is 
responsible for the protein’s function (Henderson and Lam, 2001). Pmp6, Pmp20 and Pmp21 
of C. pneumoniae (orthologs of PmpG, PmpB and PmpD of C. trachomatis, respectively) and 
all Pmps of C. trachomatis are proposed to function as adhesins, based on adhesion assays 
and specific neutralization of the infection by incubation of the host cells with the 
recombinant Pmps (Crane et al., 2006; Mölleken et al., 2010; Becker and Hegemann, 2014). 
Up to now, anti-PmpD and anti-Pmp21 antibodies are the only Pmp-specific antibodies that 
are tested for their possible neutralizing capacity. Specific anti-PmpD and anti-Pmp21 
antibodies can partially neutralize C. trachomatis and C. pneumoniae infection, respectively, 
in vitro (Wehrl et al., 2004; Crane et al., 2006; Mölleken et al., 2010). Patients infected with 
C. trachomatis usually elicit high titer antibodies against a subset of the Pmps, that varies 
between infected individuals (Tan et al., 2009). The different antibody profiles in patients 
may reflect different transcription and protein production profiles along the developmental 
cycle or as a result of strain variation or site specificity (Grimwood and Olinger, 2001; 
Vandahl et al., 2002; Tan et al., 2009; Wheelhouse et al., 2009; Carrasco et al., 2011; 
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Wheelhouse et al., 2012b). An attractive hypothesis is that variation of pmp gene expression 
and the resulting antigenic variation phenotype contribute to immune evasion in the infected 
host. Finally, Pmps were reported to be involved in host and tissue tropism (Becker and 
Hegemann, 2014). Previous studies have mainly focused on the Pmps of C. trachomatis 
(Belland et al., 2003b; Crane et al., 2006; Kiselev et al., 2007; Tan et al., 2009; Kiselev et al., 
2009; Swanson et al., 2009; Tan et al., 2010; Carrasco et al., 2011; Saka et al., 2011; 
Humphrys et al., 2013; Becker and Hegemann, 2014) and C. pneumoniae (Vandahl et al., 
2002; Wehrl et al., 2004; Mölleken et al., 2010; Mölleken et al., 2013), both human 
pathogens, and on the zoonotic C. abortus (Longbottom et al., 1998a,b; Wheelhouse et al., 
2009; Wheelhouse et al., 2012a,b; Forsbach-Birk et al., 2013). However, the pmp gene family 
of C. psittaci has not been investigated so far.  
In this study, we hypothesize that Pmps play an important role in C. psittaci pathogenesis and 
in immunity to infection. To test this hypothesis, we studied developmental expression and 
abundance profiles of different Pmps using quantitative real-time PCR (RT-qPCR) and 
immunofluorescence microscopy (IF), respectively, for C. psittaci strain Cal10. Immuno-
electron microscopy (IEM) was used to assess subcellular localization of the Pmps on 
individual chlamydiae. As previous studies suggested a unique role in chlamydial 
pathogenesis for virulence genes expressed during stress, RT-qPCR, IF and EM analyses of 
the pmp transcripts and Pmp products of C. psittaci were conducted under both normal and 
stressed conditions (Carrasco et al., 2011).  
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2. Material and methods 
2.1 Bioinformatics analyses 
We re-annotated the pmp genes of the C. psittaci Cal10 genome (AEZD00000000.1) using the 
Hidden Markov Model that was described in paragraph 2.2 of chapter II. 
2.2 Chlamydia psittaci cell culture conditions 
HeLa 229 cells were seeded in 100 mm² tissue culture dishes for 24h at 37°C with 5% CO2 in 
Dulbecco’s modified Eagle’s medium (DMEM, Mediatech, Herndon, VA) supplemented with 
10% heat inactivated fetal bovine serum (Atlanta Biologicals, Lawrenceville, GA), 
gentamycin (25 µg ml-1; Quality Biological, Gaithersburg, MD) and fungizone (1.25 µg ml-1; 
Invitrogen, Carlsbad, CA). The medium was aspirated and cells were inoculated with C. 
psittaci Cal10 in SPG (0.25 M sucrose, 10 mM sodium phosphate and 5mM L-glutamic acid) 
at a multiplicity of infection (MOI) of 1 followed by incubation on a rocking platform for 2 h 
at 37°C. The unbound organisms were washed away with PBS and the bacterium was grown 
either under normal conditions using the above-mentioned medium, or by adding penicillin 
(100U ml-1) to the above-mentioned medium as a way to induce Chlamydia persistence (Hu et 
al., 2015). One ml SPG was added to a mock-infected dish. For all cells, addition of medium 
after rocking and washing marked time 0 hpi of the experiment. 
2.3 Total RNA extraction and cDNA synthesis 
At 2, 6, 12, 18, 24, 32, and 48 hours post infection (hpi), total RNA was extracted from the 
monolayers according to the manufacturer’s instructions (TRIzol, Invitrogen). Total RNA was 
quantified (Nanodrop 2000, Thermo Scientific, Wilmington, DE) and the samples were 
treated with RNase-free amplification grade DNase I (Promega, Madison, WI) following the 
manufacturer’s protocol and confirmed to be DNA-free by PCR (Table 3.1) for the C. psittaci 
Cal10 16S rRNA gene. One µg of total RNA was reverse transcribed (Superscript II RT, 
Invitrogen) with random hexamer primers (Invitrogen) following the manufacturer’s protocol. 
RNA and cDNA samples were stored at -80°C and -20°C, respectively. 
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2.4 Primer design and validation for RT-qPCR 
Pmp-specific regions were identified by ClustalW2 alignment. Primers for all pmp genes were 
designed using Primer3 software with the following settings: amplicon size of 100-200 bp, 
optimal melting temperature of 60°C and a GC content of 50-60% (Table 4.1). For each 
primer pair, different primer concentrations (100 nM, 150 nM and 200 nM) were tested in 
duplicate. The concentration resulting in the best sigmoid expression curve was chosen (Table 
4.1). Melt curve analysis was used to ensure the specificity of the primers. RT-qPCR 
efficiencies for each gene were determined using slope analysis with a linear regression model. 
Serial dilutions of genomic DNA of purified EBs (1/5 = 8 ng µl-1, 1/25, 1/ 125, 1/625, 1/3125, 
1/15625) were used to generate standard curves. Corresponding RT-qPCR efficiencies (E) 
were calculated according to the equation E = (10(-1/slope)-1) x 100(Pfaffl, 2001). Ideally, 
efficiencies should be between 90-110%, but because of the difficulty to find specific regions 
in the pmp genes, primer pairs with efficiencies outside this range were also used (Table 4.1). 
Obtained Cq-values were corrected for the differences in PCR-efficiencies. Primers that 
displayed a coefficient of correlation greater than 0.98 were selected for RT-qPCR.
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Table 4.1: Primers used for RT-qPCR analysis. 
Gene Primer Primer sequence(5'-3') Amplicon size (bp) Tm (°C) GC (%) Primer concentration (nM) Efficiency (%) 
pmpA pmpA-1 GTCGCCAGAGAAGGTGTTCC 112 62,2 60,0 200 85,6 
 
pmpA-2 GGGACAAGAAGCACTCAACCT 
 
60,7 52,4 200 
 pmpB pmpB-1 TGCTGCAGCGTTAAGAGTGA 116 56,9 50,0 200 66,9 
 
pmpB-2 CCCTAGGCGGTAGCATTACA 
 
56,4 55,0 200 
 pmpD pmpD-1 CCAAGACCCTTTGGATTCACC 115 62,9 52,4 200 95,4 
 
pmpD-2 GGGTATCTTTGCTGGGTCGT 
 
61,3 55,0 200 
 pmpE1 pmpE1-1 CGTGGTAGTATCGATGGTGGAA 101 56,2 50,0 200 88,1 
 
pmpE1-2 GCAGCTGCAACTCGAACAG 
 
57,0 57,9 200 
 pmpE2 pmpE2-1 GGGTTGAGTGGAGGGCATT 112 57,6 57,9 200 77,2 
 
pmpE2-2 CATGGAGACGCACCCAAGT 
 
57,7 57,9 200 
 pmpH pmpH-1 GCAGCTGGATTATCGCCTGT 105 62,6 55,0 200 86,6 
 
pmpH-2 CGCTAACCTCAATGTCCTTGGT 
 
62,6 50,0 200 
 pmpG1a pmpG1a-1 CCTCCAAATCTGAAGGGACA 119 54,3 50,0 200 69,9 
 
pmpG1a-2 GGCAAGGTTACCAGCAGTATCA 
 
57,0 50,0 200 
 pmpG1b pmpG1b-1 GATAGCGTGGCTGTTCGAGT 178 60,4 55,0 200 66,8 
 
pmpG1b-2 ATCCCATACTCTCCGCATCA 
 
60,5 50,0 200 
 pmpG1c pmpG1c-1 AGAAGGTCCCTCTCCGTCAG 174 60,8 60,0 200 63,3 
 
pmpG1c-2 GGTAGAAGCGATCCCGATGT 
 
61,4 55,0 200 
 pmpG1d pmpG1d-1 TGACTGTTGCAGCACTGTCTCT 128 58,7 50,0 200 73,6 
 
pmpG1d-2 CCCTACAGGCGGAGCTATTT 
 
56,7 55,0 200 
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pmpG2 pmpG2-1 CACCACTAATACGGCGGAAA 108 55,0 50,0 200 81,2 
 
pmpG2-2 GCTGTGATGGCTTTGGCTAC 
 
56,7 55,0 200 
 pmpG3 pmpG3-1 CGTAAGGATAGGCGCTTTGG 156 61,9 55,0 200 68,2 
 
pmpG3-2 GACATTCGCGGACCTGTAGT 
 
60,1 55,0 200 
 pmpG4 pmpG4-1 GAGGGTTGCACGTCGATTAG 171 60,7 55,0 200 68,7 
 
pmpG4-2 ATCCATACCGAGGGCTTCA 
 
60,4 52,6 200 
 pmpG5 pmpG5-1 GCGCCTATATGGCTGATGAA 177 61,1 50,0 200 61,2 
 
pmpG5-2 TGATCAAGATTCCCGTCCTG 
 
61,0 50,0 200 
 pmpG6 pmpG6-1 TAGAACCCGCATAGACGTTTCC 131 62,5 50,0 100 63,3 
 
pmpG6-2  GGGATATGTGTTAGGAGCCACA 
 
61,1 50,0 100 
 pmpG7 pmpG7-1  CCCAGAATCCTTCAGAACACAG 194 61,0 50,0 200 66,5 
 
pmpG7-2  GGTGACTACTCTTGGCACGAAA 
 
61,6 50,0 200 
 pmpG8 pmpG8-1  CTGGAGAGTCCTCCCAGGTT 111 60,6 60,0 200 73,3 
 
pmpG8-2  TATCCGCTACAGGGCAAGTC 
 
60,2 55,0 200 
 tufA  ef-tu-1 ACATAGCTTGCATCGCCTTC 125 60,4 50,0 200 92,2 
 
ef-tu-2 GATGCCGAGCTTGTAGACTTG 
 
60,0 52,4 200 
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2.5 Developmental expression of pmp genes (RT-qPCR) 
The expression of the pmp genes was examined by RT-qPCR on an iQ5 Real-Time PCR 
Detection System (Bio-Rad, Richmond, CA). Each reaction mixture contained 1 µl cDNA, 
the optimal primer concentration for each primer pair (Table 4.1), 10 µl iQ SYBR Green 
Supermix (Bio-Rad) and ddH2O to a final volume of 20 µl. RT-qPCR reaction conditions 
were as follows: initial denaturation at 95°C for 3 min, 40 cycles each consisting of 30 s at 
95°C and 30 s at 58°C, followed by the melting curve program (95°C for 1 min, 55°C-95°C in 
steps of 0.5°C each 10 s). Two biological replicates of each sample (normal infection vs. 
penicillin-induced persistence, each at 7 different time points during the developmental cycle) 
were tested in duplicate. Genomic DNA of C. psittaci Cal10 was used as a positive control. In 
addition, tufA encoding the elongation factor EF-Tu involved in protein synthesis was also 
included as a positive control, because the gene is constitutively expressed throughout the 
developmental cycle and it is a reliable indicator of exponential growth (Carrasco et al., 2011). 
cDNA of HeLa 229 cells, non-reverse-transcribed total RNA of C. psittaci Cal10, and ddH2O 
were used as negative controls. Data analyses were carried out with qBasePLUS software 
(version 2.4, Biogazelle, Ghent, Belgium) and validated reference genes (Table 3.4) were 
used for normalization. Expression categories were defined as early (2–6 hpi), middle (12–18 
hpi) and late (> 24 hpi). 
2.6 RT-PCR 
An RT-PCR was performed on cDNA samples (24, 32 and 48 hpi normal condition) to 
evaluate the putative organization of the pmp genes in operons in the C. psittaci Cal10 
genome. Primers spanning the intergenic regions were designed using Primer3 software 
(http://bioinfo.ut.ee/primer3-0.4.0/) (Table 4.2). C. psittaci Cal10 genomic DNA was used as 
a positive control while cDNA from uninfected HeLa 229 cells, non-reverse-transcribed C. 
psittaci Cal10 total RNA and ddH2O were used as negative controls. 
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Table 4.2: Primers spanning the intergenic regions, used for RT-PCR to test the putative organization of pmp genes in operons. 
Intergenic region Primer Primer sequence (5'-3') Amplicon size (bp) Tm (°C) GC (%) 
pmpA, pmpB A-B-F ACCTACTGCGAATATTCACTGTC 225 58.32 43.5 
 
A-B-R GCGACGCTTTTGGTGGTATA 
 
58.64 50 
pmpE1, pmpE2 E1-E2-F CTGAGAAATTGGGCAGGTAAAGA 197 58.66 43.5 
 
E1-E2-R TCCAGATCCACATTATGCAACT 
 
57.49 40.9 
pmpH, pmpG2 H-G2-F GCATGCCTCAACCCTATCGT 207 60.18 55 
 
H-G2-R CAACGGCGCTAGATGGAAAA 
 
58.92 50 
pmpG2, pmpG5 G2-G5-F TGCTAGACAGGATGCAACAAG 260 58.3 47.6 
 
G2-G5-R GGGATCTGGGAAGCCAATTG 
 
58.59 55 
pmpG5, pmpG8 G5-G8-F TTGTCGCCGCTACATTTTGT 561 61.58 45 
 
G5-G8-R AAGACATGCTGCACGATTCG 
 
62.35 50 
pmpG8, pmpG7 G8-G7-F ATATAGCCCCGCCGTTATCG 902 59.54 55 
 
G8-G7-R GAGGGTTAGCTCCATGGACA 
 
58.8 55 
pmpG7, pmpG3 G7-G3-F TAAATTGCCCGCCTCCTGTA 408 59.09 50 
 
G7-G3-R GCTCTGTTGCAAGGATCGAG 
 
58.99 55 
pmpG1d, pmpG1b G1d-G1b-F TGTTGTTCCTTGAGGTGCAG 366 59.87 50 
 
G1d-G1b-R TTGAGCTCCGAGGTTCTTGT 
 
59.99 50 
pmpG1c, pmpG6 G1c-G6-F TTGATCCCCAGCTGTATTCC 419 54.4 50 
 
G1c-G6-R GGTTAACCACAGCGACGAAT 
 
55.4 50 
pmpG6, pmpG4 G6-G4-F GCTCCATTTGCATCGAGAAT 299 60.19 45 
  G6-G4-R CGTTGACATAGGAGGCAGGT   60.13 55 
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2.7 Cloning of pmp genes 
Fragments of pmpA, B, D, E1, G3 and H were amplified from C. psittaci Cal10 genomic DNA 
by PCR using Pfu polymerase (St. Leon-Roth, Germany) and primers flanked with specific 
restriction sites (Table 4.3) for subsequent cloning. The pmpA (aa 309-898) and pmpH (aa 
420-942) fragments were cloned in pGEX-2T (Amersham Pharmacia Biotech, Piscataway, 
NJ), while pmpB (aa 296-955), pmpD (aa 321-1193), pmpE1 (aa 313-958) and pmpG3 
(aa323-791) fragments were cloned in pET-19b (Novagen, Madison, WI) (Figure 4.1). Clone 
inserts were completely sequenced to confirm correct in-frame insertion and N-terminal 
fusion with the GST-tag (pGEX-2T) or His6-tag (pET-19b). 
 
Figure 4.1: Graphical representation of the protein structure of PmpA, PmpB, PmpD 
and PmpH and the cloned fragment of these proteins. FxxN and GGA (I,L,V) motifs are 
shown as orange and black vertical lines, respectively. 
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Table 4.3: Primers and restriction enzymes used for the cloning of the pmp genes. 
Gene Primer Primer sequence (5'-3') Vector 
Restriction 
enzymes 
Molecular mass (kDa) 
Calculated 
pmpA pmpA-F CCCGGGTGCGGAATTTCAGGTTGAGTGC pGEX-2T XmaI 96 
 pmpA-R GGATCCAGCCAAAACTCCGCAGAAGG  BamHI  
pmpB pmpB-F GGATCCAGTGTGAAGCTCGTCTTAGC pET-19b BamHI 74 
 pmpB-R CTCGAGGCTGAATCTGGAATTGGCGG  XhoI  
pmpD pmpD-F CTCGAGCATGCGGATATCCAGTACC pET-19b XhoI 95 
 pmpD-R AAGCTTTTAAGACCACGTTCCCATATGTCC  HindIII  
pmpE1 pmpE1-F AAGCTTTTAAGCATGTCGTGAGTTTGGCG pET-19b HindIII 74 
 pmpE1-R CATATGGCAGACCTTAACGGTGGAGC  NdeI  
pmpG3 pmpG3-F GGATCCAGGGGAGTAGGCCTCCAGA pET-19b BamHI 60 
 pmpG3-R CATATGAACTTTTTCATTCATTCCCCTGA  NdeI  
pmpH pmpH-F GAATTCTCCATTACGAGCGATATGCGC pGEX-2T EcoRI 88 
  pmpH-R GGATCCGGGGATATGGTCTTTATCGGC  BamHI   
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2.8 Expression and purification of recombinant Pmps 
Escherichia coli BL21 cells were transformed by electroporation and Pmp expression was 
induced at an OD600 of 0.5-0.8 upon the addition of 0.1 mM isopropyl β-D-thiogalactoside for 
4 h at 28°C. GST or His6-tagged protein expressing cells were centrifuged (6 000 x g for 15 
min at 4°C), resuspended in ice-cold PBS or in 50 mM sodium phosphate, and 300 mM NaCl 
respectively. Cells were lysed by passing them twice through a French Press cell (American 
Instrument Co., Urbana, IL) followed by sonication (3 x 30 s). One percent Triton X-100 
(Sigma, St Louis, MO) was added and the lysates were placed on ice on a rocking platform 
for 30 min. Soluble and insoluble proteins were separated by centrifugation (16 000 x g for 20 
min at 4°C) and analyzed by sodium dodecyl sulfate-polyacrylamide gel electrophoresis 
(SDS-PAGE). Recombinant Pmps were present in the insoluble fractions, which were 
resuspended in buffer (50 mM Tris-HCl, 1 mM EDTA, 1 mM DTT, and 8 M urea) and placed 
on a rocking platform (1 h, RT). Refolding of the recombinant Pmps was established by 
overnight incubation (42°C) in the non-ionic detergent n-octyl-b-D-glucopyranoside 
(Biosynth, Staad, Switzerland) (McConnell and Pachón, 2011). The samples were dialyzed 
three times against 1x PBS with 0.1% Triton X-100 and subsequently subjected to affinity 
chromatography using a Glutathione-Sepharose 4B (GE Healthcare, Little Chalfont, UK) 
column for GST-tagged proteins, and a TALON metal affinity resin (Clontech, Palo Alto, CA) 
was used for His6-tagged proteins according to the manufacturers’ instructions. The recovered 
recombinant protein fractions were subjected to SDS-PAGE and stained by Coomassie blue. 
Elution fractions containing the recombinant proteins were dialyzed and concentrated with a 
vacuum concentrator (Spectrum Laboratories, Rancho Dominguez, CA). 
2.9 Generation and characterization of Pmp-specific polyclonal antibodies 
Polyclonal antibodies (pAbs) against purified recombinant Pmp E1, H and G3 of C. psittaci 
Cal 10 were generated by immunization of guinea pigs. Animal maintenance and 
experimental treatments were conducted in accordance with the ethical guidelines for animal 
research established and approved by the institutional Animal Care and Use Committee at 
University of Arkansas for Medical Sciences, more specifically this study has been approved 
in protocol number 2975. Two female guinea pigs (strain Hartley) were immunized with each 
antigen. The guinea pigs were housed individually, fed with Harlan Teklad guinea pig diet, 
checked twice a day and sacrificed by carbon dioxide. For each animal, 500 µg of immunogen 
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was mixed with the same volume of Freund’s Complete Adjuvant for primary immunization 
and two subsequent boosters with immunogen and Freund’s Incomplete Adjuvant were 
administered. Previously, pAbs against recombinant PmpA, B and D of C. caviae had been 
generated in the same way (P. Bavoil, unpublished data). All pAbs were characterized by 
immunoblotting using purified recombinant PmpA, B, D, E1, G3 and H of C. psittaci Cal10 
as well as density gradient purified EBs of C. psittaci Cal10 as antigens. The pAbs were pre-
adsorbed with HeLa 229 cells and with inclusion bodies of E.coli BL21 expressing an 
irrelevant antigen (His6-tagged recombinant β-galactosidase or GST, purified by the same 
protocol as the recombinant Pmps) to remove any non-specific reactivity. Secondary HRP-
rabbit anti-guinea pig antibody (Invitrogen) was used for detection.  
2.10 Immunofluorescence microscopy 
At 12, 18, 24, 32 and 48 hpi infected HeLa 229 cell cultures (with or without penicillin) were 
washed with PBS and fixed for 30 min at -20°C with 100% methanol. Monolayers were 
blocked for 1 h with 5% fetal bovine serum and subsequently double-labelled; Chlamydiae 
were stained by anti-LPS-FITC (IMAGEN chlamydia test, Novo Nordisk Diagnostics, 
Cambridge, UK) and Pmps were observed by indirect immunofluorescence after staining with 
anti-PmpA, anti-PmpB, anti-PmpD or anti-PmpH primary antibodies in combination with 
Alexa Fluor 568-conjugated goat anti-guinea pig IgG (Invitrogen), and counterstaining with 
DAPI. Images were acquired and recorded manually via confocal laser scanning microscopy 
(Nikon A1R, Nikon Instruments Inc., Paris, France), using a 40x Plan Apo oil objective with 
a numerical aperture of 1.3. DAPI, FITC and AF568 were respectively excited with a 405 nm 
diode, a 488 nm Ar and a 561 diode laser and their fluorescence emission was respectively 
detected through a 440/50 nm, 525/50 nm and 595/50 nm bandpass filter. The pinhole was set 
to 1 Airy unit and acquisition settings (laser power, gain and offset, scan speed) were kept 
constant throughout the experiment. Image analysis was conducted with ImageJ freeware 
(Schneider et al., 2012) on ten independent experiments by an in-house written colocalization 
script for Image J to determine the percentage of inclusions expressing PmpA, B, D and H, as 
described before (Verdoodt et al., 2012). In brief, the analyses determined the percentage of 
inclusions that is positive for specific Pmp proteins (i.e. above an intensity threshold) by 
calculating the overlap of both binarized channels per object (inclusion). The analysis 
was benchmarked using a manually curated image data set with varying number of positive 
inclusions and varying intensity levels. Two different settings were used: setting 1 with both 
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normal and smaller size inclusions and setting 2 with normal size inclusions only for late 
developmental times.  
2.11 Immuno-electron microscopy 
Infected HeLa 229 cell cultures (with or without penicillin) were fixed in 4% 
paraformaldehyde and 0.1 M PIPES buffer (pH 7.35) at 24 and 48 hpi. Cells were removed 
with a cell scraper, washed, pelleted, and enrobed in 2.5% low-melting-temperature agarose. 
Agarose blocks were trimmed into ~1mm3 size, washed, dehydrated, infiltrated, and 
embedded in unicryl at -20°C under UV from 24 to 48 h. Ultrathin sections were cut on a 
Leica UC6 ultramicrotome (Leica Microsystems, Inc., Bannockburn, IL) and collected onto 
formvar-coated Nickel grids. Immunogold labeling was performed using the guinea pig anti-
PmpA, B, D and H specific pAbs followed by a secondary gold conjugated goat anti-guinea 
pig IgG (H&L) antibody (Electron Microscopy Sciences, Hatfield, PA). Sections were also 
stained using a rabbit anti-MOMP-specific serum followed by a secondary gold conjugated 
goat anti-rabbit IgG (H&L) antibody (Electron Microscopy Sciences). Images were acquired 
using a Tecnai T12 transmission electron microscope (FEI, Hillsboro, OR) at 80 keV and an 
AMT digital camera (Advanced Microscopy Techniques, Woburn, MA).  
2.12 Statistics 
Statistical analyses were performed using R (version 3.0.3). The percentage of positive 
inclusions for PmpA, PmpB, PmpD and PmpH (median for PmpA, B and H and average for 
PmpD) at different times post-infection were compared based on 10 biological replicates by 
use of the non-parametric Kruskal-Wallis test (PmpA, B and H) followed by the Mann-
Whitney test or the parametric one-way ANOVA followed by Tukey’s post hoc analysis 
(PmpD). For 24, 32 and 48hpi the median percentage of positive inclusions for PmpA, PmpB, 
PmpD and PmpH, with both normal size and smaller inclusions included was compared with 
the median percentage of positive inclusions with only normal size inclusions, by the 
Wilcoxon signed rank test. The abundance of the immunogold labeling for PmpA, PmpH and 
MOMP was compared on 10 biological replicates by use of the Kruskal-Wallis test followed 
by the Mann-Whitney test. For all tests, results were considered significantly different if P < 
0.05.  
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3. Results 
3.1 The C. psittaci Cal10 genome encodes 17 predicted pmp coding sequences (CDSs) 
We developed a Hidden Markov Model for the identification of the pmp CDSs in the C. 
psittaci Cal10 genome. Seventeen pmp CDS were identified (Table 4.4), representing 4.1% of 
the genome size at 4 distant genomic loci (Figure 4.2A). All predicted pmp CDSs of C. 
psittaci Cal10, except for pmpG1a, are encoded on the complementary strand (Figure 4.2B). 
Eleven pmpG alleles are present in the genome, two of which (pmpG1c and G1d) are 
predicted to encode truncated products. The pmpG8 allele codes for a 75.81 kDa protein, 
therewith reducing the previously determined lower molecular mass boundary (90 kDa) for 
Pmps (Grimwood and Stephens, 1999). 
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Table 4.4: pmp genes and gene products of C. psittaci Cal10 
a The Chlamydia psittaci Cal10 pmpG sequences were used to search for pmpG sequences across the collection of isolates currently in the NCBI database. All 
hits were parsed, and protein sequences were aligned using ClustalW. The alignments were used to manually subdivide the pmpG family into subfamilies. 
b The theoretical Mw includes the signal sequence.  
Pmp subtypea Start position Stop position Size (bp) Theoretical pI Theoretical Mw (kDa)b Locus tag 
A 222944 225745 2799 8.82 101.84 G5Q_0224 
B 217351 222744 5391 6.04 190.48 G5Q_0223 
D 924237 928841 4602 5.22 163.72 G5Q_0827 
E1 293884 296886 3000 5.86 109.95 G5Q_0290 
E2 296908 299793 2883 6.60 106.57 G5Q_0291 
G1a 710413 712956 2541 5.25 91.27 G5Q_0648 
G1b 322009 324513 2502 5.81 89.39 G5Q_0303 
G1c 326413 327735 1320 5.16 45.85 G5Q_0306 
G1d 320559 321878 1317 4.96 45.34 G5Q_0302 
G2 304565 307696 3129 7.55 110.88 G5Q_0294 
G3 316390 318924 2532 8.01 92.34 G5Q_0300 
G4 330783 333605 2820 6.24 100.51 G5Q_0308 
G5 307929 310211 2280 7.94 83.90 G5Q_0296 
G6 327859 330555 2694 5.79 95.08 G5Q_0307 
G7 313712 316234 2520 6.50 90.12 G5Q_0299 
G8 310741 312858 2115 6.77 75.81 G5Q_0297 
H 301585 304539 2952 7.06 105.05 G5Q_0293 
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Figure 4.2: pmp CDS organization in the C. psittaci Cal10 genome. (A) The pmp CDSs map to 4 distinct loci on the C. psittaci Cal10 genome. 
Distances (bp) between nearest loci are indicated. (B) Linear representation of the pmp loci. CDSs and inter-CDS regions are drawn to scale. 
Number of bp between 2 nearest CDSs are indicated. A break (//) is added if the inter-CDS region is bigger than 5000 bp. 
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3.2 Transcription of pmp CDSs 
To start unravelling Pmp function, we first determined the timing of pmp transcription during 
chlamydial development. To this end, pmp transcript levels were measured under normal 
culture conditions at early (2 and 6 hpi), mid (12 and 18 hpi), and late (24, 32 and 48 hpi) 
stages of the developmental cycle (Figure 4.3). Analysis at very late developmental times (e.g. 
72 hpi) was not possible because of gradual loss of viability and lysis of the host cells. The 
gene tufA (encoding Elongation Factor Tu, EF-Tu) was included for comparative purposes as 
a house-keeping gene presumed to be expressed throughout the developmental cycle 
(Carrasco et al., 2011). Unexpectedly, transcript levels for tufA peaked at 6 hpi, then gradually 
diminished until 32 hpi, and rose again at 48 hpi. Overall, all pmp CDSs were transcribed at a 
detectable level at some stage of the developmental cycle. All pmp genes, were transcribed at 
very low levels early in the developmental cycle (2 hpi), except pmpA, pmpH, and pmpG5, 
that were transcribed at or near peak levels. For most pmp genes (pmpE1, pmpE2, pmpG1a, 
pmpG1b, pmpG1c, pmpG1d, pmpG2, pmpG3, pmpG6, pmpG8, and pmpH), transcript levels 
were highest at 24, 32 and 48 hpi, typically peaking at 24 hpi except for pmpG3 and pmpG6 
that peaked at 32 and 48 hpi respectively, and pmpG8 that remained high from 24 hpi onward. 
Surprisingly, pmpH transcription was highest at 2-6 hpi, minimal at 12-18 hpi and rose again 
to similar high level from 24 hpi onward. Somewhat similarly, pmpA transcript levels were 
highest between 2 and 18 hpi, and, although lower, rose again from 24 hpi onward. pmpB 
transcription was highest between 18 and 32 hpi. Transcription of pmpD and pmpG4 peaked 
at 48 hpi. 
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Figure 4.3: Relative expression of the pmp genes during normal C. psittaci culture 
conditions. At 2, 6, 12, 18, 24, 32 and 48 hpi, transcript levels were measured by real-time 
RT-qPCR in C. psittaci grown under normal conditions. For each gene, the average 
expression level of all samples was determined and the expression level of each sample of that 
gene is represented relative to the average expression level. Therefore, the expression level of 
a sample can only be compared to the expression level of another sample of the same gene. 
Two biological and two technical replicates were analyzed for each sample. Error bars are 
based on the standard error of the mean. 
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3.3 pmp transcription is altered during penicillin-induced stress in C. psittaci  
Previous studies suggested a unique role for pmpA, pmpD and pmpI in C. trachomatis 
intracellular pathogenesis as the transcription of these genes remained unaffected during 
penicillin-induced stress, while the expression of all other pmp genes was down-regulated 
(Carrasco et al., 2011). Therefore, we compared transcript levels of all pmp genes during 
normal C. psittaci culture conditions and penicillin-induced stress (Figure 4.4). Transcription 
of tufA, pmpB, pmpD, pmpG2, pmpG4 and pmpG8 was up-regulated, while that of pmpA, the 
co-regulated pmpE1-E2, pmpH, pmpG1a-d, pmpG3 and pmpG6 was down-regulated. 
 
Figure 4.4: Fold change of the pmp genes during penicillin-induced stress compared 
normal C. psittaci culture conditions. At 2, 6, 12, 18, 24, 32 and 48 hpi, transcript levels 
were measured by real-time RT-qPCR in C. psittaci grown under normal conditions and in the 
presence of penicillin. For all samples, the fold change of the penicillin-induced stress 
condition compared to the normal condition is shown.  
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3.4 Most pmp genes of C. psittaci Cal10 are not co-transcribed 
The genetic linkage and colinearity of pmpG4-G6-G1c, pmpG1b-G1d, pmpG3-G7, pmpG8-
G5-G2-H, pmpE2-E1 and pmpA-B (Figure 4.2) suggested that these genes might be organized 
in operons, leading to co-transcription. To partially test this hypothesis, we performed RT-
PCR using primers designed to span the relevant intergenic regions (Table 4.3) on cDNA 
samples generated during normal cell culture conditions at 24, 32 and 48 hpi. The latter time 
points were selected as the pmp genes of C. trachomatis, C. pneumoniae and C. abortus were 
highly transcribed at mid and late time points (Grimwood and Olinger, 2001; Wheelhouse et 
al., 2009; Carrasco et al., 2011). Only intergenic regions between pmpE1-E2 and pmpH-G2 
were amplified (Figure 4.5), suggesting that pmpE1-E2 and pmpG2-H are arranged in operons, 
whereas that pmpG4-G6-G1c, pmpG1b-G1d, pmpG3-G7, pmpG8-G5, and pmpA-B are not.  
 
Figure 4.5: pmpE1-E2 and pmpH-G2 are organized in operons. Based on co-linearity, 6 
putative operons were identified: pmpE2-E1, pmpG8-G5-G2-H, pmpG3-G7, pmpG1b-G1d 
pmpG4-G6-G1c, and pmpA-B. cDNAs generated at 24, 32 and 48 hpi were amplified by RT-
PCR using specific primers spanning the intergenic regions (Table 2). Only results for 
pmpE1-E2 and pmpH-G2 are presented as amplicons were not detected for all other intergenic 
regions. M: MassRuler Low Range DNA ladder (Thermo Scientific); +C: positive control C. 
psittaci Cal10 genomic DNA; -C HeLa: negative control cDNA from uninfected HeLa cells; 
RT/NRT: with or without reverse transcriptase. 
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3.5 Protein production profiles differ between C. psittaci Pmps 
RT-qPCR profiles provide an indication of when the pmp genes are transcribed at the 
population level. To assess expression at the protein level in individual inclusions, polyclonal, 
monospecific antibodies against PmpA, PmpB, PmpD, PmpE1, PmpG3, and PmpH were 
generated in guinea pigs. Analysis of the specificity of the antisera by immunoblot against a 
panel of recombinant Pmps (rPmps) and gradient-purified C. psittaci EBs indicated that 
PmpA-, PmpB-, PmpD- and PmpH-specific antibodies reacted with high molecular mass 
bands (Figure 4.6A) in the corresponding immunizing antigen lane, while PmpE1- and 
PmpG3-specific antibodies cross-reacted with multiple bands in multiple lanes (not shown). 
Therefore, PmpA-, PmpB-, PmpD- and PmpH-specific antisera were selected for further 
analysis. The observed molecular masses of rPmpA and rPmpH were smaller than the 
calculated molecular masses of the corresponding recombinant polypeptides. This may be 
caused by the instability of the full-length recombinant polypeptides. rPmpH was detected as 
a triplet of bands of 75, 70 and 60 kDa. However, the 70kDa band was also detected in the 
rPmpD and rPmpG lanes, suggesting that it is an Escherichia coli cross-reactive contaminant. 
Antibody-reactive bands detected in Western blots against purified EB proteins, were also 
smaller than the calculated molecular masses of each Pmp (Figure 4.6B), suggesting that 
proteolytic processing or degradation of these Pmps may have occurred pre- or post-EB 
purification. 
Characterization of Pmp proteins in C. psittaci                                                                      97 
 
Figure 4.6: Guinea pig polyclonal antibodies against PmpA, B, D and H are specific for 
their respective immunizing antigens. (A) The specificity of polyclonal antibodies raised 
against rPmpA (α PmpA), rPmpB (α PmpB), rPmpD (α PmpD) and rPmpH (α PmpH) was 
verified by immunoblotting using (A) partially purified recombinant PmpA, B, D, E1, G3 and 
H as well as (B) density gradient purified EBs of C. psittaci Cal10. The calculated molecular 
masses of recombinant PmpA, PmpB, PmpD, PmpE1, PmpH and PmpG3 are 92 kDa, 74 kDa, 
95 kDa, 74 kDa, 88 kDa and 60 kDa, respectively. The observed molecular masses were 75 
kDa, 74 kDa, 95 kDa, 70 kDa, 75 kDa and 60 kDa, respectively. (B) The calculated and 
observed molecular masses of the protein bands detected in EBs are shown. 
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Immunofluorescence microscopy (IF) was used to investigate the PmpA, PmpB, PmpD and 
PmpH protein production profiles in individual inclusions in 10 biological replicates, and to 
examine potential post-transcriptional and post-translational regulation. Inclusions positive for 
a specific Pmp subtype were determined under normal C. psittaci culture conditions and 
during penicillin-induced stress (Figure 4.7). The same time points as used for RT-qPCR were 
analyzed. At 24 and 48 hpi, both large size and smaller, ovoid and irregularly shaped 
inclusions were observed during normal culture conditions, possibly the result of the 
asynchronous start and/or growth of these inclusions.  
A macro excluding the smaller inclusions was used to quantify the percentage of inclusions 
producing PmpA, PmpB, PmpD and PmpH, as the large inclusions are representative for the 
late developmental times (Figure 4.8). At 12 hpi, under normal C. psittaci culture conditions, 
PmpA was highly produced in all 10 biological replicates, with a median of 90% PmpA 
positive inclusions (Figure 4.8). At the same developmental time, PmpH was not equally 
produced in all replicates, such that in 3 replicates, PmpH was detected in 88% of the 
inclusions, while in 7 replicates, it was only detected with a median of 4% positive inclusions. 
Thus, PmpH production displayed substantial variation between cultures inoculated with the 
same seed. Neither PmpB- nor PmpD-positive inclusions were detected at 12 hpi and PmpB-
positive inclusions were also not detected at 18 hpi. At 24, 32 and 48 hpi, PmpA and PmpH 
were highly expressed in all replicates with a median percentage of positive inclusions of 
100%. PmpB was first detected at 24 hpi in a median of 67% of the inclusions and was highly 
expressed in all inclusions at 32 and 48 hpi (median of 100%). Noticeably, the expression of 
PmpD varied significantly between biological replicates at 18 and 24 hpi, as PmpD was not 
detectably produced in 1 replicate at both times and between 88% and 99% in the other 9 
replicates.  
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Figure 4.7: The Pmp production profile differs for different Pmp subtypes. C. psittaci-infected 
HeLa cells were fixed at 12, 18, 24, 32 and 48 hpi, and double-stained with chlamydial LPS-specific 
antibody (FITC-conjugated, green) and Pmp-specific antibody (Alexa Fluor 568-conjugated, red). At 
12 and 18 hpi, only colored merged images are shown under normal and penicillin-induced persistence 
culture conditions (top row). At 24 and 48 hpi, single channel images are shown in black and white (2 
left-most columns), while merged images and insets thereof are shown in color (2 right-most columns). 
Representative micrographs for (A) PmpA, (B) PmpB, (C) PmpD and (D) PmpH are shown. Staining 
patterns at 32 hpi (not shown) were similar to those at 48 hpi. Bar = 2 µm for the 12 and 18 hpi times, 
and 24 and 48 hpi insets (i.e. top row and right-most column) and 10 µm for all remaining images. 
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Figure 4.8: PmpA, B, D and H production differs under normal (n) C. psittaci and 
during penicillin-induced stress (p) culture conditions. C. psittaci infected HeLa cells were 
fixed at 12, 18, 24, 32 and 48 hpi, and double-stained with a chlamydial LPS-specific 
antibody and Pmp-specific antibody. For each Pmp subtype, the percentage of positive 
inclusions was determined by a macro based on co-localization of the two antigens. The 
results shown here did not take into account smaller inclusions that are formed at 24, 32 and 
48 hpi. The data are expressed as box plots: the box represents the 25th-75th percentiles, the 
median is depicted by a bar across the box and the whiskers on each box represent minimum 
and maximum value. Outliers are depicted by dots. Statistically significant differences (P < 
0.05) are indicated with an asterix. 
 
3.6 Penicillin-induced stress differentially alters protein production profiles of specific C. 
psittaci Pmps 
Because of their obligate intracellular life style, the pathogenesis of chlamydiae is intimately 
linked to their capacity to grow inside cells and on their specific physiologic properties in 
response to threats such as innate host defenses or nutrient deprivation. To start evaluating 
potential differential production of Pmp subtypes under different growth conditions, we used 
penicillin-induced stress as a previously well-defined modulator of pmp gene expression in C. 
trachomatis (Carrasco et al., 2011). Under penicillin-induced stress, PmpA was the only 
detectable Pmp at the early developmental time of 12 hpi (Figures 4.7 & 4.8). PmpA 
production was observed in all 10 biological replicates, yielding a median of 61% PmpA 
positive inclusions, which is significantly lower than the 90% observed during the normal 
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condition (Figure 4.8). At the same developmental time, PmpH was unevenly expressed with 
100% of the inclusions staining positive for PmpH in 1 biological replicate, but only 0.3% in 
the other nine, yielding a median of 0.5% PmpH-positive inclusions (Figure 4.8) Thus, we 
showed a substantial variation in PmpH production. PmpB and PmpD, which were not 
expressed at 12-18 hpi, and 12 hpi respectively in unstressed cultures, were also not detected 
at these times during penicillin-induced stress (Figures 4.7 & 4.8).  
At 18, 24, 32 and 48 hpi, PmpA, PmpD and PmpH were expressed in all biological replicates 
experiencing penicillin-induced stress at levels at or near those of unstressed cultures (Figure 
4.8). The median percentage of Pmp positive inclusions was 100% for PmpA at all time 
points and 91%, 100%, 100% and 100% at 18, 24, 32 and 48 hpi respectively for PmpH. 
Relatively fewer PmpD-positive inclusions (59%) were observed at 18 hpi, i.e. significantly 
less than for PmpA and PmpH (P < 0.05), while 93%, 84% and 88% of the inclusions were 
PmpD-positive at 24, 32, 48 hpi, respectively, under penicillin-induced stress. Interestingly, at 
18 hpi and 32 hpi, the level of PmpD expression also varied among the biological replicates 
experiencing penicillin-induced stress, with no expression in 1 replicate, and 65% to 88% 
respectively in the remaining nine. PmpB expression was significantly down-regulated at all 
developmental times during penicillin-induced stress (Figure 4.8). It is noteworthy that the 
median percentages of inclusions producing PmpB, PmpD or PmpH rose significantly (P < 
0.05) when smaller inclusions were omitted from the analysis. However, this was not the case 
for PmpA, highlighting the very high level of expression of PmpA at early stages of the C. 
psittaci developmental cycle. 
3.7 PmpA, PmpD and PmpH target the chlamydial cell envelope 
Immuno-electron microscopy (IEM) was used to assess the subcellular localization of PmpA, 
PmpB, PmpD and PmpH at the late developmental times under both normal conditions and 
under penicillin-induced stress. Probably due to compromised antigen recognition or 
accessibility during dehydration and fixing for IEM, PmpB staining was poor preventing 
further analysis of ths Pmp subtype by this method. In general, the levels and topology of the 
three remaining Pmps were grossly similar under both unstressed and stressed conditions. 
IEM revealed strong PmpA-specific signal mostly localized at the chlamydial cell envelope in 
both unstressed and stressed cultures (Figure 4.9A). PmpH IEM staining was similar to that of 
PmpA in localization and relative abundance in both unstressed and stressed cultures (Figure 
4.9A). PmpD-specific labeling was also observed at the chlamydial envelope, but less 
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abundant than PmpA and H (Figure 4.9A). To evaluate relative antigenicity and immuno-
accessibility, we compared IEM staining of MOMP, the most abundant chlamydial protein 
and a strong antigen during infection in other Chlamydia spp. (Caldwell et al., 1981; Caldwell 
et al., 1987), with that of C. psittaci PmpA and PmpH at 24 hpi (Figure 4.9B). Surprisingly, 
PmpA and PmpH were significantly more labeled at the cell envelope than MOMP (P < 0.05, 
Figure 4.9C). PmpA was also significantly more labeled than PmpH (P < 0.05).  
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Figure. 4.9: PmpA and PmpH stain more heavily in the chlamydial envelope than 
MOMP. (A) Immuno-electron microscopic images of C. psittaci infected HeLa cells, which 
were fixed at 24 and 48 hpi both during normal cell culture conditions and during penicillin-
induced persistence, and stained with the primary Pmp-specific antibody and the secondary 
gold conjugated goat anti-guinea pig antibody. Only results for 24 hpi are shown, as the 
subcellular localization did not change at 48 hpi. (B) Immuno-electron microscopic image at 
24 hpi during normal cell culture conditions only, the cells were also labeled with MOMP-
specific antibody and the secondary gold conjugated goat anti-rabbit antibody. (C) C. psittaci 
infected HeLa cells were fixed 24 hpi, labeled with MOMP-, PmpA- and PmpH- specific 
antibodies and secondary gold conjugated goat anti-rabbit (MOMP) or gold conjugated goat 
anti-guinea pig (PmpA and H) antibody and the number of immunogold particles was counted 
on 100 chlamydiae. Error bars are based on standard error of the mean. Different letters 
indicate statistically significant differences (P < 0.05). Bars = 0.1 µm. 
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Detailed examination of higher magnification images revealed inclusion membrane labeling 
and suggested inner and outer membrane labeling of all analyzed Pmps (Figure 4.10). At 48 
hpi, most of the penicillin-stressed aberrant bodies were lysed, probably due to the harsh EM 
fixation technique. Therefore, only normal culture conditions IEM images were analyzed. As 
observed at 24hpi, the order of the Pmps in decreasing amount of immunogold labeling was 
PmpA, PmpH and PmpD. PmpA-, PmpD- and PmpH-specific staining of small vesicles, 
possibly corresponding to outer membrane vesicles (OMVs) was observed at 48 hpi during 
normal cell culture conditions (Figure 4.11). Both labeled and unlabeled vesicles were 
observed. 
 
Figure 4.10: PmpA, PmpD and PmpH localize to the inclusion membrane and probably 
also to the inner membrane (IM), outer membranes (OM). Immuno-electron microscopic 
images of C. psittaci infected HeLa cells, which were fixed at 24 hpi and stained with the 
primary PmpA-, PmpD- or PmpH- specific antibody and secondary gold conjugated goat anti-
guinea pig antibody. The suggested IM and OM localization is shown for PmpA only (A, long 
arrows). Inclusion membrane labeling (short arrows) is displayed for PmpA, D and H (B, C 
and D respectively). Bars = 0.1 µm.  
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Figure 4.11: PmpA, PmpD and PmpH localize to vesicles observed at 48 hpi. Immuno-
electron microscopic images of C. psittaci infected HeLa cells, which were fixed at 48 hpi and 
stained with primary PmpA-, PmpD- or PmpH-specific antibodies and secondary gold 
conjugated goat anti-guinea pig antibody. Arrows point to the vesicles. Bar = 0.1 µm. 
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4. Discussion 
4.1 Transcription of pmp genes 
An ultimate assessment of the involvement of the Pmp family in C. psittaci virulence and 
their potential use as vaccine candidates requires the fundamental characterization of the 
expression and topology properties of these proteins. We used C. psittaci Cal10, a previously 
well-characterized, prototypic strain (Narita et al., 1976; Matsumoto, 1982; Hovis et al., 2013; 
Mojica et al., 2015), with a complete genome sequence (Grinblat-Huse et al., 2011). 
Consistent with observations of pmp gene expression in other Chlamydia species (Grimwood 
and Olinger, 2001; Wheelhouse et al., 2009; Carrasco et al., 2011), transcripts were 
detectable for all 17 C. psittaci pmp CDSs, although the level of transcription varied over a 
wide range between pmps and with developmental time for each pmp. Although nearly all 
pmp transcript levels were high at late developmental times (24-48 hpi; typically with a dip at 
48 hpi), pmpA transcript levels were high at early-to-mid developmental times (2-18 hpi), 
similar to the pmpA ortholog of C. trachomatis, but opposite to the late expressed pmpA 
ortholog of C. abortus (Wheelhouse et al., 2009; Carrasco et al., 2011). Transcript levels for 
pmpH stood out in that they were high at early (2-6 hpi), low at mid (12-18 hpi) and high 
again at late developmental times (24-32 hpi). This feature appears to be unique for pmpH of 
C. psittaci as in all other species, pmpH is characteristically transcribed late (Wheelhouse et 
al., 2009; Carrasco et al., 2011) and suggests PmpH plays an important role at both ends of 
the C. psittaci developmental cycle. It also indicates that pmpH transcript is relatively 
unstable during mid-cycle development. These observations and the additional observation 
that pmpH is co-transcribed with pmpG2 suggest that the regulation of pmpH expression may 
follow a complex, multi-level mechanism, and may betray a key role of PmpH in overall Pmp 
function in C. psittaci.  
Late transcription of most pmp genes is in general agreement with the results of pmp 
transcription analyses for C. abortus and C. trachomatis where all pmp genes, with the 
exception of pmp5E for C. abortus and pmpA and I for C. trachomatis, were differentially 
highly expressed during late development (Wheelhouse et al., 2009; Carrasco et al., 2011). It 
is also consistent with transcription of the pmp gene family in C. pneumoniae, where 
transcripts could be detected for all known pmp genes at 72 hpi (Grimwood and Olinger, 
2001). Globally, transcription analyses of pmp gene families across several Chlamydia 
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species suggests an important role for these proteins either at late stages of development or, 
upon storage of late-expressed Pmps in EBs during the early steps of infection. The 
expression level of a large subgroup of pmp genes, including pmpE and most pmpG alleles 
parallels that observed for their respective pmp orthologs in other Chlamydia species 
(Wheelhouse et al., 2009; Carrasco et al., 2011). Conversely, differences at the species level 
(e.g. pmpA and pmpH of C. psittaci Cal10 versus orthologs in C. trachomatis and C. abortus) 
may reveal functional differences that are intrinsic to the properties of each species. 
Multiple types of stress have been shown to affect chlamydial growth and morphology and to 
down- or up-regulate various chlamydial genes important in virulence (Hogan et al., 2004; 
Mpiga and Ravaoarinoro, 2006; Goellner et al., 2006). We used penicillin-induced stress to 
comparatively investigate pmp transcription and Pmp production in C. psittaci inclusions, 
because the expression of pmpA, pmpD and pmpI genes of C. trachomatis, was uniquely not 
affected by penicillin-induced stress and therefore they were previously hypothesized to play 
a critical role in the pathogenesis of C. trachomatis (Carrasco et al., 2011). In C. psittaci 
Cal10, the expression of all pmp genes was affected by penicillin, as it either resulted in a 
down- or an up-regulated expression level but unaffected expression was not observed. 
Adding penicillin resulted in a lower transcript level for all pmp genes except for pmpB, 
pmpD, pmpG2, pmpG4 and pmpG8, as their transcript levels were augmented as for tufA. This 
might be an indication for being even more important in the biology of C. psittaci and/or it is 
a (survival) response to stress, by creating antibiotic resistance, like described for the 
expression of prokaryotic heat shock proteins in the presence of penicillin in other bacteria, 
like for instance Streptococcus pneumoniae. The major heat shock protein and molecular 
chaperon Clpl of S. pneumoniae play a role in increased resistance to penicillin by 
augmenting the expression and translocation of the penicillin-binding protein PBP2x to the 
bacterial cell wall, leading to increased resistance to penicillin (Tran et al., 2011). In our study, 
C. psittaci Cal10 remained susceptible to penicillin, but less susceptible than C. trachomatis, 
as more and smaller aberrant bodies were observed for C. psittaci compared to C. trachomatis 
(data not shown). This indicates that aberrant RBs of C. psittaci can divide in the presence of 
penicillin and therewith suggest that C. psittaci is less susceptible to penicillin. This is 
confirmed by a minimal inhibitory concentration (MIC) of 0.1 µg/ml and 1 µg/ml for 
penicillin for C. trachomatis and C. psittaci respectively (Tamura and Manire, 1968; Kuo et 
al., 1977). The possible involvement of PmpB, PmpD, PmpG2, PmpG4 and PmpG8 in 
mediating penicillin-resistance should further be examined, for example by inducing stress 
Characterization of Pmp proteins in C. psittaci                                                                      111 
through iron depletion or IFN-ɣ, where we do not expect up-regulation of the corresponding 
pmp genes. 
To assess transcriptional regulation, we examined the putative organization of the C. psittaci 
pmp CDSs in operons. Remarkably, only the pmpE2-E1 and pmpG2-H intergenic regions 
were amplified. Thus, it seems like most pmp genes of C. psittaci Cal10 are not cotranscribed. 
As the expression of all pmp genes at late time points was confirmed by RT-qPCR, the 
negative result is not due to the chosen time points. Our results differ from the ones obtained 
for C. trachomatis, where the intergenic regions of pmpA-B-C, pmpF-E and pmpG-H were 
cotranscribed indicating their organization in operons. Although pmpG2 and pmpH are 
organized in an operon, the two genes have a distinct developmental profile at 2 and 6 hpi, 
which might be the result of a second promoter in addition to the operon promoter. The latter 
was also suggested for the pmpABC operon of C. trachomatis (Carrasco et al., 2011).  
4.2 Protein production profiles differ for different C. psittaci Pmp proteins 
The expression level of the pmp genes in the population is determined by RT-qPCR. However, 
different variants may be present in the population (e.g. due to SNPs) (Read et al., 2000; 
Jasper et al., 2015). To address this issue, we investigated pmp expression at the protein level 
both during normal and during penicillin-induced stress cultures, using immunofluorescence 
(IF) and immuno-electron microscopy (IEM) to determine Pmp production respectively at the 
inclusion and at the chlamydial cell levels, in multiple biological replicates. We will first 
focus on the normal culture condition. The early high-level pmpA transcription was matched 
by high-level production of PmpA during all stages of development in all biological replicates, 
indicating the relative stability of the pmpA mRNA and PmpA protein and suggesting a 
relative absence of pmpA variation at the genomic level in the study population (the C. 
psittaci culture). PmpB, whose transcript level peaked mid-cycle was detectably produced late 
in the majority of inclusions in all replicates. Production of PmpD was also detected at 
developmental times generally corresponding to maximum transcription levels, but was 
undetectable in one of ten biological replicates at 18 and 24 hpi. The latter was also observed 
for PmpH, whose transcript exhibited discontinuous high-low-high levels during development, 
was strongly produced late in all replicates, but only in some of the replicates at mid 
developmental cycle. This may be loosely comparable to the on-off phase-like variation 
described for Pmps of C. trachomatis (Tan et al., 2010).  
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Next, we focus on the penicillin induced-stress condition. Similar to its ortholog in C. 
trachomatis (Carrasco et al., 2011), production of PmpA was not significantly affected by 
penicillin-induced stress. PmpB production was also similarly down-regulated in C. psittaci 
and C. trachomatis. PmpD and PmpH productions however, whose orthologs are down-
regulated in C. trachomatis (Carrasco et al., 2011), were unaffected by penicillin in C. psittaci. 
This may again highlight a yet-to-be-determined species-specific function of PmpD and 
PmpH in C. psittaci. It is noteworthy that transcript and protein levels observed for the Pmps 
during penicillin-induced stress culture conditions were not always concordant. For example, 
pmpA and pmpH transcript levels were lower during stress, but the protein levels showed no 
significant difference (except 12 hpi for PmpA). Similar findings were observed for C. 
trachomatis, in which pmpF transcription was shut down during stress, while the same 
amount of PmpF protein was present during both normal and stress conditions (Carrasco et al., 
2011). These results implicate the existence of unknown posttranscriptional and 
posttranslational mechanisms in Chlamydia spp. and suggest the occurrence of multiple 
transcripts and proteins, which can display a different stability under specific conditions.  
The infectious EB was previously suggested to determine the on/off status of each Pmp 
subtype in an inclusion, as the off frequency did not change over developmental times in C. 
trachomatis (except for pmpG) (Carrasco et al., 2011). However, the off frequency of C. 
psittaci Pmps did change over time, as was the case for C. abortus (Wheelhouse et al., 2012b). 
Furthermore, 10 biological replicates were analyzed in this study and the percentage of PmpD 
and PmpH positive inclusions ranged from 0% to 100% in some replicates. This is 
reminiscent of PmpG production in C. trachomatis cultures, where the percentage of PmpG-
positive inclusions varied between 90 and 99% between experiments (Tan et al., 2010). In 
contrast, the observed high rate of variation of PmpD production at the inclusion level at two 
developmental times is entirely discordant from that observed for PmpD of C. trachomatis, 
which was the least frequently “off” Pmp subtype in this species (Tan et al., 2010). It is 
unlikely that individual replicates were infected with EBs with PmpD or PmpH in either on- 
or off- status, as all replicates were infected with the same seed. These results suggest that it is 
not the incoming EB that determines the on/off status of Pmp production in an inclusion in C. 
psittaci. We postulate that another mechanism determines the on/off status of Pmps and we 
suggest a mechanism which is both tightly regulated and involves variable factors. For 
example, frame shifts, SNPs and reversible recombination of pmp gene fragments from 
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transcriptionally silent CDSs into expressed pmp genes, might explain the variation between 
biological replicates.  
4.3 PmpA, PmpD and PmpH target the chlamydial cell envelope 
IEM was used to assess the subcellular localization of the Pmps. PmpA, D and H localized at 
the C. psittaci cell envelope. This is consistent with the observed surface localization for all 
nine Pmps of C. trachomatis (Crane et al., 2006; Swanson et al., 2009; Tan et al., 2010), 
Pmp6, 8, 10, 11, 18 and 21 of C. pneumoniae (orthologs of PmpGs [Pmp6, 8, 10 and 11], 
PmpE and PmpD of C. trachomatis, respectively) (Vandahl et al., 2002; Wehrl et al., 2004) 
and the 90kDa Pmp (ortholog of PmpG of C. trachomatis) of C. abortus (Longbottom et al., 
1998a). However, there have not been any thorough investigations to distinguish inner and 
outer membrane labeling. The IEM images suggested labeling of PmpA, D and H at the inner 
and outer membrane, but better resolution images are needed to provide conclusive evidence. 
Remarkably, we observed more abundant antibody labeling of PmpA and H at the chlamydial 
cell envelope compared to MOMP, the major surface-accessible protein in all Chlamydia 
species. Although this observation may owe to differential properties of the antibodies or the 
influence of the post-embedding immunolabeling techniques used in our analysis, it may also 
relate to the unusual antigenicity and immuno-accessibility of these 2 proteins in C. psittaci. 
Similar abundant Pmp labeling at the cell envelope has not been observed for C. trachomatis 
and C. pneumoniae, which are phylogenetic relatively distant from C. psittaci (Sachse et al., 
2015). However, the 90kDa Pmp of C. abortus, a close phylogenetic relative of C. psittaci, 
was also abundantly labeled at the chlamydial surface (Longbottom et al., 1998a). We also 
detected PmpA-, D- and H-specific immunogold-labeling of small vesicles within the 
inclusion and of the inclusion membrane itself, which was not observed before for other 
Chlamydia species. We speculate that the observed vesicles may have pinched-off from the 
outer membranes of RBs and fused to the inclusion membrane. Similarly, Vanrompay et al., 
(1996) observed the small vesicles within the inclusion of four different C. psittaci strains and 
suggested that the fusion of these vesicles with the inclusion membrane could account for its 
labeling by the polyclonal antibodies used in their study. Similar results were also reported by 
Taraska et al., (1996), who suggested that the expansion of the inclusion membrane of C. 
trachomatis and C. psittaci is driven by fusion with bacterium-derived material. Comparable 
shedding of vesicular material and the contiguous localization of these vesicles with the 
vacuolar membrane has also been observed for intracellular protozoan parasites (Sibley et al., 
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1986; Speer and Whitmire, 1989). More thorough IEM analyses are needed to confirm 
whether inclusion membrane and small vesicle labeling is unique for C. psittaci Pmps and if 
the remaining C. psittaci Pmps are also found at those membranes. Further research is needed 
to elucidate the function of Pmps present at those membranes. 
In conclusion, C. psittaci Cal10 has 17 pmp genes. Our experiments confirmed that variation 
is a central requisite of the C. psittaci Pmp family as gene transcription profiles and protein 
expression profiles differed along development and in different biological replicates. We 
detected PmpA-, D- and H- specific immunogold-labeling of the inclusion membrane and of 
small vesicles within the inclusion membrane. In addition, the IEM images suggested PmpA-, 
D- and H- specific immunogold-labeling of the inner and outer membrane of Chlamydia 
particles. PmpA and PmpH of C. psittaci, by virtue of their unique expression properties 
emerge as important players in pathogenesis and their apparent 
immunoaccessibility/antigenicity suggest their potential in vaccine design.  
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Abstract 
Chlamydiaceae are very successful pathogens and up to now no vaccine is available for none 
of the Chlamydia species. As the infections lead to significant economic losses in animal 
production, the need for an effective vaccine is high. Immunity to Chlamydia infections is 
mainly mediated by cellular immune responses. In general, the proteins present in the 
Chlamydia outer membrane complex are expected to be important for vaccine design. The 
composition of the chlamydial outer membrane complex was previously only determined for 
C. trachomatis, C. abortus and C. pneumoniae. We therefore determined whether PmpA, 
PmpB, PmpD and PmpH proteins of C. psittaci are present in the C. psittaci outer membrane 
complex by immuno-electron microscopy. Those four Pmp proteins are the most conserved 
Pmp proteins of C. psittaci and we therefore hypothesize that they are essential for the 
pathogenesis of C. psittaci. For all analyzed Pmp proteins specific labeling was observed at 
the C. psittaci outer membrane complex. 
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1. Introduction 
Chlamydia psittaci causes respiratory disease in birds. Birds show symptoms such as 
conjunctivitis, pneumonia and rhinitis (Vanrompay et al., 1997). The pathogen has a unique 
biphasic developmental cycle. The infectious elementary body (EB) attaches to the host cell 
and after the subsequent endocytosis, mainly at clathrin-coated pits, it differentiates to the 
metabolic active reticulate body (RB) within an inclusion, which is derived from the host cell 
membrane during the internalization (Vanrompay et al., 1996; Harkinezhad et al., 2009). 
Infections lead to significant economic losses in the duck and turkey industry due to mortality, 
reduced egg production and the expense of antibiotic treatment (Vanrompay et al., 1997). 
Nowadays, C. psittaci is also emerging on chicken farms (Dickx et al., 2010; Dickx and 
Vanrompay, 2011; Yin et al., 2013). An efficacious vaccine is needed to control C. psittaci 
infections. An ideal vaccine should generate long-lasting and sterilizing immunity while 
avoiding immunopathology. Previous studies showed that vaccines for intracellular bacteria, 
such as Chlamydia, require cell-mediated immune responses (Seder and Hill, 2000). CD4+ T 
cells are essential to resolve a chlamydial infection (Ramsey and Rank, 1991; Su and 
Caldwell, 1995; Morrison et al., 2000), while CD8+ T cells and B cells are not necessary to 
clear a primary infection (Ramsey et al., 1988; Su and Caldwell, 1995; Su et al., 1997), 
however, they can contribute to clear the infection by the release of gamma interferon 
(Igietseme et al., 1994) and they play an important role in resistance to chlamydial reinfection 
(Su et al., 1997; Morrison et al., 2000; Rank and Whittum-Hudson, 2010), respectively.  
The polymorphic membrane protein (Pmp) family is the largest membrane protein family in 
Chlamydia species and it is a unique feature of the genus (Horn et al., 2004; Vandahl et al., 
2004). The Pmps have been studied intensively because of their relatively high proportion of 
the coding capacity (3.15 and 5.1% in C. trachomatis and C. pneumoniae, respectively) and 
the presence of the protein family in all currently sequenced chlamydial genomes (Grimwood 
and Stephens, 1999). Some Pmp proteins are highly immunogenic (Caldwell et al., 1975a,b; 
Kuo et al., 1977; Longbottom et al., 1996; Livingstone et al., 2005; Tan et al., 2010; Marques 
et al., 2010), all Pmps of C. trachomatis are proposed to function as adhesins (Becker and 
Hegemann, 2014) and anti-PmpD antibodies can partially neutralize a C. trachomatis 
infection (Crane et al., 2006). Therefore, the Pmps are hypothesized to be vaccine candidates 
(Crane et al., 2006; Mölleken et al., 2010; Carrasco et al., 2011).  
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Karunakaran et al. (2008) identified four Pmp proteins (PmpE, PmpF, PmpG and PmpH) in C. 
muridarum, which is phylogenetically highly related to C. trachomatis (Read et al., 2000), as 
CD4+ T cell vaccine candidates by an immunoproteomic approach. Briefly, bone marrow-
derived dendritic cells were infected with C. muridarum, subsequently MHC–II bound 
peptides were purified by affinity chromatography using monoclonal antibodies specific to 
mouse B cells and those peptides were identified by mass spectrometry. Those MHC-II 
peptides were recognized by CD4+ T cells harvested from immune mice and transfer of 
dendritic cells pulsed ex vivo with those peptides partially protected mice against a chlamydial 
infection. Yu et al. (2014) compared the single antigen (PmpE, PmpF, PmpG and PmpH) 
vaccines to multisubunit vaccines (PmpE, PmpF, PmpG, PmpH with or without the major 
outer membrane protein, MOMP). The multisubunit vaccines were more immunogenic and 
cleared the infection faster than the single antigen vaccines (Yu et al., 2014). Remarkably, 
those four Pmp proteins are overrepresented in the C. trachomatis outer membrane complex 
(COMC), purified from EBs, compared to the Sarkosyl soluble fraction (Liu et al., 2010), 
while PmpD and PmpI were overrepresented in the soluble fraction and PmpA was not 
detected in the experiment. The absence of PmpA was explained by reports that showed the 
RB specificity of this protein (Skipp et al., 2005; Saka et al., 2011) and by the finding that it 
is not an outer membrane protein in C. trachomatis (Grimwood and Stephens, 1999). PmpD 
and PmpI were also shown to be RB specific proteins by Saka et al. (2011). In addition, Tan 
et al. (1990) showed that the C. abortus outer membrane complex conferred protective 
immunity when used in an experimental vaccine. Overall these results suggest that proteins 
present in the chlamydial outer membrane complex might be potential vaccine candidates. Up 
to now, the chlamydial outer membrane complex was only studied for C. trachomatis 
(Mygind et al., 2000; Birkelund et al., 2009; Liu et al., 2010), C. pneumoniae (Knudsen et al., 
1999) and C. abortus (Tan et al., 1990; Cevenini et al., 1991; McCafferty et al., 1995; 
Longbottom et al., 1996). In this study the presence or absence of PmpA, PmpB, PmpD and 
PmpH in the Chlamydia psittaci outer membrane complex was analyzed by immuno-electron 
microscopy. Those are the four most conserved Pmp proteins of C. psittaci and therefore we 
hypothesize that they are essential for the pathogenesis of C. psittaci. 
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2. Material and methods 
2.1 Chlamydia psittaci strain and growth curve 
The previously well-characterized, prototypic C. psittaci strain Cal10 (Narita et al., 1976; 
Matsumoto, 1982; Hovis et al., 2013; Mojica et al., 2015), was used in this study. The strain 
was isolated from ferrets inoculated with throat washings from humans with an influenza-like 
respiratory infection (Francis and Magill, 1938). The bacterium was grown in HeLa 229 cells, 
the first human cell line established in culture, starting from human cervical carcinoma cells 
(Gey et al., 1952). HeLa 229 cells were seeded on a sterile glass coverslip (13mm) at the 
bottom of Chlamydia Trac Bottles (Bibby Sterilin Ltd., Stone, UK) and grown for 24h at 
37°C and 5% CO2 in Dulbecco’s modified Eagle’s medium (DMEM, Invitrogen, Merelbeke, 
Belgium) supplemented with 10% heat inactivated fetal bovine serum (Greiner Bio One, 
Wemmel, Belgium), gentamycin (25 µg ml-1; Invitrogen) and fungizone (1.25 µg ml-1; 
Invitrogen). The medium was aspirated and cells were inoculated with C. psittaci Cal10 in 
SPG at an MOI of 1 followed by a centrifugation of 3000 rpm for 30 min at 37°C. The 
inoculum was removed, the cells were washed with PBS and DMEM was added, which was 
marked time 0 hpi of the experiment. At 2, 8, 15, 24, 32, 38, 48, 54 and 60 hours post 
infection (hpi) SPG was added to the Chlamydia Trac Bottle, which was subsequently stored 
at -80°C. Titration of the EBs present in the supernatant at each time point was performed on 
HeLa 229 cells by the method of Spearman and Kaerber (Mayr et al., 1974) determining the 
tissue culture infective dose 50 (TCID50) per ml.  
2.2 Chlamydia psittaci mass production and purification 
HeLa 229 cells were seeded in 25 cm2 culture dishes and incubated for 24h at 37°C with 5% 
CO2 in DMEM (Invitrogen) supplemented with 10% heat inactivated fetal bovine serum 
(Greiner Bio One), gentamycin (25 µg ml-1; Invitrogen) and fungizone (1.25 µg ml-1; 
Invitrogen). The medium was aspirated and the monolayer was inoculated with C. psittaci 
Cal10 in SPG (0.25 M sucrose, 10 mM sodium phosphate and 5mM L-glutamic acid) at a 
multiplicity of infection (MOI) of 1 followed by incubation on a rocking platform for 2 h at 
37°C. The unbound organisms were washed away with PBS and the above-mentioned 
medium was added to each tissue culture flask. Elementary bodies were harvested at the 
developmental time at which most EBs were determined (growth curve result, see paragraphs 
2.1 and 3.1) and purified by discontinuous gradient centrifugation following standard 
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protocols (Caldwell et al., 1981), with minor modifications. Briefly, renografin was replaced 
by Omnipaque 350 (GE Healthcare, Princeton, New Jersey) supplemented with NaCl 160 
mM. The gradients were prepared by diluting Omnipaque 350-160 mM NaCl in SPG buffer, 
such that final concentrations of Omnipaque 350 were 30%, 40%, 44% and 54%. Titration of 
the EBs was performed on HeLa 229 cells by the method of Spearman and Kaerber (Mayr et 
al., 1974).  
2.3 Chlamydia psittaci whole cell lysate and isolation of C. psittaci outer membrane 
complex  
Two protocols to isolate the Chlamydia psittaci outer membrane complex (COMC) were 
compared. Envelope proteins constitute only 4-16% of the proteome. So a clean extract is 
expected to produce a distinctive band pattern with very little overlap with that generated by a 
whole cell extraction (Quan et al., 2013). The whole cell extract was prepared by the protocol 
described by Marques et al. (2010) with minor modifications. In short, 2 x 109 EBs were 
centrifuged (16 000 x g for 30 min at 4°C), the pellet was washed twice by Tris-EDTA (TE; 
10mM Tris-HCl, 1 mM EDTA, pH 8.0) buffer and afterwards resuspended by lysis buffer (7 
M urea [Sigma-Aldrich, Bornem, Belgium], 2 M thiourea (Sigma-Aldrich), 1% ASB-14 
(Sigma-Aldrich) and protease inhibitor (Roche Diagnostics, Mannheim, Germany)). The 
sample was incubated at room temperature for 30 min and centrifuged (16 000 x g for 30 min 
at 4°C) to remove insoluble material. The two COMC isolation procedures are the Sarkosyl 
method (Caldwell et al., 1981) and the Tris-sucrose-EDTA method (Quan et al., 2013). In 
brief, during the first method 2 x 109 EBs were resuspended in Sarkosyl buffer (2% sodium 
lauryl sarkosinate (Sarkosyl; Sigma-Aldrich), 1.5 mM EDTA, PBS, pH 8). The samples were 
sonicated for 2 min and incubated at 37°C for 1 h. The Sarkosyl insoluble fraction was 
pelleted by centrifugation (16 000 x g for 30 min) and the supernatant was collected as the 
Sarkosyl soluble fraction. The procedure was repeated one more time and the two soluble and 
insoluble fractions were pooled. The resulting insoluble pellet was washed twice with PBS to 
remove the detergent and was resuspended in resuspension buffer (0.02 mM sodium 
phosphate, 10 mM magnesium chloride, 25 µg deoxyribonuclease I [Sigma-Aldrich] and 25 
µg ribonuclease [Sigma-Aldrich]) and incubated for 2 h at 37°C. Pellets from these digestions 
(16 000 g for 10 min) were sonicated (10 x 1 min, with intermittent cooling of the samples on 
ice) and washed with PBS to remove the nucleases (16 000 g for 10 min). The pellet, 
containing the COMC, was resuspended in digestion buffer (50 mM ammonium bicarbonate, 
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8 M urea, protease inhibitor). During the second method resuspended 2 x 109 EBs in Tris-
sucrose-EDTA buffer (TSE; 200 mM Tris-HCl, pH 8.0, 500 mM sucrose, 1 mM EDTA, and 
add protease inhibitor before use). The samples were incubated on ice for 30 min and 
centrifuged (16 000 x g for 30 min at 4°C). The supernatant contained periplasmic and outer 
membrane proteins, while the pellet contained the inner membrane and cytoplasmic proteins. 
The fractions were analyzed by SDS-PAGE (4.5 µg protein was loaded of each sample). 
2.4 Immuno-electron microscopy  
COMC pellets were fixed in 4% paraformaldehyde. Cells were washed, pelleted, and 
embedded in 2.5% low-melting-temperature agarose. Agarose blocks were trimmed into 
~1mm3 size, washed, dehydrated, infiltrated, and embedded in unicryl at -20°C under UV 
from 24 to 48 h. Ultrathin sections were cut on a Leica UC6 ultramicrotome (Leica 
Microsystems, Inc., Bannockburn, IL) and collected onto formvar-coated Nickel grids. 
Immunogold labeling was performed using the guinea pig anti-PmpA, B, D and H specific 
polyclonal antibodies (pAbs) (generated by immunization of guinea pigs with the purified 
recombinant proteins) followed by a secondary gold conjugated goat anti-guinea pig IgG 
(H&L) antibody (Electron Microscopy Sciences, Hatfield, PA). Sections were also stained 
using a rabbit anti-MOMP-specific serum followed by a secondary gold conjugated goat anti-
rabbit IgG (H&L) antibody (Electron Microscopy Sciences). Images were acquired using a 
Tecnai T12 transmission electron microscope (FEI, Hillsboro, OR) at 80 keV and an AMT 
digital camera (Advanced Microscopy Techniques, Woburn, MA). 
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3. Results 
3.1 Choice of time point and isolation method for Chlamydia psittaci outer membrane 
complex analysis 
C. psittaci grows asynchronically, so a high amount of EBs is difficult to obtain when using 
discontinuous gradient centrifugation as such, without determining the optimal cell culture 
harvest time point. Therefore, the growth curve of C. psittaci Cal10 was first determined. 
Enrichment of EBs was successfully achieved by harvesting C. psittaci Cal10 at 54 hpi 
(Figure 5.1) and subsequent discontinuous gradient centrifugation of the cell culture harvest.  
 
Figure 5.1: Growth curve of C. psittaci Cal10. Titration of C. psittaci Cal10 grown in HeLa 
cells was performed at 2, 8, 15, 24, 32, 38, 48, 54 and 60 hpi. Errors are based on standard 
deviation of the mean. 
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Two different outer membrane complex extraction methods for Gram-negative bacteria were 
compared. The method using the detergent Sarkosyl was best to isolate the C. psittaci outer 
membrane complex (Figure 5.2). 
 
Figure 5.2: Isolation of the C. psittaci outer membrane complex (COMC) by two 
methods using either Sarkosyl detergent or Tris-sucrose-EDTA. The protein profile 
observed in lane 5 (encompassing the COMC) resembled the profile of the whole cell lysate 
(lanes 1 and 4), while the protein profile in lane 2 (encompassing the COMC) clearly differed 
from the whole cell lysate. Three predominant protein bands were observed in the Sarkosyl 
insoluble lane (~ 38 kDa, ~55 kDa and ~ 90 kDa). The use of Sarkosyl was optimal to extract 
the C. psittaci outer membrane complex. 
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The SDS-PAGE gel (Figure 5.2) showed a distinctive profile of the outer membrane fraction 
compared to the whole cell lysate, but the presence of the outer membrane fraction could also 
successfully be verified by IEM (Figure 5.3). 
 
Figure 5.3: The extraction of the C. psittaci outer membrane complex (COMC), starting 
from enriched C. psittaci Cal10 EBs and visualized by IEM. Arrows point to the C. psittaci 
outer membrane complexes. Bar = 0.5 µm. 
3.2 PmpA, PmpB, PmpD and PmpH localize to the Chlamydia psittaci outer membrane 
complex 
The localization of PmpA, PmpB, PmpD and PmpH in the C. psittaci outer membrane 
complex (COMC) was analyzed by IEM (Figure 5.4). PmpA localized most abundantly at the 
COMC (Figure 5.4 A), while PmpH was present at a lower abundance than PmpA. However, 
PmpH was observed in all COMCs (Figure 5.4 B), which is different from the other three 
analyzed proteins, which are only present in a few COMCs.  
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Figure 5.4: PmpA (1), PmpB (2), PmpD (3) and PmpH (4) localize to the C. psittaci Cal10 outer membrane complex. Bars = 0.1 µm.
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4. Discussion 
Chlamydiaceae are very successful intracellular pathogens and up to now, no vaccine is 
available for none of the different Chlamydia species. Liu et al. (2010) suggested previously 
that antibodies to COMC might neutralize Chlamydia infections. This was confirmed by 
vaccination of pregnant ewes by C. abortus outer membrane complex, which conferred 
protective immunity (Tan et al., 1990). Yu et al. (2014) showed that a multisubunit vaccine 
comprising the major outer membrane protein and PmpE, PmpF, PmpG and PmpH, which 
were previously detected in the COMC of C. trachomatis (Liu et al., 2010), conferred better 
protection than the single protein antigens. Therefore, knowing the composition of the COMC 
is relevant for vaccine design. As variation is a central trait of the Pmp family, it was 
hypothesized that the Pmp proteins might play a role in the observed host and tissue tropism 
among Chlamydia species, which was confirmed by Becker et al. (2014). If the proteins 
present in the COMC determine the host or tissue to which the Chlamydia species might 
adhere and subsequently infect, we expect that the COMC composition would differ between 
Chlamydia species. The composition of the C. psittaci outer membrane complex was not 
determined before, and we hypothesize that other Pmp proteins might be present in the 
COMC of C. psittaci. 
In a first step, we compared two different COMC extraction methods to isolate the C. psittaci 
outer membrane complex. Quan et al. (2013) compared three different outer membrane 
extraction methods for Gram-negative bacteria and reported that the Tris–sucrose–EDTA 
method produced the cleanest extract of periplasmic and outer membrane proteins from 
Escherichia coli. However, we were unable to enrich the outer membrane proteins of C. 
psittaci by the method of Quan et al. (2013), as the SDS-PAGE protein profile looked similar 
to the one of the whole cell lysate of the C. psittaci Cal10 strain. The cell wall of 
Chlamydiaceae is different compared to other Gram-negative bacteria, as the peptidoglycan 
synthesis is minimal early and late in the developmental cycle and it peaks at 18 hpi (Packiam 
et al., 2015). The low amount of peptidoglycan present in the EBs harvested at 54 hpi might 
contribute to failure of the Tris-sucrose-EDTA method. In contrast, the SDS-PAGE protein 
pattern obtained by using the Sarkosyl method, was similar to the ones obtained during 
previous COMC purifications of C. trachomatis and C. abortus (Caldwell et al., 1981; 
McCafferty et al., 1995). Three predominant protein bands were observed, which were 
previously identified as the major outer membrane protein (MOMP; ~ 38 kDa), the outer 
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membrane protein 2 (Omp2; ~ 55 kDa) and the polymorphic membrane proteins (Pmps; 90 
kDa) (McCafferty et al., 1995; Mygind et al., 2000; Liu et al., 2010). The C. psittaci COMC 
morphology observed in our study by IEM was indistinguishable from the electron 
microscopic images of the C. trachomatis outer membrane complex demonstrated by other 
researchers (Caldwell et al., 1981; Liu et al., 2010). 
In this study we observed immunogold labeling of PmpA, PmpB, PmpD and PmpH in the C. 
psittaci outer membrane complex. Birkelund et al. (2009), detected all Pmps except PmpA 
and PmpI in the C. trachomatis outer membrane complex, while Liu et al. (2010) observed all 
Pmps except PmpA, PmpD and PmpI. Tanzer et al. (2001) detected PmpE, PmpG and PmpH 
and Mygind et al. (2000) detected only PmpG and H in the C. trachomatis L2 outer 
membrane complex. Different COMC extraction and analyses methods might explain these 
differences. Mygind et al. (2000), Birkelund et al. (2009) and Liu et al. (2010) extracted the 
COMC by the previously described Sarkosyl method, while Tanzer et al. (2001), labeled the 
outer membrane proteins with a photoactivatable lipophilic reagent after which the Sarkosyl 
extraction method was applied. Tanzer et al. (2001) subsequently separated the COMC by 
SDS-PAGE and protein bands were visualized on the dried gel by phosphorimaging. Mygind 
et al. (2000) stained the SDS-PAGE gel by silver staining. Birkelund et al. (2009) applied a 
combined fractional diagonal chromatography to the COMC, as described by Gevaert et al. 
(2003). In a final step, they all identified the separated proteins by matrix-assisted laser 
desorption/ionization time-of-flight (MALDI-TOF) mass spectrometry, while Liu et al. (2010) 
immediately determined the composition of the COMC by liquid chromatography-tandem 
mass spectrometry without first separating the proteins. Despite the differences, PmpG and 
PmpH were observed in all studies that examined the C. trachomatis outer membrane 
complex. 
Few studies examined the localization of the Pmps in other Chlamydia species. In C. abortus 
three 90 kDa Pmp proteins were identified in the COMC (Cevenini et al., 1991; McCafferty et 
al., 1995; Longbottom et al., 1996), which are orthologs of PmpG of C. trachomatis. Knudsen 
et al. (1999) detected Omp4 and Omp5, also referred to as Pmp10 and Pmp11 (both orthologs 
of PmpG of C. trachomatis) in the C. pneumoniae outer membrane complex. The labeling of 
PmpA in the C. psittaci outer membrane complex is unique as it was not observed in the 
above-mentioned studies on other Chlamydia species. This might suggest an important 
function for PmpA in the pathogenesis of C. psittaci, as it is present on the surface of C. 
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psittaci EBs while it is RB specific in C. trachomatis. It is also remarkable that PmpG was 
detected in the COMC of C. trachomatis, C. pneumoniae and C. abortus. The presence of 
PmpG in C. psittaci COMC could not be confirmed in this study, as specific pAb for C. 
psittaci PmpG were not available. It might be possible that PmpG has a redundant function in 
all Chlamydia species and that other Pmps have a more species-specific function such as 
antigenic variation or adhesion to a specific tissue or host. However, the COMC composition 
of multiple C. psittaci strains, including avian strains, should be determined.  
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General discussion and perspectives 
Members of the family of the Chlamydiaceae are important pathogens of both 
animals and humans. Abortion, carcass condemnation, bad semen quality and reduced 
egg production are only some of the sequelae of animal chlamydial infections, which 
lead to significant economic losses (Vanrompay et al., 1997; Kerr et al., 2005; 
Longbottom and Livingstone, 2006). Chlamydial infections in animals are currently 
mainly treated by tetracycline and its derivatives (chlortetracycline, oxytetracycline, 
doxycycline), because it is a cheap, broad spectrum antibiotic with an excellent tissue 
distribution and low toxicity, which easily resolves the infection (Sandoz and Rockey, 
2011). However, the extensive use of the antibiotic also for other bacterial infections 
in animals, both as therapy and in the past also as a prophylaxis, led to the fast spread 
of tetracycline resistant Gram-positive and Gram-negative bacteria (Michalova et al., 
2004). Tetracycline-resistant C. suis isolates have been detected (Dugan et al., 2004). 
The potential transfer of the tetracycline resistence, tet(C), gene to other Chlamydia 
species highlights the need for an effective vaccine.  
As both humoral and cellular immune responses are essential for an efficient and 
long-lasting immunity, the ideal vaccin should contain both B- and T-cell epitopes 
(Su and Caldwell, 1992; Morrison et al., 2000). For decades, MOMP was the focus of 
vaccination studies, as the protein accounts for 60% of the protein content of the EB 
envelope (Caldwell et al., 1981), it is highly immunogenic (Caldwell et al., 1981; 
Anderson et al., 1990; Miettinen et al., 1990; Pal et al., 2005; Marques et al., 2010), 
anti-MOMP antibodies neutralized the infection in vitro and in vivo (Caldwell and 
Perry, 1982; Zhang, Stewart, et al., 1987; Zhang et al., 1989) and it has both B- and 
T- cell epitopes (Su and Caldwell, 1992; Batteiger, 1996), which made this protein a 
very promising vaccine candidate. However, none of the studies, with either DNA-
vaccines (Pal et al., 1999), recombinant protein (Tuffrey et al., 1992; Shaw et al., 
2002), synthetic peptides corresponding to B- and T-cell epitopes (Su et al., 1995) or 
even native protein (Pal et al., 2005; Kari et al., 2009), resulted in a complete 
protection against one or more Chlamydia species. Complete protection might not be 
feasible. However, a significant reduction in the excretion of Chlamydia particles 
might already reduce the infection pressure, which might consequently result in a 
lower chance that the population get infected. Therefore, the use of additional 
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candidate vaccine antigens needs to be explored to increase the protection level. The 
Pmp family has been suggested as vaccine candidate, based on their surface 
localization (Longbottom et al., 1998a; Knudsen et al., 1999; Vandahl et al., 2002; 
Wehrl et al., 2004; Tan et al., 2010; Mölleken et al., 2010), immunogenicity 
(Caldwell and Kuo, 1977; Longbottom et al., 1998b; Knudsen et al., 1999; Bunk et 
al., 2008; Marques et al., 2010; Forsbach-Birk et al., 2013), function as adhesins 
(Mölleken et al., 2010; Becker and Hegemann, 2014) and because neutralizing anti-
Pmp antibodies were observed (Wehrl et al., 2004; Crane et al., 2006; Mölleken et al., 
2010). However, up to now only some Pmp proteins of C. pneumoniae and all Pmps 
of C. trachomatis are confirmed to be adhesins, but the Pmp family is subdivided in 
different subtypes and it is currently unknown whether all subtypes are involved in 
the same function, whether Pmps of the same subtype have similar or different 
functions across Chlamydia species, whether all Pmps are surface localized in all 
Chlamydiaceae,…  
Previously, researchers focused mainly on PmpD. This can be attributed to its high 
level of conservation (Gomes et al., 2006; Carrasco et al., 2011) and immunogenicity 
(Caldwell et al., 1975a,b; Caldwell and Kuo, 1977; Crane et al., 2006; Tan et al., 
2009) for C. trachomatis. However, although the Chlamydiaceae share a unique 
biphasic developmental cycle, different species manipulate different hosts and tissues 
which manifest in different symptoms, indicating diverse infection strategies. Hence, 
results of one species cannot always be extrapolated. Based on the variation observed 
in the Pmp family, we hypothesized at the beginning of this doctoral thesis that host 
and tissue preferences of different Chlamydia species might be mediated through the 
Pmp proteins, which was recently confirmed by Becker et al. (2014). Pre-incubation 
of host cells with C. pneumoniae Pmp proteins did protect against a subsequent C. 
pneumoniae infection but not against a subsequent C. trachomatis infection and vice 
versa, which indicate that Pmp proteins of different Chlamydia species use different 
receptors (Becker and Hegemann, 2014). Consequently, we suggested that if different 
Pmp proteins might be responsible for the adherence to different hosts and tissues, the 
most conserved Pmp protein might differ within and among Chlamydia species. 
Therefore, we determined the level of conservation of all Pmp proteins both within 
and across four Chlamydia species in chapter II. As expected, different Pmp proteins 
were most conserved in the different Chlamydia species. PmpD was the most 
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conserved Pmp protein only in C. trachomatis and it was not the most conserved Pmp 
protein across all analyzed Chlamydia species. This confirmed our expectation, Pmp 
analyses should not be restricted to PmpD analyses. In addition, it also supports our 
hypothesis that the most conserved Pmp protein might be important for adhesion, as 
PmpD showed the strongest adhesion capacity of all C. trachomatis Pmp proteins 
(Becker and Hegemann, 2014). PmpA was an exception, as it is the only Pmp protein 
that was the most conserved Pmp protein in more than one species, namely in both C. 
psittaci and C. pneumoniae. Our observation that PmpA is present in the C. psittaci 
outer membrane complex (chapter V) supports our hypothesis that the most conserved 
Pmp protein, PmpA in C. psittaci, might be involved in adhesion. However, PmpA of 
C. pneumoniae did not mediate adhesion in vitro (Mölleken et al., 2010), anti-PmpA 
antibodies did not react with any EB protein (Vandahl et al., 2002) and PmpA was not 
observed in the C. pneumoniae outer membrane complex (Knudsen et al., 1999). 
These results suggest that PmpA is involved in another, essential function than 
adhesion in C. pneumoniae. However, as transcript and protein levels of Pmp proteins 
in C. pneumoniae have only been tested at 72 hpi (Grimwood and Olinger, 2001) and 
not along the developmental cycle, we cannot suggest what the function of PmpA 
might be in C. pneumoniae. This further highlights the need to molecularly 
characterize all the Pmp proteins of each Chlamydia species along the developmental 
cycle, as the latter will give us insight in the function of the Pmp proteins in different 
Chlamydia species. This is also why we sequenced the genomes of all C. psittaci 
genotype reference strains (Van Lent et al., 2012).  
A first step to gain insight in the function of chlamydial genes is to determine the 
transcript profile along the developmental cycle, as timing can give a clue about the 
function. However, before the start of this work, reference genes for the normalization 
of gene expression data were only determined for C. trachomatis (Borges et al., 2010). 
Furthermore, Borges et al. (2010) induced stress by D-cycloserine treatment, while 
the transcript level of pmp genes in C. trachomatis during normal and stress 
conditions was previously compared by Carrasco et al. (2011), who induced stress by 
penicillin treatment. There is no general persistence model, as the type of stress (e.g. 
iron depletion, penicillin treatment and IFN-γ exposure) influences the transcript level 
of chlamydial genes differently (Mukhopadhyay et al., 2006; Goellner et al., 2006). It 
was previously suggested that pmpA, pmpD and pmpI, whose transcript levels are 
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unaffected during penicillin-induced stress, might play a critical role in the 
pathogenesis of C. trachomatis (Carrasco et al., 2011). As we wanted to compare the 
influence of stress on the transcript level of the pmp genes of C. psittaci with those of 
C. trachomatis, it was required that we used the same stressor. In chapter III we 
determined the stability of transcript levels of ten potential reference genes during 
both normal conditions and penicillin-induced stress. The 16S rRNA and opp2_A gene 
were the most stably expressed genes during normal and stress conditions, 
respectively, in C. trachomatis (Borges et al., 2010). However, the ideal number of 
reference genes that should be used for normalization was not determined, neither 
were the most stable reference genes during normal+stress conditions defined. The 
latter are needed in order to compare the expression level of a gene during normal and 
stress conditions. We had to use five reference genes (16S rRNA, map, radA, gidA and 
tyrS), of which 16S rRNA and tyrsS were the least and most stable reference gene, 
respectively, to compare the transcript levels of the pmp CDSs of C. psittaci at 
different time points (early, mid and late) during normal and penicillin-induced stress 
conditions. This highlights the need to use multiple, validated reference genes, instead 
of using a single, unvalidated reference gene such as 16S rRNA (Vandesompele et al., 
2002). For each different setting, which can be a different species or a different strain, 
time point, stressor,… new reference genes should be validated.  
We determined the transcript level of the pmp CDSs under both normal and 
penicillin-induced stress conditions in chapter IV. One remarkable finding was that 
pmpA was transcribed early both in C. psittaci and C. trachomatis, while in C. 
abortus pmpA is transcribed late. This is different from our expectations, as C. psittaci 
is phylogenetically closely related to C. abortus and PmpA is highly conserved in 
both species. This suggests that Pmp subtypes might have different functions in 
different Chlamydia species and that the function does not seem to be similar in more 
closely related species. The high expression levels of pmpA and pmpH early, and for 
pmpH late as well, in the normal developmental cycle attracted our attention.  
However, in contrast to C. trachomatis, all C. psittaci pmp genes were affected by 
penicilin, as the transcript levels were either up- or down-regulated. The pmpA and 
pmpH genes were down-regulated during the stress condition. However, in chapters II, 
IV and V we observed that PmpA is the most conserved Pmp protein in C. psittaci, 
and that PmpA and H labeling was abundant at the chlamydial envelope, the inclusion 
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membrane and in the COMC. Those results suggested that PmpA and PmpH are 
strong antigenic proteins in C. psittaci and that they are potential vaccine candidates. 
Therefore, we suggest that the genes whose transcript levels are unaffected during 
stress, might not be most important for the pathogenesis of a Chlamydia species, as 
the transcript level as such does not tell us something about the stability and turn-over 
of the transcript, the post-transcriptional and post-translational modifications that 
occur in the cell. Intuitively we would think that Pmp proteins whose production level 
is unaffected during stress might be most important for the pathogenesis. However, 
the protein level of C. trachomatis PmpD is affected by penicillin, while the protein is 
immunogenic (Caldwell and Kuo, 1977) and the partially neutralizing capacity of 
anti-PmpD antibodies (Crane et al., 2006) suggest an important function for this Pmp 
protein in C. trachomatis. In general, the result of our RT-qPCR experiment 
highlights peak transcript levels of most pmp genes in different Chlamydia species 
late in the developmental cycle, however, there are also species-specific differences, 
which might indicate both redundant and different functions throughout the 
developmental cycle of different Pmp subtypes. However, before we can make that 
conclusion, more thorough analyses on the production level of Pmp proteins should 
be performed, as currently only for C. trachomatis the production level of all Pmp 
proteins is determined along the developmental cycle (Carrasco et al., 2011), while 
for C. psittaci the production profile along the developmental cycle was only 
determined for a subset (PmpA, PmpB, PmpD and PmpH) of Pmp proteins. The C. 
abortus Pmp production profile was also only determined for a subset of Pmp proteins 
(PmpD and 4 PmpG’s), and the production level was only determined at late time 
points (36 hpi – 72 hpi) (Wheelhouse et al., 2012b). For C. pneumoniae the 
production of Pmp proteins was only analyzed at 72 hpi (Grimwood and Olinger, 
2001). The protein level determined by IF suggest that both C. trachomatis and C. 
psittaci use multiple post-transcriptional and post-translational regulation mechanisms, 
as the transcript and protein level are not always comparable (Carrasco et al., 2011). 
The protein performs the function in the cell, however, IF is less sensitive than RT-
qPCR and not all antibodies have the same affinity for their corresponding antigen 
and also the immunoaccessibility of different proteins can differ. Consequently, not 
all antibodies are equally suited for IF and IEM, and a negative staining result does 
not proof the absence of the protein as it might be due to the limitations of the 
136                                                                                                                  Chapter VI 
microscopy techniques. Therefore, both the transcript and protein results are 
important.  
To further unravel the function of the Pmp proteins, a thorough analyses of all Pmp 
proteins of different Chlamydia species is necessary. Ideally, polyclonal antibodies 
should be generated against multiple surface localized epitopes, as some epitopes 
might lead to low affinity antibodies and other epitopes might not be 
immunoaccessible. Thorough IEM analyses are needed to find out whether inclusion 
membrane labeling of Pmp proteins is unique for C. psittaci and to elucidate the 
possible function of the Pmp proteins at that location. Proteomic analysis of the 
inclusion membrane fraction of C. trachomatis revealed the presence of PmpD in this 
fraction. However, that analysis can not distinguish whether PmpD is associated with 
the inclusion membrane or if it is inserted in the inclusion membrane. We hypothesize 
that Pmp proteins are only present in the inclusion membrane of more virulent C. 
psittaci strains, as it was previously observed that virulent strains were often found 
devoid of inclusion membranes scattered throughout the cytoplasm (Vanrompay et al., 
1996). Therefore, cells infected with more and less virulent C. psittaci strains should 
be analyzed by IEM. In addition, thorough IEM analyses should be performed to 
determine whether all Pmps of different Chlamydia species can be found at both the 
inner and outer membrane of the cell envelope. Pre- and post-embedding IEM 
analyses should be compared, as the first one preserves the antigenicity and the last 
one is better for localization (Longbottom et al., 1998a). As IEM is not quantitative, 
LC/MS-MS analyses should be performed, in addition to IEM analyses, to 
quantitatively determine the protein composition of EBs, RBs, COMC and the 
sarkosyl soluble fractions. Saka et al. (2011) noticed that PmpA is absent in EBs, 
which is consistent with the results of Liu et al. (2010), who observed that PmpA is 
absent in the C. trachomatis outer membrane complex. These results clarify why 
PmpA antibodies are rare in C. trachomatis-infected patients, while PmpA is 
produced in nearly all C. trachomatis-infected inclusions (off frequency < 1%) (Tan 
et al., 2010). Therefore, we suggest that PmpA does not play a key role in the 
pathogenesis of C. trachomatis and that it is not a vaccine candidate for C. 
trachomatis, which is in contrast to our results for C. psittaci.  
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In conclusion, the main result of this thesis is that PmpA and PmpH are potential 
vaccine candidates for C. psittaci. However, the immunogenicity  of these proteins 
and the neutralizing capacity of the PmpA and PmpH specific antibodies should be 
tested. This can be done by immunoblotting with sera from C. psittaci infected 
specified pathogen free chickens and by pre-incubating C. psittaci EBs with the Pmp 
antibodies. If the proteins are immunodominant and the specific antibodies neutralize 
the infectivity by at least 50% in vitro, then the vaccine candidate should be tested in 
vivo. The in vivo experiment will reveal whether the vaccine candidates 
reduce/eliminate C. psittaci excretion, which should be linked to a strong B- and T-
cell response to the corresponding vaccine candidates. The latter should be tested by 
an antibody ELISA and T-cell proliferation tests, respectively. 
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Summary 
Chlamydiaceae are obligate intracellular Gram-negative bacteria that cause a variety 
of diseases in humans and animals. This thesis focuses on Chlamydia psittaci, which 
is an avian respiratory pathogen that is able to cause zoonotic disease in human. 
Chlamydia psittaci is mainly spread via inhalation of infected aerosols of pharyngeal 
or nasal secretions or dried feces. Infections of C. psittaci lead to significant economic 
losses due to reduced feed conversion, carcass condemnation at slaughter, mortality, 
reduced egg production and/or the expense of antibiotic treatment (Vanrompay et al., 
1997). Avian psittacosis is often systemic. Symptoms vary from inapparent to severe, 
including respiratory problems, conjunctivitis, diarrhea and polyuria. The sequelae of 
a human psittacosis are highly variable, ranging from inapparent to flu-like symptoms 
or pneumonia (Harkinezhad et al., 2009). 
Vaccination is the best approach to control the spreading of chlamydial infections, 
both in animals and humans (Longbottom and Livingstone, 2006). Currently, eleven 
Chlamydia species have been identified (Sachse et al., 2015) and for none of them a 
vaccine is available. Members of the polymorphic membrane protein (Pmp) family 
have been suggested as vaccine candidates (Vasilevsky et al., 2016).  
Chapter I gives an overview of the biology of chlamydial infections, with a focus on 
the composition and events occuring at different membranes that play a key function 
during the chlamydial developmental cycle. 
Conserved proteins are suggested to be essential for the pathogenesis of an organism. 
Therefore, in chapter II, we determined the conservation of the Pmp proteins both 
within and across C. trachomatis, C. pneumoniae, C. abortus and C. psittaci. The first 
two are the main human Chlamydia pathogens and the last two are the most 
devastating animal Chlamydia species. The pmp coding sequences were identified in 
16 C. trachomatis, 6 C. pneumoniae, 2 C. abortus and 16 C. psittaci genomes by a 
Hidden Markov Model. PmpD, PmpA, PmpH and PmpA were the most conserved 
Pmp protein in C. trachomatis, C. pneumoniae, C. abortus and C. psittaci, 
respectively. While PmpB was the most conserved Pmp protein across the four 
analyzed Chlamydia species. Previously, researchers focused mainly on PmpD, as it 
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is the most conserved and also an immunogenic Pmp protein in C. trachomatis. 
However, PmpD is not the most conserved in all analyzed Chlamydia species and also 
not across Chlamydia species, which highlights the need to analyze all Pmp proteins 
to accurately determine their utility as vaccine candidates. 
The transcript profile of the pmp coding sequences across the chlamydial 
developmental cycle can give us a first indication about their function. Validated 
reference genes are necessary to accurately normalize RT-qPCR data. Up to now, 
reference genes were only validated for C. trachomatis. Therefore, in chapter III, we 
validated reference genes for both normal and persistent C. psittaci Cal10 infections 
at early, mid and late time points during the developmental cycle. The reference genes 
for normalization of expression data differed depending on the culture conditions and 
interestingly also on the selected time points. We are the first to show that different 
reference genes should be used along the developmental cycle. Therefore, our results 
stress the importance to systematically validate reference genes for the specific 
culture conditions and examined time points of an experiment, instead of using a 
single, unvalidated reference gene throughout an experiment. 
In chapter IV, we used the reference genes validated in chapter III to normalize the 
transcript level of all 17 C. psittaci pmp coding sequences during both normal and 
persistent culture conditions, at early, mid and late time points during the 
developmental cycle. RT-qPCR profiles provide an indication of when the pmp genes 
are transcribed at the population level. However, different variants may be present in 
the population (e.g. due to SNPs). Therefore, we determined the Pmp production 
profile at the inclusion level and at the chlamydial cell level by immunofluorescence 
microscopy and immuno-electron microscopy, respectively. PmpA and PmpH 
emerged as important players in C. psittaci pathogenesis by virtue of their unique 
expression properties, both at the transcript and protein level and their apparent 
immunoaccessiblity and antigenicity suggest their potential in vaccine design. 
Proteins present in the chlamydial outer membrane complex (COMC) might be 
potential vaccine candidates. The composition of the COMC was previously only 
determined for C. trachomatis, C. abortus and C. pneumoniae. Therefore, in chapter 
V, we determined whether the four most conserved C. psittaci Pmp proteins (PmpA, 
PmpD, PmpB and PmpH, in order of decreasing conservation) localized in the C. 
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psittaci outer membrane complex. Two different outer membrane complex extraction 
methods for Gram-negative bacteria were compared. The method using the detergent 
Sarkosyl was best to isolate the C. psittaci outer membrane complex All four Pmp 
proteins localized in the C. psittaci outer membrane complex, however, PmpA was 
previously not determined to be present in the COMC of another Chlamydia species 
and therefore we hypothesize that PmpA is important for adhesion of C. psittaci. 
Further analyses are needed to confirm that. 
Finally, in chapter IV, we described our conclusions and perspectives for further 
research. The overall conclusion of this thesis is that PmpA and PmpH are potential 
vaccine candidates for C. psittaci, however, further in vitro and in vivo experiments 
are needed to confirm this hypothesis. 
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Samenvatting 
Chlamydiaceae zijn obligaat intracellulaire, Gram-negatieve bacteriën die 
verscheidene ziekten veroorzaken bij mens en dier. In deze thesis onderzochten we 
specifiek Chlamydia psittaci, een ziekteverwekker die voornamelijk 
ademhalingsinfecties veroorzaakt bij vogels, maar deze zoönotische bacterie kan ook 
infecties bij de mens veroorzaken. Infecties met C. psittaci worden voornamelijk 
veroorzaakt door het inademen van aërosols van faryngeale of nasale excreties of van 
uitwerpselen afkomstig van geïnfecteerde dieren. C. psittaci infecties leiden tot grote 
economische verliezen door een verlaagde voederconversie, de afkeuring van 
karkassen bij het slachten, een verhoogd sterftecijfer, een verlaagde eierproductie 
en/of de kosten van antibioticabehandelingen (Vanrompay et al., 1997). Psittacosis in 
vogels leidt vaak tot een systemische infectie waarbij de symptomen sterk variëren 
van ademhalingsproblemen, conjunctivitis, diarree tot polyurie. Humane psittacosis 
heeft een zeer divers klinisch beeld dat varieert van onbeduidend tot griep-achtige 
symptomen of  een longontsteking (Harkinezhad et al., 2009).  
Vaccinatie wordt aanzien als de beste manier om de verspreiding van Chlamydia 
infecties, zowel in dieren als in mensen, te voorkomen (Longbottom and Livingstone, 
2006). Momenteel zijn er elf Chlamydia soorten geïdentificeerd (Sachse et al., 2015), 
maar voor geen enkele soort is een vaccin beschikbaar. Eiwitten van de polymorfe 
membraan eiwitfamilie (Pmp) worden gesuggereerd als kandidaat vaccinantigenen 
(Vasilevsky et al., 2016).  
Hoofdstuk I van deze thesis geeft een overzicht van de biologie van Chlamydia 
infecties, met focus op de samenstelling van de verschillende bacteriële membranen 
en de geassocieerde kiem-gastheerinteracties die een sleutelfunctie vervullen in de 
ontwikkelingscyclus van Chlamydia.  
Er wordt gedacht dat geconserveerde eiwitten een essentiële rol vervullen in het 
ziekteproces van een pathogeen. Daarom werd in hoofdstuk II de conservering van 
de Pmp eiwitten zowel in als tussen vier Chlamydia soorten bepaald, namelijk C. 
trachomatis, C. pneumoniae, C. abortus en C. psittaci. C. trachomatis en C. 
pneumoniae zijn de belangrijkste humane pathogenen en C. abortus en C. psittaci zijn 
 de meest virulente zoönotische Chlamydia soorten, die een dier als primaire gastheer 
hebben. De pmp coderende sequenties werden geïdentificeerd in 16 C. trachomatis, 6 
C. pneumoniae, 2 C. abortus en 16 C. psittaci genomen. PmpD, PmpA, PmpH en 
PmpA waren het sterkst geconserveerd in C. trachomatis, C. pneumoniae, C. abortus 
en C. psittaci, respectievelijk. PmpB daarentegen was het sterkst geconserveerd 
tussen de vier geanalyseerde Chlamydia soorten. Eerdere studies waren voornamelijk 
toegespitst op PmpD, omdat dit het meest geconserveerde Pmp eiwit is in C. 
trachomatis en dit een immunogeen eiwit is. PmpD is echter niet het meest 
geconserveerde Pmp eiwit binnen en tussen de andere geanalyseerde Chlamydia 
soorten. Dit resultaat toont aan dat het noodzakelijk is om alle Pmp eiwitten te 
bestuderen om te kunnen bepalen of de Pmp eiwitten al dan niet mogelijke kandidaat 
vaccinantigenen zijn. 
Het transcript profiel van de pmp coderende sequenties doorheen de chlamydiale 
ontwikkelingscyclus geeft een eerste indicatie wat betreft hun functionele rol. Het 
transcriptie profiel kan bepaald worden via een “reverse transcriptase quantitative 
polymerase chain reaction” (RT-qPCR), maar deze techniek vereist echter 
gevalideerde referentiegenen – genen die stabiel tot expressie gebracht worden tijdens 
de vermeningvuldigingscyclus van de bacterie - om accuraat RT-qPCR data te kunnen 
normaliseren. Voorafgaand aan deze studie waren enkel voor C. trachomatis 
gevalideerde referentiegenen voorhanden. Daarom werden in hoofdstuk III 
referentiegenen gevalideerd voor twee verschillende cultuurcondities, met name een 
standaard infectie en een persistente C. psittaci infectie op vroege, middenste en late 
tijdstippen van de chlamydiale ontwikkelingscyclus. De referentiegenen die nodig 
zijn om expressiedata te normaliseren verschillen per conditie en tijdstip. Dit is de 
eerste studie die aantoont dat verschillende referentiegenen gebruikt moeten worden 
op verschillende tijdstippen gedurende de vermenigvuldigingscyclus. Deze resultaten 
bevestigen daarom de noodzaak om steeds referentiegenen te valideren voor de 
specifieke cultuurcondities en de onderzochte tijdstippen, in plaats van één, niet-
gevalideerd gen te gebruiken als referentiegen doorheen de cyclus.  
De referentiegenen die gevalideerd werden in hoofdstuk III, werden vervolgens 
gebruikt in hoofdstuk IV om het transcriptniveau van alle 17 C. psittaci pmp 
coderende sequenties tijdens zowel standaard als persistente cultuurcondities op 
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vroege, middenste en late tijdstippen van de ontwikkelingscyclus te bepalen. De RT-
qPCR profielen geven een indicatie van wanneer de pmp genen afgeschreven worden 
op populatieniveau, maar er kunnen echter verschillende varianten voorkomen in de 
populatie (bijvoorbeeld ten gevolge van mutaties). Daarom werd ook het Pmp 
productieniveau bepaald, zowel op het niveau van de inclusie als op het niveau van 
individuele chlamydiale partikels door middel van immunofluorescentiemicroscopie 
en immuno-electronenmicroscopie, respectievelijk. PmpA en PmpH traden naar voor 
als mogelijke belangrijke spelers in het ziekteproces van C. psittaci. Door hun unieke 
expressie eigenschappen, zowel op het transcript als op het eiwitniveau en door hun 
duidelijke immunotoegankelijkheid en antigeniciteit zijn deze twee Pmp eiwitten 
mogelijke kandidaat vaccinantigenen. 
Eiwitten die onderdeel uitmaken van het chlamydiale buitenste membraan complex 
(COMC) zijn mogelijks kandidaat vaccinantigenen. De samenstelling van het COMC 
was voordien enkel bepaald voor C. trachomatis, C. abortus en C. pneumoniae. In 
hoofdstuk V werd nagegaan of de vier meest geconserveerde Pmp eiwitten (PmpA, 
PmpD, PmpB and PmpH, geordend volgens dalende conservering) aanwezig waren in 
het C. psittaci buitenste membraan complex. Eerst en vooral werden twee 
verschillende buitenste membraan extractiemethoden voor Gram-negatieve bacteriën 
vergeleken, waarbij de methode die gebruik maakt van het detergent Sarkosyl de 
beste bleek. Alle vier Pmp eiwitten bevonden zich in het C. psittaci buitenste 
membraan complex. PmpA werd nooit eerder gedetecteerd in het COMC van een 
andere Chlamydia soort en daarom suggereren wij dat PmpA belangrijk is voor de 
vasthechting van C. psittaci aan zijn gastheercel. Verder onderzoek is echter nodig 
om deze hypothese te bevestigen. 
Ten slotte brengt hoofdstuk VI de conclusies en toekomstperspectieven. De 
algemene conclusie van deze thesis is dat PmpA en PmpH potentiële kandidaat 
vaccinantigenen zijn voor C. psittaci, maar er zijn nog aanvullende in vitro en in vivo 
experimenten nodig om deze hypothese te bevestigen.  
  
 
References                                                                                                                  147 
References 
Abromaitis, S., and Stephens, R.S. (2009). Attachment and entry of Chlamydia have distinct 
requirements for host protein disulfide isomerase. PLoS Pathog 5: e1000357.  
Ahmed, B., De Boeck, C., Dumont, A., Cox, E., De Reu, K., and Vanrompay, D. (2015). First 
Experimental Evidence for the Transmission of Chlamydia psittaci in Poultry through Eggshell 
Penetration. Transbound Emerg Epub Dis: 10.1111. 
Aistleitner, K., Anrather, D., Schott, T., Klose, J., Bright, M., Ammerer, G., and Horn, M. (2014). 
Conserved features and major differences in the outer membrane protein composition of chlamydiae. 
Environ Microbiol 17: 1397-413. 
Allen, J.E., Cerrone, M.C., Beatty, P.R., and Stephens, R.S. (1990). Cysteine-rich outer membrane 
proteins of Chlamydia trachomatis display compensatory sequence changes between biovariants. Mol 
Microbiol 4: 1543–50.  
Allen, J.E., and Stephens, R.S. (1989). Identification by sequence analysis of two-site posttranslational 
processing of the cysteine-rich outer membrane protein 2 of Chlamydia trachomatis serovar L2. J 
Bacteriol 171: 285–91.  
Almeida, F., Borges, V., Ferreira, R., Borrego, M.J., Gomes, J.P., and Jaime Motaa, L.J. (2012). 
Polymorphisms in inc proteins and differential expression of inc genes among Chlamydia trachomatis 
strains correlate with invasiveness and tropism of Lymphogranuloma venereum isolates. J Bacteriol 
194: 6574–6585. 
Anderson, I.E., Tan, T.W., Jones, G.E., and Herring, A.J. (1990). Efficacy against ovine enzootic 
abortion of an experimental vaccine containing purified elementary bodies of Chlamydia psittaci. Vet 
Microbiol 24: 21–27. 
Angiuoli, S.V., and Salzberg, S.L. (2011). Mugsy: Fast multiple alignment of closely related whole 
genomes. Bioinformatics 27: 334–342. 
Argudín, M.A., Cariou, N., Salandre, O., Le Guennec, J., Nemeghaire, S., and Butaye, P. (2013). 
Genotyping and antimicrobial resistance of Staphylococcus aureus isolates from diseased turkeys. 
Avian Pathol 42: 572–80.  
Azuma, Y., Hirakawa, H., Yamashita, A., Cai, Y., Rahman, M.A., Suzuki, H., et al. (2006). Genome 
sequence of the cat pathogen, Chlamydophila felis. DNA Res 13: 15–23. 
Bachmann, N.L., Fraser, T.A., Bertelli, C., Jelocnik, M., Gillett, A., Funnell, O., et al. (2014). 
Comparative genomics of koala, cattle and sheep strains of Chlamydia pecorum. BMC Genomics 15: 
667.  
Baehr, W., Zhang, Y.X., Joseph, T., Su, H., Nano, F.E., Everett, K.D., and Caldwell, H.D. (1988). 
Mapping antigenic domains expressed by Chlamydia trachomatis major outer membrane protein genes. 
Proc Natl Acad Sci U S A 85: 4000–4004. 
Bardwell, J. (1994). Building bridges: disulphide bond formation in the cell. Mol Microbiol 14: 199–
205. 
Bastidas, R.J., Elwell, C.A., Engel, J.N., and Valdivia, R.H. (2013). Chlamydial intracellular survival 
strategies. Cold Spring Harb Perspect Med 3: a010256. 
Batteiger, B.E. (1996). The major outer membrane protein of a single Chlamydia trachomatis serovar 
can possess more than one serovar-specific epitope. Infect Immun 64: 542–7. 
148                                                                                                              References 
Batteiger, B.E., Newhall, W.J.V., and Jones, R.B. (1985). Differences in outer membrane proteins of 
the lymphogranuloma venereum and trachoma biovars of Chlamydia trachomatis. Infect Immun 50: 
488–494. 
Bavoil, P.M., Ohlin, A., and Schachter, J. (1984). Role of Disulfide Bonding in Outer Membrane 
Structure and Permeability in  Chlamydia trachomatis. Infect Immun 44: 479–485. 
Beatty, W.L. (2006). Trafficking from CD63-positive late endocytic multivesicular bodies is essential 
for intracellular development of Chlamydia trachomatis. J Cell Sci 119: 350–359. 
Beatty, W.L., Morrison, R.P., and Byrne, G.I. (1994). Persistent chlamydiae: from cell culture to a 
paradigm for chlamydial pathogenesis. Microbiol Rev 58: 686–99.  
Becker, E., and Hegemann, J.H. (2014). All subtypes of the Pmp adhesin family are implicated in 
chlamydial virulence and show species-specific function. Microbiologyopen 3: 544–56.  
Beeckman, D.S.A., and Vanrompay, D. (2009). Zoonotic Chlamydophila psittaci infections from a 
clinical perspective. Clin Microbiol Infect 15: 11–17. 
Belland, R.J., Nelson, D.E., Virok, D., Crane, D.D., Hogan, D., Sturdevant, D., et al. (2003). 
Transcriptome analysis of chlamydial growth during IFN-gamma-mediated persistence and 
reactivation. Proc Natl Acad Sci U S A 100: 15971–6.  
Belland, R.J., Ouellette, S.P., Gieffers, J., and Byrne, G.I. (2004). Chlamydia pneumoniae and 
atherosclerosis. Cell Microbiol 6: 117–127. 
Belland, R.J., Zhong, G., Crane, D.D., Hogan, D., Sturdevant, D., Sharma, J., et al. (2003). Genomic 
transcriptional profiling of the developmental cycle of Chlamydia trachomatis. Proc Natl Acad Sci U S 
A 100: 8478–83. 
Bini, L., Sanchez-campillo, M., Magi, B., Marzocchi, B., Comanducci, M., Birkelund, S., et al. (1996). 
Mapping of Chlamydia trachomatis proteins by electrophoresis : Spot identification by N-terminal 
sequencing and immunoblotting. Electrophoresis 17: 185–190. 
Birkelund, S., Lundemose, A.G., and Christiansen, G. (1989). Immunoelectron microscopy of 
lipopolysaccharide in Chlamydia trachomatis. Infect Immun 57: 3250–3.  
Birkelund, S., Morgan-Fisher, M., Timmerman, E., Gevaert, K., Shaw, A.C., and Christiansen, G. 
(2009). Analysis of proteins in Chlamydia trachomatis L2 outer membrane complex, COMC. FEMS 
Immunol Med Microbiol 55: 187–95. 
Borel, N., Dumrese, C., Ziegler, U., Schifferli, A., Kaiser, C., and Pospischil, A. (2010). Mixed 
infections with Chlamydia and porcine epidemic diarrhea virus - a new in vitro model of chlamydial 
persistence. BMC Microbiol 10: 201. 
Borges, V., Ferreira, R., Nunes, A., Nogueira, P., Borrego, M.J., and Gomes, J.P. (2010). 
Normalization strategies for real-time expression data in Chlamydia trachomatis. J Microbiol Methods 
82: 256–64.  
Borges, V., Pinheiro, M., Vieira, L., Sampaio, D.A., Nunes, A., Borrego, M.J., and Gomes, P. (2014). 
Complete Genome Sequence of Chlamydia trachomatis Ocular Serovar. Genome Announc 2: 3–4. 
Boyle, E.C., and finlay, B.B. (2003). Bacterial pathogenesis: Exploiting cellular adherence. Curr Opin 
Cell Biol 15: 633–639. 
Brade, H., Brade, L., and Nano, F.E. (1987). Chemical and serological investigations on the genus-
specific lipopolysaccharide epitope of Chlamydia. Proc Natl Acad Sci U S A 84: 2508–12.  
References                                                                                                                  149 
Bunk, S., Susnea, I., Rupp, J., Summersgill, J.T., Maass, M., Stegmann, W., et al. (2008). 
Immunoproteomic identification and serological responses to novel Chlamydia pneumoniae antigens 
that are associated with persistent C. pneumoniae infections. J Immunol 180: 5490–8.  
Bustin, S.A. (2005). Quantitative real-time RT-PCR - a perspective. J Mol Endocrinol 34: 597–601.  
Bustin, S.A. (2001). Quantification of mRNA using real-time reverse transcription PCR ( RT-PCR ): 
trends and problems. J Mol Endocrinol 29: 23–39. 
Caldwell, H.D., and Hitchcock, P.J. (1984). Monoclonal antibody against a genus-specific antigen of 
Chlamydia species: location of the epitope on chlamydial lipopolysaccharide. Infect Immun 44: 306–
314. 
Caldwell, H.D., Kromhout, J., and Schachter, J. (1981). Purification and Partial Characterization of the 
Major Outer Membrane Protein of Chlamydia trachomatis. Infection 31: 1161–1176. 
Caldwell, H.D., and Kuo, C. (1977). Purification of a Chlamydia Trachomatis-Specific Antigen by 
Immunoadsorption with Monospecific Antibody. J Immunol 118: 437–441. 
Caldwell, H.D., Kuo, C., and Kenny, G.E. (1975a). Antigenic Analysis of Chlamydiae by Two-
Dimensional Immunoelectrophoresis : I . Antigenic Heterogeneity Between C . Trachomatis and C . 
Psittaci. J Immunol 115: 963-968. 
Caldwell, H.D., Kuo, C., and Kenny, G.E. (1975b). Antigenic Analysis of Chlamydiae by Two-
Dimensional Immunoelectrophoresis : II . A Trachoma-LGV-Specific Antigen. J Immunol 115: 969–
975. 
Caldwell, H.D., and Perry, L.J. (1982). Neutralization of Chlamydia trachomatis infectivity with 
antibodies to the major outer membrane protein. Infect Immun 38: 745–754. 
Caldwell, H.D., Stewart, S., Johnson, S., and Taylor, H. (1987). Tear and serum antibody response to 
Chlamydia trachomatis antigens during acute Chlamydial conjunctivitis in monkeys as determined by 
immunoblotting. Infect Immun 55: 93–98. 
Campbell, L.A., and Kuo, C. (2006). Interactions of  Chlamydia with the Host Cells that Mediate 
Attachment and Uptake. In Chlamydia : genomics and pathogenesis. Bavoil, P.M., and Wyrick, P.B. 
(eds). Horizon Bioscience, Wymondham, pp. 505–522. 
Campbell, L.A., Kuo, C.C., Wang, S.P., and Grayston, J.T. (1990). Serological response to Chlamydia 
pneumoniae infection. J Clin Microbiol 28: 1261–4.  
Campbell, L.A., Kuo, C.C., Wang, S.P., and Grayston, J.T. (1990). Serological response to Chlamydia 
pneumoniae infection. J Clin Microbiol 28: 1261–4. 
Capmany, A., and Damiani, M.T. (2010). Chlamydia trachomatis intercepts golgi-derived 
sphingolipids through a rab14-mediated transport required for bacterial development and replication. 
PLoS One 5:e14084. 
Carabeo, R.A., Mead, D.J., and Hackstadt, T. (2003). Golgi-dependent transport of cholesterol to the 
Chlamydia trachomatis inclusion. Proc Natl Acad Sci U S A 100: 6771–6. 
Carabeo, R.A., Dooley, C.A., Grieshaber, S.S., and Hackstadt, T. (2007). Rac interacts with Abi-1 and 
WAVE2 to promote an Arp2/3-dependent actin recruitment during chlamydial invasion. Cell Microbiol 
9: 2278–2288. 
Carabeo, R.A., Grieshaber, S.S., Hasenkrug, A., Dooley, C.A., and Hackstadt, T. (2004). Requirement 
for the Rac GTPase in  Chlamydia trachomatis  invasion of non-phagoycytic cells. Traffic 5: 418–425. 
150                                                                                                              References 
Carrasco, J.A., Tan, C., Rank, R.G., Hsia, R., and Bavoil, P.M. (2011). Altered developmental 
expression of polymorphic membrane proteins in penicillin-stressed Chlamydia trachomatis. Cell 
Microbiol 13: 1014–25.  
Carvalho, D.M., de Sá, P.H., Castro, T.L.P., Carvalho, R.D., Pinto, A., Gil, D.J.P., et al. (2014). 
Reference genes for RT-qPCR studies in Corynebacterium pseudotuberculosis identified through 
analysis of RNA-seq data. Antonie Van Leeuwenhoek 106: 605–614.  
Cerrone, M.C., Ma, J.J., and Stephens, R.S. (1991). Cloning and sequence of the gene for heat shock 
protein 60 from Chlamydia trachomatis and immunological reactivity of the protein. Infect Immun 59: 
79–90. 
Cevenini, R., Donati, M., Broncchi, E., De Simone, F., and La Placa, M. (1991). Partial 
characterization of an 89-kDa highly immunoreactive protein from  Chlamydia psittaci  A/22 causing 
ovine abortion. FEMS Microbiol Lett 65: 111–115. 
Chotinun, S., Rojanasthien, S., Unger, F., Tadee, P., and Patchanee, P. (2014). Prevalence and 
antimicrobial resistance of  Salmonella  isolated from carcasses, processing facilities and the 
environment surrounding small scale poultry slaughterhouses in Thailand. Southeast Asian J Trop Med 
Public Heal 45: 1392–1400. 
Clifton, D.R., Fields, K.A., Grieshaber, S.S., Dooley, C.A., Fischer, E.R., Mead, D.J., et al. (2004). A 
chlamydial type III translocated protein is tyrosine-phosphorylated at the site of entry and associated 
with recruitment of actin. Proc Natl Acad Sci U S A 101: 10166–10171. 
Cocchiaro, J., Kumar, Y., Fischer, E.R., Hackstadt, T., and Valdivia, R.H. (2008). Cytoplasmic lipid 
droplets are translocated into the lumen of the Chlamydia trachomatis parasitophorous vacuole. Proc 
Natl Acad Sci U S A 105: 9379–9384. 
Cocchiaro, J., and Valdivia, R.H. (2009). New insights into Chlamydia intracellular survival 
mechanisms. Cell Microbiol 72: 181–204. 
Coles, M., Reynolds, D., Harper, A., Devitt, A., and Pearce, J. (1993). Low-nutrient induction of 
abnormal chlamydial development: A novel component of chlamydial pathogenesis? FEMS Microbiol 
Lett 106: 193–200. 
Collett, B.A., Newhall, W.J., Jersild, R.A., and Jones, R.B. (1989). Detection of surface-exposed 
epitopes on Chlamydia trachomatis by immune electron microscopy. J Gen Microbiol 135: 85–94.  
Cortes, C., Rzomp, K.A., Tvinnereim, A., Scidmore, M.A., and Wizel, B. (2007). Chlamydia 
pneumoniae inclusion membrane protein Cpn0585 interacts with multiple rab GTPases. Infect Immun 
75: 5586–5596. 
Crane, D.D., Carlson, J.H., Fischer, E.R., Bavoil, P., Hsia, R., Tan, C., et al. (2006). Chlamydia 
trachomatis polymorphic membrane protein D is a species-common pan-neutralizing antigen. Proc 
Natl Acad Sci U S A 103: 1894–9.  
Danilition, S.L., Maclean, I.W., Peeling, R., Winston, S., and Brunham, R.C. (1990). The 75-kilodalton 
protein of Chlamydia trachomatis: A member of the heat shock protein 70 family? Infect Immun 58: 
189–196. 
Dautin, N., and Bernstein, H.D. (2007). Protein secretion in gram-negative bacteria via the 
autotransporter pathway. Annu Rev Microbiol 61: 89–112.  
Dean, D., Suchland, R.J., and Stamm, W.E. (2000). Evidence for long-term cervical persistence of 
Chlamydia trachomatis by omp1 genotyping. J Infect Dis 182: 909–916. 
References                                                                                                                  151 
Deckert, A., Valdivieso-Garcia, A., Reid-Smith, R., Tamblyn, S., Seliske, P., Irwin, R., et al. (2010). 
Prevalence and antimicrobial resistance in Campylobacter spp. isolated from retail chicken in two 
health units in Ontario. J Food Prot 73: 1317–1324. 
Denzer, K., Kleijmeer, M.J., Heijnen, H.F., Stoorvogel, W., and Geuze, H.J. (2000). Exosome: from 
internal vesicle of the multivesicular body to intercellular signaling device. J Cell Sci 113 Pt 19: 3365–
3374. 
Derré, I., Pypaert, M., Dautry-Varsat, A., and Agaisse, H. (2007). RNAi screen in Drosophila cells 
reveals the involvement of the tom complex in Chlamydia infection. PLoS Pathog 3: 1446–1458. 
Derré, I., Swiss, R., and Agaisse, H. (2011). The lipid transfer protein CERT interacts with the 
Chlamydia inclusion protein IncD and participates to ER-Chlamydia inclusion membrane contact sites. 
PLoS Pathog 7: e1002092. 
Dheda, K., Huggett, J.F., Chang, J.S., Kim, L.U., Bustin, S.A., Johnson, M.A., et al. (2005). The 
implications of using an inappropriate reference gene for real-time reverse transcription PCR data 
normalization. Anal Biochem 344: 141–143.  
Dickx, V., Geens, T., Deschuyffeleer, T., Tyberghien, L., Harkinezhad, T., Beeckman, D.S.A., et al. 
(2010). Chlamydophila psittaci zoonotic risk assessment in a chicken and turkey slaughterhouse. J Clin 
Microbiol 48: 3244–3250. 
Dickx, V., and Vanrompay, D. (2011). Zoonotic transmission of Chlamydia psittaci in a chicken and 
turkey hatchery. J Med Microbiol 60: 775–779. 
Di Francesco, A., Donati, M., Rossi, M., Pignanelli, S., Shurdhi, A., Baldelli, R., and Cevenini, R. 
(2008). Tetracycline-resistant Chlamydia suis isolates in Italy. Vet Rec 163: 251–2. 
Douglas, A.L., and Hatch, T.P. (2000). Expression of the transcripts of the sigma factors and putative 
sigma factor regulators of Chlamydia trachomatis L2. Gene 247: 209–214. 
Dugan, J., Rockey, D.D., Jones, L., Arthur, A., and Andersen, A.A. (2004). Tetracycline Resistance in 
Chlamydia suis Mediated by Genomic Islands Inserted into the Chlamydial inv -Like Gene 
Tetracycline Resistance in Chlamydia suis Mediated by Genomic Islands Inserted into the Chlamydial 
inv -Like Gene. Antimicrob Agents Chemother 48: 3989–3995. 
Dugan, J., Anderson A.A., Rockey D.D. (2007). Functional characterization of IScs605, an insertion 
element carried by tetracycline-resistant Chlamydia suis. Microbiology 153: 71-79. 
Dumoux, M., and Hayward, R.D. (2016). Membrane contact sites between pathogen-containing 
compartments and host organelles. Biochim Biophys Acta 16: 30017-8. 
Egan, A.J.F., and Vollmer, W. (2013). The physiology of bacterial cell division. Ann N Y Acad Sci 
1277: 8–28. 
Elwell, C.A., Jiang, S., Kim, J.H., Lee, A., Wittmann, T., Hanada, K., et al. (2011). Chlamydia 
trachomatis co-opts GBF1 and CERT to acquire host sphingomyelin for distinct roles during 
intracellular development. PLoS Pathog 7: e1002198. 
Elwell, C.A., Ceesay, A., Jung, H.K., Kalman, D., and Engel, J.N. (2008). RNA interference screen 
identifies Abl kinase and PDGFR signaling in Chlamydia trachomatis entry. PLoS Pathog 4: 1–15. 
Everett, K.D.E. (2000). Chlamydia and Chlamydiales: More than meets the eye. Vet Microbiol 75: 
109–126. 
Everett, K.D., Bush, R.M., and Andersen, A.A. (1999). Emended description of the order Chlamydiales, 
152                                                                                                              References 
proposal of Parachlamydiaceae fam. nov. and Simkaniaceae fam. nov., each containing one monotypic 
genus, revised taxonomy of the family Chlamydiaceae, including a new genus and five new species, 
and standards. Int J Syst Bacteriol 49: 415–40. 
Everett, K.D.E., Desiderio, D.M., and Hatch, T.P. (1994). Characterization of lipoprotein EnvA in 
Chlamydia psittaci 6BC. J Bacteriol 176: 6082–6087. 
Everett, K.D., and Hatch, T.P. (1995). Architecture of the cell envelope of Chlamydia psittaci 6BC. J 
Bacteriol 177: 877–82. 
Fadel, S., and Eley, A. (2007). Chlamydia trachomatis OmcB protein is a surface-exposed 
glycosaminoglycan-dependent adhesin. J Med Microbiol 56: 15–22. 
Fadel, S., and Eley, A. (2008). Differential glycosaminoglycan binding of Chlamydia trachomatis 
OmcB protein from serovars E and LGV. J Med Microbiol 57: 1058–1061. 
Fan, T., Lu, H., Hu, H., Shi, L., McClarty, G.A, Nance, D.M., et al. (1998). Inhibition of apoptosis in 
chlamydia-infected cells: blockade of mitochondrial cytochrome c release and caspase activation. J 
Exp Med 187: 487–496. 
Ferreira, R., Borges, V., Nunes, A., Borrego, M.J., and Gomes, J.P. (2013). Assessment of the load and 
transcriptional dynamics of Chlamydia trachomatis plasmid according to strains’ tissue tropism. 
Microbiol Res 168: 333–339.  
Fields, K.A., Mead, D.J., Dooley, C.A., and Hackstadt, T. (2003). Chlamydia trachomatis type III 
secretion: Evidence for a functional apparatus during early-cycle development. Mol Microbiol 48: 671–
683. 
Filip, C., Fletcher, G., Wulff, J.L., and Earhart, C.F. (1973). Solubilization of the cytoplasmic 
membrane of Escherichia coli by the ionic detergent sodium-lauryl sarcosinate. J Bacteriol 115: 717–
22.  
Forsbach-Birk, V., Foddis, C., Simnacher, U., Wilkat, M., Longbottom, D., Walder, G., et al. (2013). 
Profiling Antibody Responses to Infections by Chlamydia abortus  Enables Identification of Potential 
Virulence Factors and Candidates for Serodiagnosis. PLoS One 8: e80310. 
Francis, T., and Magill, T.P. (1938). An unidentified virus producing acute meningitis and pneumonitis 
in experimental animals. J Exp Med 68: 147–160. 
Gambarte Tudela, J., Capmany, A., Romao, M., Quintero, C., Miserey-Lenkei, S., Raposo, G., et al. 
(2015). The late endocytic Rab39a GTPase regulates multivesicular bodies-chlamydial inclusion 
interaction and bacterial growth. J Cell Sci  11: 3068–3081. 
Geens, T. (2005). Identification and characterization of a type three secretion system in genotypes of 
Chlamydophila psittaci. PhD thesis, Ghent University. 
Geens, T., Desplanques, A., Loock, M. Van, Bo, B.M., Kaleta, E.F., Magnino, S., et al. (2005). 
Sequencing of the Chlamydophila psittaci ompA Gene Reveals a New Genotype , E/B , and the Need 
for a Rapid Discriminatory Genotyping Method. J Clin Microbiol 43: 2456–2461. 
Gentle, I.E., Burri, L., and Lithgow, T. (2005). Molecular architecture and function of the Omp85 
family of proteins. Mol Microbiol 58: 1216–1225. 
Gevaert, K., Goethals, M., Martens, L., Damme, J. Van, Staes, A., Thomas, G., and Vandekerckhove, J. 
(2003). Exploring proteomes and analyzing protein processing by mass spectrometric identification of 
sorted N-terminal peptides. Nat Biotechnol 21: 566–569. 
References                                                                                                                  153 
Gey, G.O., Coffmar, W.D., and Kubicek, M.T. (1952). Tissue culture studies of the proliferative 
capacity of cervical carcinoma and normal epithelium. Cancer Res 12: 264–265. 
Giannikopoulou, P., Bini, L., Simitsek, P.D., Pallini, V., and Vretou, E. (1997). Two-dimensional 
electrophoretic analysis of the protein family at 90 kDa of abortifacient Chlamydia psittaci. 
Electrophoresis 18: 2104–8.  
Girard, V., and Mourez, M. (2006). Adhesion mediated by autotransporters of Gram-negative bacteria: 
structural and functional features. Res Microbiol 157: 407–16.  
Glauert, A., and Thornley, M. (1969). The topology of the bacterial cell wall. Annu Rev Microbiol 23: 
159–198. 
Godlewska, R., Wiśniewska, K., Pietras, Z., and Jagusztyn-Krynicka, E.K. (2009). Peptidoglycan-
associated lipoprotein (Pal) of Gram-negative bacteria: Function, structure, role in pathogenesis and 
potential application in immunoprophylaxis: Minireview. FEMS Microbiol Lett 298: 1–11. 
Goellner, S., Schubert, E., Liebler-Tenorio, E., Hotzel, H., Saluz, H.P., and Sachse, K. (2006). 
Transcriptional response patterns of Chlamydophila psittaci in different in vitro models of persistent 
infection. Infect Immun 74: 4801–8.  
Gomes, P., Nunes, A., Bruno, W.J., Borrego, M.J., Florindo, C., Dean, D., and Acteriol, J.B. (2006). 
Polymorphisms in the Nine Polymorphic Membrane Proteins of Chlamydia trachomatis across All 
Serovars : Evidence for Serovar Da Recombination and Correlation with Tissue Tropism. J Bacteriol 
188: 275–286. 
Grieshaber, S.S., Grieshaber, N.A., and Hackstadt, T. (2003). Chlamydia trachomatis uses host cell 
dynein to traffic to the microtubule-organizing center in a p50 dynamitin-independent process. J Cell 
Sci 116: 3793–3802. 
Grimwood, J., and Olinger, L. (2001). Expression of Chlamydia pneumoniae  Polymorphic Membrane 
Protein Family Genes. Infect Immun 69: 2383–2389. 
Grimwood, J., and Stephens, R.S. (1999). Computational analysis of the polymorphic membrane 
protein superfamily of Chlamydia trachomatis and Chlamydia pneumoniae. Microb Comp Genomics 4: 
187–201.  
Grinblat-Huse, V., Drabek, E.F., Creasy, H.H., Daugherty, S.C., Jones, K.M., Santana-Cruz, I., et al. 
(2011). Genome sequences of the zoonotic pathogens Chlamydia psittaci 6BC and Cal10. J Bacteriol 
193: 4039–40. 
Hackstadt, T., Rockey, D.D., Heinzen, R.A., and Scidmore, M.A. (1996). Chlamydia trachomatis 
interrupts an exocytic pathway to acquire endogenously synthesized sphingomyelin in transit from the 
Golgi apparatus to the plasma membrane. EMBO J 15: 964–977. 
Hanada, K. (2010). Intracellular trafficking of ceramide by ceramide transfer protein. Proc Jpn Acad 
Ser B Phys Biol Sci 86: 426–437. 
Hanh, D., Azenabor, A., Beatty, W.L., and Byrne, G.I. (2002). Chlamydia pneumoniae as a respiratory 
pathogen. Front Biosci 7: 66–76. 
Harkinezhad, T., Geens, T., and Vanrompay, D. (2009). Chlamydophila psittaci infections in birds: a 
review with emphasis on zoonotic consequences. Vet Microbiol 135: 68–77. 
Harris, S.R., Clarke, I.N., Seth-Smith, H.M.B., Solomon, A.W., Cutcliffe, L.T., Marsh, P., et al. (2012). 
Whole-genome analysis of diverse Chlamydia trachomatis strains identifies phylogenetic relationships 
masked by current clinical typing. Nat Genet 44: 413–9.  
154                                                                                                              References 
Hatch, T.P. (1996). Disulfide Cross-Linked Envelope Proteins : the Functional Equivalent of 
Peptidoglycan in Chlamydiae? J Bacteriol 178: 1–5. 
Hatch, T.P., Allan, I., and Pearce, J.H. (1984). Structural and polypeptide differences between 
envelopes of infective and reproductive life cycle forms of Chlamydia spp. J Bacteriol 157: 13–20. 
Hatch, G.M., and Mcclarty, G. (1998). Phospholipid composition of purified Chlamydia trachomatis 
mimics that of the eucaryotic host cell. Infect Immun 66: 3727–3735. 
Hatch, T.P., Miceli, M., and Sublett, J.E. (1986). Synthesis of disulfide-bonded outer membrane 
proteins during the developmental cycle of Chlamydia psittaci and Chlamydia trachomatis. J Bacteriol 
165: 379–85.  
Hatch, T.P., Vance  Jr., D.W., and Al-Hossainy, E. (1981). Attachment of Chlamydia psittaci to 
formaldehyde-fixed and unfixed L cells. J Gen Microbiol 125: 273–283. 
Heckels, J.E., Blackett, B., Everson, J.S., and Ward, M.E. (1976). The Influence of Surface Charge on 
the Attachment of Neisseria gonorrhoeae to Human Cells. J Gen Microbiol 96: 359–364. 
Heddema, E.R., van Hannen, E.J., Duim, B., Vandenbroucke-Grauls, C.M.J.E., and Pannekoek, Y. 
(2006). Genotyping of Chlamydophila psittaci  in human samples. Emerg Infect Dis 12: 1989–90.  
Heine, H., Müller-Loennies, S., Brade, L., Lindner, B., and Brade, H. (2003). Endotoxic activity and 
chemical structure of lipopolysaccharides from Chlamydia trachomatis serotypes E and L2 and 
Chlamydophila psittaci 6BC. Eur J Biochem 270: 440–450. 
Henderson, I.R., and Lam, A.C. (2001). Polymorphic proteins of Chlamydia spp.--autotransporters 
beyond the Proteobacteria. Trends Microbiol 9: 573–8.  
Henderson, I.R., Nataro, J.P., and Henderson, I.R. (2001). Virulence Functions of Autotransporter 
Proteins MINIREVIEW. Infect Immun 69: 1231-1243. 
Henderson, I.R., Navarro-garcia, F., Fernandez, R.C., and Aldeen, D.A. (2004). Type V Protein 
Secretion Pathway : the Autotransporter Story. Microbiol Mol Biol Rev 68: 692-744. 
Hesse, L., Bostock, J., Dementin, S., Blanot, D., Mengin-Lecreulx, D., and Chopra, I. (2003). 
Functional and Biochemical Analysis of Chlamydia trachomatis MurC, an Enzyme Displaying UDP-
N-Acetylmuramate:Amino Acid Ligase Activity. J Bacteriol 185: 6507–6512. 
Heuer, D., Rejman Lipinski, A., Machuy, N., Karlas, A., Wehrens, A., Siedler, F., et al. (2009). 
Chlamydia causes fragmentation of the Golgi compartment to ensure reproduction. Nature 457: 731–
735. 
Hogan, R.J., Mathews, S.A., Summersgill, J.T., Timms, P., and Mukhopadhyay, S. (2004). Chlamydial 
Persistence : beyond the Biphasic Paradigm MINIREVIEW. Infect Immun 72: 1843–1855. 
Holland, S.M., Hudson, A.P., Bobo, L., Whittum-Hudson, J.A., Viscidi, R.P., Quinn, T.C., and Taylor, 
H.R. (1992). Demonstration of chlamydial RNA and DNA during a culture-negative state. Infect 
Immun 60: 2040–2047. 
Horn, M., Collingro, A., Schmitz-Esser, S., Beier, C.L., Purkhold, U., Fartmann, B., et al. (2004). 
Illuminating the evolutionary history of chlamydiae. Science 304: 728–30. 
Hovis, K.M., Mojica, S., McDermott, J.E., Pedersen, L., Simhi, C., Rank, R.G., et al. (2013). Genus-
optimized strategy for the identification of chlamydial type III secretion substrates. Pathog Dis 69: 
213–22. 
References                                                                                                                  155 
Hower, S., Wolf, K., and Fields, K.A. (2009). Evidence that CT694 is a novel Chlamydia trachomatis 
T3S substrate capable of functioning during invasion or early cycle development. Mol Microbiol 72: 
1423–1437. 
Hsia, R.C., Ohayon, H., Gounon, P., Dautry-Varsat, A., and Bavoil, P.M. (2000). Phage infection of 
the obligate intracellular bacterium, Chlamydia psittaci strain Guinea Pig Inclusion Conjunctivitis. 
Microbes Infect 2: 761–772. 
Hu, Y., Chen, L., Wang, C., Xie, Y., Chen, Z., Liu, L., et al. (2015). Transcriptional Analysis of 10 
Selected Genes in a Model of Penicillin G Induced Persistence of Chlamydophila psittaci  in HeLa 
Cells. J Microbiol Biotechnol 25: 1246–56.  
Humphrys, M.S., Creasy, T., Sun, Y., Shetty, A.C., Chibucos, M.C., Drabek, E.F., et al. (2013). 
Simultaneous transcriptional profiling of bacteria and their host cells. PLoS One 8: e80597.  
Hybiske, K., and Stephens, R.S. (2007). Mechanisms of Chlamydia trachomatis entry into 
nonphagocytic cells. Infect Immun 75: 3925–3934. 
Hybiske, K., and Stephens, R.S. (2007). Mechanisms of host cell exit by the intracellular bacterium 
Chlamydia. Proc Natl Acad Sci U S A 104: 11430–5.  
Igietseme, J.U., Magee, D.M., Williams, D.M., and Rank, R.G. (1994). Role for CD8+ T cells in 
antichlamydial immunity defined by chlamydia- specific T-lymphocyte clones. Infect Immun 62: 5195–
5197. 
Iliffe-Lee, E.R., and McClarty, G. (1999). Glucose metabolism in Chlamydia trachomatis: the energy 
parasite hypothesis revisited. Mol Microbiol 33: 177–187. 
Ingalls, R.R., Rice, P.A., Qureshi, N., Takayama, K., Lin, J.S., Golenbock, D.T., and Mmun, I.N.I. 
(1995). The Inflammatory Cytokine Response to Chlamydia trachomatis Infection Is Endotoxin 
Mediated. Infect Immun 63: 3125–3130. 
Ito, K., Sato, T., and Yura, T. (1977). Synthesis and assembly of the membrane proteins in E. coli . Cell 
11: 551–559. 
Jasper, D.K., Sigar, I.M., Schripsema, J.H., Sainvil, C.K., Smith, C.L., Yeruva, L., et al. (2015). 
Genomic variant representation in a Chlamydia population is dynamic and adaptive with dependence 
on in vitro and in vivo passage. Pathog Dis 73: 1–12.  
Jeffrey, B.M., Suchland, R.J., Quinn, K.L., Davidson, J.R., Stamm, W.E., and Rockey, D.D. (2010). 
Genome sequencing of recent clinical Chlamydia trachomatis strains identifies loci associated with 
tissue tropism and regions of apparent recombination. Infect Immun 78: 2544–2553. 
Jewett, T.J., Dooley, C.A., Mead, D.J., and Hackstadt, T. (2008). Chlamydia trachomatis  tarp is 
phosphorylated by src family tyrosine kinases. Biochem Biophys Res Commun 371: 339–344. 
Jewett, T.J., Fischer, E.R., Mead, D.J., and Hackstadt, T. (2006). Chlamydial TARP is a bacterial 
nucleator of actin. Proc Natl Acad Sci U S A 103: 15599–15604. 
Kalman, S., Mitchell, W., Marathe, R., Lammel, C., Fan, J., Hyman, R.W., et al. (1999). Comparative 
genomes of Chlamydia pneumoniae and C. trachomatis. Nat Genet 21: 385–389. 
Kalmar, I., Berndt, A., Yin, L., Chiers, K., Sachse, K., and Vanrompay, D. (2015). Host–pathogen 
interactions in specific pathogen-free chickens following aerogenous infection with Chlamydia psittaci 
and Chlamydia abortus. Vet Immunol Immunopathol 164: 30-9.  
Kari, L., Whitmire, W.M., Crane, D.D., Reveneau, N., Carlson, J.H., Goheen, M.M., et al. (2009). 
156                                                                                                              References 
Chlamydia trachomatis native major outer membrane protein induces partial protection in nonhuman 
primates: implication for a trachoma transmission-blocking vaccine. J Immunol 182: 8063–8070. 
Karunakaran, K.P., Rey-Ladino, J., Stoynov, N., Berg, K., Shen, C., Jiang, X., et al. (2008). 
Immunoproteomic discovery of novel T cell antigens from the obligate intracellular pathogen 
Chlamydia. J Immunol 180: 2459–65.  
Kawa, D.E., and Stephens, R.S. (2002). Antigenic topology of chlamydial PorB protein and 
identification of targets for immune neutralization of infectivity. J Immunol 168: 5184–91.  
Kerr, K., Entrican, G., McKeever, D., and Longbottom, D. (2005). Immunopathology of 
Chlamydophila abortus infection in sheep and mice. Res Vet Sci 78: 1–7. 
Kidie, D., Bae, D., and Lee, Y. (2013). Prevalence and antimicrobial resistence of  Salmonella  isolated 
from poultry slaughterhouses in Korea. J Vet Res 61: 129–136. 
Kim, S., and DeMars, R. (2001). Epitope clusters in the major outer membrane protein of Chlamydia 
trachomatis. Curr Opin Immunol 13: 429–436.  
Kirk, D.G., Palonen, E., Korkeala, H., and Lindström, M. (2014). Evaluation of normalization 
reference genes for RT-qPCR analysis of spo0A and four sporulation sigma factor genes in Clostridium 
botulinum  Group I strain ATCC 3502. Anaerobe 26: 14–19.  
Kiselev, A.O., Skinner, M.C., and Lampe, M.F. (2009). Analysis of pmpD expression and PmpD post-
translational processing during the life cycle of Chlamydia trachomatis serovars A, D, and L2. PLoS 
One 4: e5191.  
Kiselev, A.O., Stamm, W.E., Yates, J.R., and Lampe, M.F. (2007). Expression, processing, and 
localization of PmpD of Chlamydia trachomatis Serovar L2 during the chlamydial developmental 
cycle. PLoS One 2: e568.  
Knittler, M.R., Berndt, A., Böcker, S., Dutow, P., Hänel, F., Heuer, D., et al. (2014). Chlamydia 
psittaci: New insights into genomic diversity, clinical pathology, host-pathogen interaction and anti-
bacterial immunity. Int J Med Microbiol. 304: 877-93. 
Knudsen, K., Madsen, A.S., Mygind, P., Christiansen, G., and Birkelund, S. (1999). Identification of 
Two Novel Genes Encoding 97- to 99-Kilodalton Outer Membrane Proteins of Chlamydia pneumoniae. 
67: 375–383. 
Kubo, A., and Stephens, R.S. (2000). Characterization and functional analysis of PorB, a Chlamydia 
porin and neutralizing target. Mol Microbiol 38: 772–780. 
Kubo, A., and Stephens, R.S. (2001). Substrate-specific diffusion of select dicarboxylates through 
Chlamydia trachomatis PorB. Microbiology 147: 3135–3140. 
Kumar, Y., Cocchiaro, J., and Valdivia, R.H. (2006). The Obligate Intracellular Pathogen Chlamydia 
trachomatis Targets Host Lipid Droplets. Curr Biol 16: 1646–1651. 
Kuo, C.C., Wang, S.P., and Grayston, J.T. (1977). Antimicrobial activity of several antibiotics and a 
sulfonamide against Chlamydia trachomatis organisms in cell culture. Antimicrob Agents Chemother 
12: 80–83. 
Lambden, P.R., Everson, J.S., Ward, M.E., and Clarke, I.N. (1990). Sulfur-rich proteins of  Chlamydia 
trachomatis : developmentally regulated transcription of polycistronic mRNA from tandem promotors. 
Gene 87: 105–112. 
Lambert, M., and Smith, S. (2009). The PagN protein mediates invasion via interaction with 
References                                                                                                                  157 
proteoglycan. FEMS Microbiol Lett 2: 209–216. 
Lane, B.J., Mutchler, C., Al Khodor, S., Grieshaber, S.S., and Carabeo, R.A. (2008). Chlamydial entry 
involves TARP binding of guanine nucleotide exchange factors. PLoS Pathog 4: e1000014. 
LaVerda, D., Kalayoglu, M.V, and Byrne, G.I. (1999). Chlamydial heat shock proteins and disease 
pathology: new paradigms for old problems? Infect Dis Obs Gynecol 7: 64–71.  
Liechti, G.W., Kuru, E., Hall, E., Kalinda, A., Brun, Y.V., VanNieuwenhze, M., and Maurelli, A.T. 
(2014). A new metabolic cell-wall labelling method reveals peptidoglycan in Chlamydia trachomatis. 
Nature 506: 507–10.  
Liu, X., Afrane, M., Clemmer, D.E., Zhong, G., and Nelson, D.E. (2010). Identification of Chlamydia 
trachomatis outer membrane complex proteins by differential proteomics. J Bacteriol 192: 2852–60.  
Livingstone, M., Entrican, G., Wattegedera, S., Buxton, D., McKendrick, I.J., and Longbottom, D. 
(2005). Antibody Responses to Recombinant Protein Fragments of the Major Outer Membrane Protein 
and Polymorphic Outer Membrane Protein POMP90 in Chlamydophila abortus-Infected Pregnant 
Sheep. Clin Diagn Lab Immunol 12: 770–777. 
Longbottom, D., and Coulter, L.J. (2003). Animal chlamydioses and zoonotic implications. J Comp 
Pathol 128: 217–244. 
Longbottom, D., Findlay, J., Vretou, E., and Dunbar, S.M. (1998a). Immunoelectron microscopic 
localisation of the OMP90 family on the outer membrane surface of Chlamydia psittaci. FEMS 
Microbiol Lett 164: 111–7. 
Longbottom, D., and Livingstone, M. (2006). Vaccination against chlamydial infections of man and 
animals. Vet J 171: 263–275. 
Longbottom, D., Russell, M., Dunbar, S.M., Jones, G.E., and Herring, A.J. (1998b). Molecular cloning 
and characterization of the genes coding for the highly immunogenic cluster of 90-kilodalton envelope 
proteins from the Chlamydia psittaci subtype that causes abortion in sheep. Infect Immun 66: 1317–24.  
Longbottom, D., Russell, M., Jones, G.E., Lainson, F.A., and Herring, A.J. (1996). Identification of a 
multigene family coding for the 90 kDa proteins of the ovine abortion subtype of Chlamydia psittaci. 
FEMS Microbiol Lett 142: 277–281. 
Lutter, E.I., Martens, C., and Hackstadt, T. (2012). Evolution and conservation of predicted inclusion 
membrane proteins in chlamydiae. Comp Funct Genomics 2012: 362104. 
Manire, G.P., and Tamura, A. (1967). Preparation and chemical composition of the cell walls of mature 
infectious dense forms of meningopneumonitis organisms. J Bacteriol 94: 1178–1183. 
Mamelak, D., Mylvaganam, M., Whetstone, H., Hartmann, E., Lennarz, W., Wyrick, P.B., et al. (2001). 
Hsp70s contain a specific sulfogalactolipid binding site. Differential aglycone influence on 
sulfogalactosyl ceramide binding by recombinant prokaryotic and eukaryotic Hsp70 family members. 
Biochemistry 40: 3572–3582. 
Mannonen, L., Markkula, E., and Puolakkainen, M. (2011). Analysis of Chlamydia pneumoniae 
infection in mononuclear cells by reverse transcription-PCR targeted to chlamydial gene transcripts. 
Med Microbiol Immunol 200: 143–154. 
Marques, P.X., Souda, P., O’Donovan, J., Gutierrez, J., Gutierrez, E.J., Worrall, S., et al. (2010). 
Identification of immunologically relevant proteins of Chlamydophila abortus using sera from 
experimentally infected pregnant ewes. Clin Vaccine Immunol 17: 1274–81.  
158                                                                                                              References 
Mathews, S., George, C., Flegg, C., Stenzel, D., and Timms, P. (2001). Differential expression of 
ompA, ompB, pyk, nlpD and Cpn0585 genes between normal and interferon-gamma treated cultures of 
Chlamydia pneumoniae. Microb Pathog 30: 337–345. 
Matsumoto, A. (1982). Electron microscopic observations of surface projections on Chlamydia psittaci 
reticulate bodies. Infect Immun 150: 358–364. 
Matsumoto, A., Bessho, H., Uehira, K., and Suda, T. (1991). Morphological studies of the association 
of mitochondria with chlamydial inclusions and the fusion of chlamydial inclusions. J Electron 
Microsc 40: 356–363. 
Mayr, A., Bachmann, P.A., Bibrack, B., and Wittmann, G. (1974). Quantitative Bestimmung der 
Virusinfektiositat (Virustitration). In Virologische Arbeitsmethoden Bd. I. Jena: Gustav Ficher Verlag, 
pp. 35-39. 
McCafferty, M.C., Herring, A.J., Andersen, A.A., and Jones, G.E. (1995). Electrophoretic analysis of 
the major outer membrane protein of Chlamydia psittaci reveals multimers which are recognized by 
protective monoclonal antibodies. Infect Immun 63: 2387–2389. 
McConnell, M.J., and Pachón, J. (2011). Expression, purification, and refolding of biologically active 
Acinetobacter baumannii OmpA from Escherichia coli inclusion bodies. Protein Expr Purif 77: 98–
103.  
McCoy, A.J., Adams, N.E., Hudson, A.O., Gilvarg, C., Leustek, T., and Maurelli, A.T. (2006). L,L-
diaminopimelate aminotransferase, a trans-kingdom enzyme shared by Chlamydia and plants for 
synthesis of diaminopimelate/lysine. Proc Natl Acad Sci 103: 17909–17914.  
McCoy, A.J., and Maurelli, A.T. (2005). Characterization of Chlamydia MurC-Ddl, a fusion protein 
exhibiting D-alanyl-D-alanine ligase activity involved in peptidoglycan synthesis and D-cycloserine 
sensitivity. Mol Microbiol 57: 41–52. 
McCoy, A.J., Sandlin, R.C., and Maurelli, A.T. (2003). In Vitro and In Vivo Functional Activity of 
Chlamydia MurA , a UDP- N -Acetylglucosamine Enolpyruvyl Transferase Involved in Peptidoglycan 
Synthesis and Fosfomycin Resistance. J Bacteriol 185: 1218–1228. 
Mehlitz, A., Banhart, S., Hess, S., Selbach, M., and Meyer, T.F. (2008). Complex kinase requirements 
for Chlamydia trachomatis Tarp phosphorylation. FEMS Microbiol Lett 289: 233–240. 
Michalova, E., Novotna, P., and Schlegelova, J. (2004). Tetracyclines in veterinary medicine and 
bacterial resistance to them. A review. Vet Med 2004: 79–100.  
Miettinen, A., Heinonen, P.K., Teisala, K., Punnonen, R., and Paavonen, J. (1990). Antigen specific 
serum antibody response to  Chlamydia trachomatis  in patients with acute pelvic inflammatory disease. 
J Clin Pathol 43: 758–761. 
Miller, J.D., Sal, M.S., Schell, M., Whittimore, J.D., and Raulston, J.E. (2009). Chlamydia trachomatis 
YtgA is an iron-binding periplasmic protein in duced by iron restriction. Microbiology 155: 2884–2894. 
Moelleken, K., and Hegemann, J.H. (2008). The Chlamydia outer membrane protein OmcB is required 
for adhesion and exhibits biovar-specific differences in glycosaminoglycan binding. Mol Microbiol 67: 
403–19. 
Mojica, S.A., Hovis, K.M., Frieman, M.B., Tran, B., Hsia, R.C., Ravel, J., et al. (2015). SINC, a type 
III secreted protein of Chlamydia psittaci, targets the inner nuclear membrane of infected cells and 
uninfected neighbors. Mol Biol Cell 26: 1918–1934. 
Mölleken, K., Becker, E., and Hegemann, J.H. (2013) The Chlamydia pneumoniae Invasin Protein 
References                                                                                                                  159 
Pmp21 Recruits the EGF Receptor for Host Cell Entry. PLoS Pathog 9: e1003325. 
Mölleken, K., Schmidt, E., and Hegemann, J.H. (2010). Members of the Pmp protein family of 
Chlamydia pneumoniae mediate adhesion to human cells via short repetitive peptide motifs. Mol 
Microbiol 78: 1004–17. 
Moore, E.R., and Ouellette, S.P. (2014). Reconceptualizing the chlamydial inclusion as a pathogen-
specified parasitic organelle: an expanded role for Inc proteins. Front Cell Infect Microbiol 4: 157.  
Morrison, S.G., Su, H., Caldwell, H.D., and Morrison, R.P. (2000). Immunity to murine Chlamydia 
trachomatis genital tract reinfection involves B cells and CD4+ T cells but not CD8+ T cells. Infect 
Immun 68: 6979–6987.  
Moulder, J.W. (1991). Interaction of chlamydiae and host cells in vitro. Microbiol Rev 55: 143–190.  
Moulder, J.W., Novosel, D.L., and Officer, J.E. (1963). Inhibition of the Growth of Agents of the 
Psittacosis Group By D-Cycloserine and Its Specific Reversal By D-Alanine. J Bacteriol 85: 707–711. 
Moulder, J.W. (1993). Why is Chlamydia sensitive to penicillin in the absence of peptidoglycan? Infect 
Agents Dis 2: 87–99. 
Mpiga, P., and Ravaoarinoro, M. (2006). Chlamydia trachomatis persistence: An update. Microbiol 
Res 161: 9–19.  
Mukhopadhyay, S., Miller, R.D., Sullivan, E.D., Theodoropoulos, C., Mathews, S.A., Timms, P., and 
Summersgill, J.T. (2006). Protein expression profiles of Chlamydia pneumoniae in models of 
persistence versus those of heat shock stress response. Infect Immun 74: 3853–3863. 
Myers, G.S.A., Mathews, S.A., Eppinger, M., Mitchell, C., O’Brien, K.K., White, O.R., et al. (2009). 
Evidence that human Chlamydia pneumoniae was zoonotically acquired. J Bacteriol 191: 7225–7233. 
Mygind, P., Christiansen, G., and Birkelund, S. (1998). Topological analysis of Chlamydia trachomatis 
L2 outer membrane protein 2. J Bacteriol 180: 5784–7.  
Mygind, P., Christiansen, G., Persson, K., and Birkelund, S. (1998). Analysis of the humoral immune 
response to Chlamydia outer membrane protein 2. Clin Diagn Lab Immunol 5: 313–8. 
Mygind, P.H., Christiansen, G., Roepstorff, P., and Birkelund, S. (2000). Membrane proteins PmpG 
and PmpH are major constituents of Chlamydia trachomatis L2 outer membrane complex. FEMS 
Microbiol Lett 186: 163–169. 
Nally, J.E., Whitelegge, J.P., Bassilian, S., Blanco, D.R., and Lovett, M.A. (2007). Characterization of 
the outer membrane proteome of Leptospira interrogans expressed during acute lethal infection. Infect 
Immun 75: 766–773. 
Narita, T., Wyrick, P.B., and Manire, G.P. (1976). Effect of Alkali on the Structure of Cell Envelopes 
of Chlamydia psittaci  Elementary Bodies. J Bacteriol 125: 300–307. 
Nemeghaire, S., Roelandt, S., Argudín, M.A., Haesebrouck, F., and Butaye, P. (2013). Characterization 
of methicillin-resistant Staphylococcus aureus from healthy carrier chickens. Avian Pathol 42: 342–6. 
Newhall, W.J. (1987). Biosynthesis and disulfide cross-linking of outer membrane components during 
the growth cycle of Chlamydia trachomatis. Infect Immun 55: 162–8.  
Newhall, W.J., and Jones, R.B. (1983). Disulfide-linked oligomers of the major outer membrane 
protein of chlamydiae. J Bacteriol 154: 998–1001.  
160                                                                                                              References 
Nicholson, T.L., Chiu, K., and Stephens, R.S. (2004). Chlamydia trachomatis Lacks an Adaptive 
Response to Changes in Carbon Source Availability. Society 72: 4286–4289. 
Nicholson, T.L., Olinger, L., Chong, K., Schoolnik, G., and Stephens, R.S. (2003). Global Stage-
Specific Gene Regulation during the Developmental Cycle of Chlamydia trachomatis. J Bacteriol 185: 
3179–3189. 
Niessner, A., Kaun, C., Zorn, G., Speidl, W., Türel, Z., Christiansen, G., et al. (2003). Polymorphic 
membrane protein (PMP) 20 and PMP 21 of Chlamydia pneumoniae induce proinflammatory 
mediators in human endothelial cells in vitro by activation of the nuclear factor-kappaB pathway. J 
Infect Dis 188: 108–13.  
Ouellette, S.P., and Carabeo, R.A. (2010). A functional slow recycling pathway of transferrin is 
required for growth of Chlamydia. Front Microbiol 1: 1–12. 
Ouellette, S.P., Dorsey, F.C., Moshiach, S., Cleveland, J.L., and Carabeo, R.A. (2011). Chlamydia 
species-dependent differences in the growth requirement for lysosomes. PLoS One 6: e16783. 
Packiam, M., Weinrick, B., Jacobs, W.R., and Maurelli, A.T. (2015). Structural characterization of 
muropeptides from Chlamydia trachomatis peptidoglycan by mass spectrometry resolves “chlamydial 
anomaly”. Proc Natl Acad Sci U S A 112: 11660–5.  
Pal, S., Barnhart, K., Wei, Q., Abai, A., Peterson, E., and De la Maza, L.M. (1999). Vaccination of 
mice with DNA plasmids coding for the  Chlamydia trachomatis  major outer membrane protein elicits 
an immune response but fails to protect against a genital challenge. Vaccine 17: 459–465. 
Pal, S., Peterson, E.M., Rappuoli, R., Ratti, G., and De La Maza, L.M. (2005). Immunization with the 
Chlamydia trachomatis major outer membrane protein, using adjuvants developed for human vaccines, 
can induce partial protection in a mouse model against a genital challenge. Vaccine 24: 766–775. 
Pannekoek, Y., Dickx, V., Beeckman, D.S.A., Jolley, K.A., Keijzers, W.C., Vretou, E., et al. (2010). 
Multi locus sequence typing of Chlamydia reveals an association between Chlamydia psittaci 
genotypes and host species. PLoS One 5: e14179.  
Pannekoek, Y., Morelli, G., Kusecek, B., Morré, S.A., Ossewaarde, J.M., Langerak, A.A., van der 
Ende, A. (2008). Multi locus sequence typing of Chlamydiales: clonal groupings within the obligate 
intracellular bacteria Chlamydia trachomatis. BMC Microbiol 8: 42. 
Parsons, L.M., Lin, F., and Orban, J. (2006). Peptidoglycan recognition by Pal, an outer membrane 
lipoprotein. Biochemistry 45: 2122–2128. 
Patin, D., Bostock, J., Blanot, D., Mengin-Lecreulx, D., and Chopra, I. (2009). Functional and 
biochemical analysis of the Chlamydia trachomatis ligase MurE. J Bacteriol 191: 7430–7435. 
Patin, D., Bostock, J., Chopra, I., Mengin-Lecreulx, D., and Blanot, D. (2012). Biochemical 
characterisation of the chlamydial MurF ligase, and possible sequence of the chlamydial peptidoglycan 
pentapeptide stem. Arch Microbiol 194: 505–512. 
Peeling, R.W., and Mabey, D.C. (1999). Heat shock protein expression and immunity in chlamydial 
infections. Infect Dis Obs Gynecol 7: 72–79.  
Peters, J., Wilson, D.P., Myers, G., Timms, P., and Bavoil, P.M. (2007). Type III secretion à la 
Chlamydia. Trends Microbiol 15: 241–251. 
Pfaffl, M.W. (2001). A new mathematical model for relative quantification in real-time RT–PCR. 
Nucleic Acids Res 29: e45.  
References                                                                                                                  161 
Piper, R.C., and Luzio, J.P. (2001). Late endosomes: sorting and partitioning in multivesicular bodies. 
Traffic 2: 612–621. 
Pospischil, A., Borel, N., and Andersen, A.A. (2010). Chlamydia. In Pathogenesis of Bacterial 
Infections in Animals. Gyles, C., Prescott, J., Songer, J., and Thoen, C. (eds). Wiley-Blackwell, pp. 
575–588. 
Putman, T.E., Suchland, R.J., Ivanovitch, J.D., and Rockey, D.D. (2013). Culture-independent 
sequence analysis of Chlamydia trachomatis in urogenital specimens identifies regions of 
recombination and in-patient sequence mutations. Microbiol (United Kingdom) 159: 2109–2117. 
Quan, S., Hiniker, A., Collet, J., and Bardwell, J.C.A. (2013). Isolation of Bacteria Envelope Proteins. 
In Bacterial Cell Surfaces. Delcour, A. (ed). Humana Press, pp. 359–366.  
Ramsey, K.H., and Rank, R.G. (1991). Resolution of chlamydial genital infection with antigen-specific 
T-lymphocyte lines. Infect Immun 59: 925–931. 
Ramsey, K.H., Soderberg, L.S.F., and Rank, R.G. (1988). Resolution of chlamydial genital infection in 
B-cell-deficient mice and immunity to reinfection. Infect Immun 56: 1320–1325. 
Rank, R.G., and Whittum-Hudson, J.A. (2010). Protective immunity to Chlamydial genital infection: 
evidence from animal studies. J Infect Dis 201: 168–177.  
Raulston, J.E. (1995). Chlamydial envelope components and pathogen-host cell interactions. Mol 
Microbiol 15: 607–16.  
Raulston, J.E. (1997). Response of Chlamydia trachomatis serovar E to iron restriction in vitro and 
evidence for iron-regulated chlamydial proteins. Infect Immun 65: 4539–47.  
Raulston, J.E., Davis, C.H., Paul, T.R., Hobbs, J.D., and Wyrick, P.B. (2002). Surface Accessibility of 
the 70-Kilodalton Chlamydia trachomatis Heat Shock Protein following Reduction of Outer Membrane 
Protein Disulfide Bonds. Infect Immun 70: 535–543. 
Read, T.D. (2003). Genome sequence of Chlamydophila caviae (Chlamydia psittaci GPIC): examining 
the role of niche-specific genes in the evolution of the Chlamydiaceae. Nucleic Acids Res 31: 2134–
2147.  
Read, T.D., Brunham, R.C., Shen, C., Gill, S.R., Heidelberg, J.F., White, O., et al. (2000). Genome 
sequences of Chlamydia trachomatis MoPn and Chlamydia pneumoniae AR39. Nucleic Acids Res 28: 
1397–406.  
Reiter, L., Kolstø, A.B., and Piehler, A.P. (2011). Reference genes for quantitative, reverse-
transcription PCR in Bacillus cereus group strains throughout the bacterial life cycle. J Microbiol 
Methods 86: 210–217.  
Rejman Lipinski, A., Heymann, J., Meissner, C., Karlas, A., Brinkmann, V., Meyer, T.F., and Heuer, D. 
(2009). Rab6 and Rab11 regulate Chlamydia trachomatis development and golgin-84-dependent Golgi 
fragmentation. PLoS Pathog 5: e1000615. 
Robertson, D.K, Gu, L., Rowe, R.K., and Beatty, W.L. (2009). Inclusion biogenesis and reactivation of 
persistent Chlamydia trachomatis requires host cell sphingolipid biosynthesis. PLoS Pathog 5: 
e1000664. 
Rockey, D.D., Fischer, E.R., and Hackstadt, T. (1996). Temporal analysis of the developing Chlamydia 
psittaci inclusion using flourescent and electron microscopy. Infect Immun 64: 4269–4278. 
Rockey, D.D., Scidmore, M.A., Bannantine, J.P., and Brown, W.J. (2002). Proteins in the chlamydial 
162                                                                                                              References 
inclusion membrane. Microbes Infect 4: 333–40. 
Roulis, E., Bachmann, N., Polkinghorne, A., Hammerschlag, M., Kohlhoff, S., and Timms, P. (2014). 
Draft Genome and Plasmid Sequences of Chlamydia pneumoniae Strain B21 from an Australian 
Endangered Marsupial , the Western Barred Bandicoot. Genome Announc 2: 3–4. 
Rzomp, K.A., Moorhead, A.R., and Scidmore, M.A. (2006). The GTPase Rab4 interacts with 
Chlamydia trachomatis inclusion membrane protein CT229. Infect Immun 74: 5362–5373. 
Rzomp, K.A., Scholtes, L.D., Briggs, B.J., Whittaker, G.R., and Scidmore, M.A. (2003). Rab GTPases 
are recruited to chlamydial inclusions in both a species-dependent and species-independent manner. 
Infect Immun 71: 5855–5870. 
Sachse, K., Bavoil, P.M., Kaltenboeck, B., Stephens, R.S., Kuo, C.-C., Rosselló-Móra, R., and Horn, 
M. (2015). Emendation of the family Chlamydiaceae: proposal of a single genus, Chlamydia, to 
include all currently recognized species. Syst Appl Microbiol 38: 99–103.  
Sachse, K., Laroucau, K., Riege, K., Wehner, S., Dilcher, M., Creasy, H.H., et al. (2014). Evidence for 
the existence of two new members of the family Chlamydiaceae and proposal of Chlamydia avium sp. 
nov. and Chlamydia gallinacea sp. nov. Syst Appl Microbiol 37: 79-88. 
Sahl, J.W., Steinsland, H., Redman, J.C., Angiuoli, S. V., Nataro, J.P., Sommerfelt, H., and Rasko, D.A. 
(2011). A comparative genomic analysis of diverse clonal types of enterotoxigenic Escherichia coli 
reveals pathovar-specific conservation. Infect Immun 79: 950–960. 
Sait, M., Clark, E.M., Wheelhouse, N., Livingstone, M., Spalding, L., Siarkou, V.I., et al. (2011). 
Genome sequence of the Chlamydophila abortus variant strain LLG. J Bacteriol 193: 4276–4277. 
Saka, H.A., Thompson, J.W., Chen, Y.-S., Kumar, Y., Dubois, L.G., Moseley, M.A., and Valdivia, 
R.H. (2011). Quantitative proteomics reveals metabolic and pathogenic properties of Chlamydia 
trachomatis developmental forms. Mol Microbiol 82: 1185–203.  
Saka, H.A., and Valdivia, R.H. (2010). Acquisition of nutrients by Chlamydiae: unique challenges of 
living in an intracellular compartment. Curr Opin Microbiol 13: 4–10. 
Sanchez-Campillo, M., Bini, L., Comanducci, M., Raggiaschi, R., Marzocchi, B., Pallini, V., and Ratti, 
G. (1999). Identification of immunoreactive proteins of  Chlamydia trachomatis  by Western blot 
analysis of a two-dimensional electrophoresis map with patient sera. Electrophoresis 20: 2269–2279. 
Sandoz, K.M., and Rockey, D.D. (2011). Antibiotic resistance in Chlamydiae. Future Microbiol 5: 
1427–1442. 
Sardinia, L.M., Segal, E., and Ganem, D. (1988). Developmental regulation of the cysteine-rich outer-
membrane proteins of murine Chlamydia trachomatis. J Gen Microbiol 134: 997–1004. 
Schachter, J., and Dawson, C. (1990). The epidemiology of trachoma predicts more blindness in the 
future. Scand J INfect Dis Suppl 69: 55–62. 
Schautteet, K., and Vanrompay, D. (2011). Chlamydiaceae infections in pig. Vet Res 42: 29. 
Schloss, P.D., Westcott, S.L., Ryabin, T., Hall, J.R., Hartmann, M., Hollister, E.B., et al. (2009). 
Introducing mothur: Open-source, platform-independent, community-supported software for describing 
and comparing microbial communities. Appl Environ Microbiol 75: 7537–7541. 
Schneider, C.A., Rasband, W.S., and Eliceiri, K.W. (2012). NIH Image to ImageJ: 25 years of image 
analysis. Nat Methods 9: 671–675. 
References                                                                                                                  163 
Schöfl, G., Voigt, A., Litsche, K., Sachse, K., and Saluz, H.P. (2011). Complete genome sequences of 
four mammalian isolates of Chlamydophila psittaci. J Bacteriol 193: 4258. 
Scidmore, M.A. (2011). Recent Advances in Chlamydia Subversion of Host Cytoskeletal and 
Membrane Trafficking Pathways. Microbes Infect 13: 527–535. 
Scidmore, M.A., Fischer, E.R., and Hackstadt, T. (2003). Restricted fusion of Chlamydia trachomatis 
vesicles with endocytic compartments during the initial stages of infection. Infect Immun 71: 973–984. 
Scidmore, M.A., Rockey, D.D., Fischer, E.R., Heinzen, R.A., and Hackstadt, T. (1996). Vesicular 
interactions of the Chlamydia trachomatis inclusion are determined by chlamydial early protein 
synthesis rather than route of entry. Infect Immun 64: 5366–5372. 
Seabra, M.C., and Wasmeier, C. (2004). Controlling the location and activation of Rab GTPases. Curr 
Opin Cell Biol 16: 451–457. 
Seder, R., and Hill, A. (2000). Vaccines against intracellular infections requiring cellular immunity. 
Nature 6797: 793–798. 
Seth-Smith, H.M.B., Harris, S.R., Rance, R., West, A.P., Severin, J.A., Ossewaarde, J.M., et al. (2011). 
Genome sequence of the zoonotic pathogen Chlamydophila psittaci. J Bacteriol 193: 1282–1283. 
Shaw, J., Grund, V., Durling, L., Crane, D., and Caldwell, H.D. (2002). Dendritic cells pulsed with a 
recombinant chlamydial major outer membrane protein antigen elicit a CD4(+) type 2 rather than type 
1 immune response that is not protective. Infect Immun 70: 1097–1105.  
Shirai, M., Hirakawa, H., Kimoto, M., Tabuchi, M., Kishi, F., Ouchi, K., et al. (2000a). Comparison of 
whole genome sequences of Chlamydia pneumoniae J138 from Japan and CWL029 from USA. 
Nucleic Acids Res 28: 2311–2314. 
Shirai, M., Hirakawa, H., Ouchi, K., Tabuchi, M., Kishi, F., Kimoto, M., et al. (2000b). Comparison of 
outer membrane protein genes omp and pmp in the whole genome sequences of Chlamydia 
pneumoniae isolates from Japan and the United States. J Infect Dis 181: S524–7. 
Sibley, L.D., Krahenbuhl, J.L., Adams, G.M.W., and Weidner, E. (1986). Toxoplasma modifies 
macrophage phagosomes by secretion of a vesicular network rich in surface proteins. J Cell Biol 103: 
867–874. 
Sihto, H.M., Tasara, T., Stephan, R., and Johler, S. (2014). Validation of reference genes for 
normalization of qPCR mRNA expression levels in Staphylococcus aureus exposed to osmotic and 
lactic acid stress conditions encountered during food production and preservation. FEMS Microbiol 
Lett 356: 134–140. 
Skipp, P., Robinson, J., O’Connor, C.D., and Clarke, I.N. (2005). Shotgun proteomic analysis of 
Chlamydia trachomatis. Proteomics 5: 1558–73. 
Smith, K., Campbell, C., Murphy, J., Stobierski, M., and Tengelsen, L. (2011). Compendium of 
measures to prevent disease associated with animals in public settings, 2009: National Association of 
State Public Health Veterinarians, Inc. (NASPHV). J Exot Pet Med 20: 32–45. 
Somboonna, N., Wan, R., Ojcius, D.M., Pettengill, M.A., Joseph, S.J., Chang, A., et al. (2011). 
Hypervirulent Chlamydia trachomatis Clinical Strain Is a Recombinant between Lymphogranuloma 
Venereum (L2) and D Lineages. MBio 2: 1–12. 
Souriau, A., Salinas, J., De Sa, C., Layachi, K., and Rodolakis, A. (1994). Identification of subspecies- 
and serotype 1-specific epitopes on the 80- to 90-kilodalton protein region of Chlamydia psittaci that 
may be useful for diagnosis of chlamydial induced abortion. Am J Vet Res 55: 510–4. 
164                                                                                                              References 
Spalatin, J., Fraser, C.E., Connell, R., Hanson, R.P., and Berman, D.T. (1966). Agents of psittacosis-
lymphogranuloma venereum group isolated from muskrats and snowshoe hares in Saskatchewan. Can 
J Comp Med Vet Sci 30: 260–264.  
Speer, C.A., and Whitmire, W.M. (1989). Shedding of the immunodominant P20 surface antigen of 
Eimeria bovis sporozoites. Infect Immun 57: 999–1001. 
Stamatakis, A. (2014). RAxML version 8: A tool for phylogenetic analysis and post-analysis of large 
phylogenies. Bioinformatics 30: 1312–1313. 
Stephens, R.S. (1998). Genome Sequence of an Obligate Intracellular Pathogen of Humans: Chlamydia 
trachomatis. Science 282: 754–759.  
Stephens, R.S., Koshiyama, K., Lewis, E., and Kubo, A. (2001). Heparin-binding outer membrane 
protein of chlamydiae. Mol Microbiol 40: 691–9.  
Stephens, R.S., and Lammel, C.J. (2001). Chlamydia outer membrane protein discovery using 
genomics. Curr Opin Microbiol 4: 16–20. 
Stephens, R.S., Sanchez-Pescador, R., Wagar, E.A., Inouye, C., and Urdea, M.S. (1987). Diversity of 
Chlamydia trachomatis major outer membrane protein genes. J Bacteriol 169: 3879–85.  
Stewardson, A.J., and Grayson, M.L. (2010). Psittacosis. Infect Dis Clin North Am 24: 7–25. 
Struyve, M., Moons, M., and Tommassen, J. (1991). Carboxy-terminal phenylalanine is essential for 
the correct assembly of a bacterial outer membrane protein. J Mol Biol 218: 141–148. 
Su, H., and Caldwell, H.D. (1991). In vitro neutralization of Chlamydia trachomatis by monovalent 
Fab antibody specific to the major outer membrane protein. Infect Immun 59: 2843–2845. 
Su, H., and Caldwell, H.D. (1992). Immunogenicity of a Chimeric Peptide Corresponding to T Helper 
and B Cell Epitopes of the  Chlamydia trachomatis  Major Outer Membrane Protein. J Exp Med 175: 
227–235. 
Su, H., and Caldwell, H.D. (1995). CD4+ T Cells Play a Significant Role in Adoptive Immunity to 
Chlamydia trachomatis Infection of the Mouse Genital Tract. Infect Immun 63: 3302–3308. 
Su, H., Feilzer, K., Caldwell, H.D., and Morrison, R.P. (1997). Chlamydia trachomatis genital tract 
infection of antibody-deficient gene knockout mice. Infect Immun 65: 1993–1999.  
Su, H., McClarty, G., Dong, F., Hatch, G.M., Pan, Z.K., and Zhong, G. (2004). Activation of 
Raf/MEK/ERK/cPLA2 Signaling Pathway Is Essential for Chlamydial Acquisition of Host 
Glycerophospholipids. J Biol Chem 279: 9409–9416. 
Su, H., Parnell, M., and Caldwell, H.D. (1995). Protective efficacy of a parenterally administered 
MOMP-derived synthetic oligopeptide vaccine in a murine model of Chlamydia trachomatis genital 
tract infection: serum neutralizing IgG antibodies do not protect against chlamydial genital tract 
infection. Vaccine 13: 1023–1032. 
Su, H.U.A., Raymond, L., Rockey, D.D., Fischert, E., Hackstadt, T.E.D., and Caldwell, H.D. (1996). A 
recombinant Chlamydia trachomatis major outer membrane protein binds to heparan sulfate receptors 
on epithelial cells. Proc Natl Acad Sci USA 93: 11143–11148. 
Su, H., Watkins, N.G., Zhang, Y.X., and Caldwell, H.D. (1990). Chlamydia trachomatis-host cell 
interactions: role of the chlamydial major outer membrane protein as an adhesin. Infect Immun 58: 
1017–25.  
References                                                                                                                  165 
Suchland, R.J., Jeffrey, B.M., Xia, M., Bhatia, A., Chu, H.G., Rockey, D.D., and Stamm, W.E. (2008). 
Identification of concomitant infection with Chlamydia trachomatis IncA-negative mutant and wild-
type strains by genomic, transcriptional, and biological characterizations. Infect Immun 76: 5438–5446. 
Suchland, R.J., Sandoz, K.M., Jeffrey, B.M., Stamm, W.E., and Rockey, D.D. (2009). Horizontal 
Transfer of Tetracycline Resistance among Chlamydia spp. in Vitro. Antimicrob Agents Chemother 53: 
4604–4611. 
Südhof, T., and Rothman, J. (2009). Membrane Fusion: Grappling with SNARE and SM Proteins. 
Science  323: 474–477. 
Swanson, K.A., Taylor, L.D., Frank, S.D., Sturdevant, G.L., Fischer, E.R., Carlson, J.H., et al. (2009). 
Chlamydia trachomatis polymorphic membrane protein D is an oligomeric autotransporter with a 
higher-order structure. Infect Immun 77: 508–16.  
Tamura, A., Matsumoto, A., Manire, G.P., and Higashi, N. (1971). Electron microscopic observations 
on the structure of the envelopes of mature elementary bodies and developmental reticulate forms of 
Chlamydia psittaci. J Bacteriol 105: 355–60.  
Tamura, A., and Manire, G.P. (1968). Effect of penicillin on the multiplication of meningopneumonitis 
organisms (Chlamydia psittaci). J Bacteriol 96: 875–880. 
Tan, C., Hsia, R., Shou, H., Carrasco, J.A., Rank, R.G., and Bavoil, P.M. (2010). Variable expression 
of surface-exposed polymorphic membrane proteins in in vitro-grown Chlamydia trachomatis. Cell 
Microbiol 12: 174–87.  
Tan, C., Hsia, R., Shou, H., Haggerty, C.L., Ness, R.B., Gaydos, C.A., et al. (2009). Chlamydia 
trachomatis-Infected Patients Display Variable Antibody Profiles against the Nine-Member 
Polymorphic Membrane Protein Family. Cell Microbiol 77: 3218–3226. 
Tan, T.W., Herring,  A.J., Anderson, I.E., and Jones, G.E. (1990). Protection of sheep against 
Chlamydia psittaci infection with a subcellular vaccine containing the major outer membrane protein. 
Infect Immun 58: 3101–8.  
Tanzer, R.J., and Hatch, T.P. (2001). Characterization of Outer Membrane Proteins in Chlamydia 
trachomatis LGV Serovar L2. J Bacteriol 183: 2686–2690. 
Taraska, T., Ward, D.M., Ajioka, R.S., Wyrick, P.B., Davis-Kaplan, S.R., Davis, C.H., and Kaplan, J. 
(1996). The late chlamydial inclusion membrane is not derived from the endocytic pathway and is 
relatively deficient in host proteins. Infect Immun 64: 3713–3727. 
Tasara, T., and Stephan, R. (2007). Evaluation of housekeeping genes in Listeria monocytogenes as 
potential internal control references for normalizing mRNA expression levels in stress adaptation 
models using real-time PCR. FEMS Microbiol Lett 269: 265–272. 
Taylor, B.D., Darville, T., Tan, C., Bavoil, P.M., Ness, R.B., and Haggerty, C.L. (2011). The role of 
Chlamydia trachomatis polymorphic membrane proteins in inflammation and sequelae among women 
with pelvic inflammatory disease. Infect Dis Obstet Gynecol 2011: 989762. 
Thalmann, J., Janik, K., May, M., Sommer, K., Ebeling, J., Hofmann, F., et al. (2010). Actin re-
organization induced by Chlamydia trachomatis serovar D - evidence for a critical role of the effector 
protein CT166 targeting rac. PLoS One 5: 1–14. 
Thibodeau, A., Fravalo, P., Laurent-Lewandowski, S., Guévremont, E., Quessy, S., and Letellier, A. 
(2011). Presence and characterization of Campylobacter jejuni in organically raised chickens in 
Quebec. Can J Vet Res 75: 298–307. 
166                                                                                                              References 
Thomson, N.R., Holden, M.T.G., Carder, C., Lennard, N., Lockey, S.J., Marsh, P., et al. (2008). 
Chlamydia trachomatis: genome sequence analysis of lymphogranuloma venereum isolates. Genome 
Res 18: 161–71. 
Thomson, N.R., Yeats, C., Bell, K., Holden, M.T.G., Bentley, S.D., Livingstone, M., et al. (2005). The 
Chlamydophila abortus genome sequence reveals an array of variable proteins that contribute to 
interspecies variation. Genome Res 15: 629–640. 
Ting, L.M., Hsia, R.C., Haidaris, C.G., and Bavoil, P.M. (1995). Interaction of outer envelope proteins 
of Chlamydia psittaci GPIC with the HeLa cell surface. Infect Immun 63: 3600–8.  
Tjaden, J., Winkler, H.H., Schwöppe, C., Van Der Laan, M., and Neuhaus, H.E. (1999). Two 
Nucleotide Transport Proteins in Chlamydia trachomatis, One for Net Nucleoside Triphosphate Uptake 
and the Other for Transport of Energy. J Bacteriol 181: 1196–1202.  
Tran, T.D.H., Kwon, H.Y., Kim, E.H., Kim, K.W., Briles, D.E., Pyo, S., and Rhee, D.K. (2011). 
Decrease in penicillin susceptibility due to heat shock protein ClpL in Streptococcus pneumoniae. 
Antimicrob Agents Chemother 55: 2714–2728. 
Tseng, T.T., Tyler, B.M., and Setubal, J.C. (2009). Protein secretion systems in bacterial-host 
associations, and their description in the Gene Ontology. BMC Microbiol 9: S2. 
Tuffrey, M., Alexander, F., Conlan, W., Woods, C., and Ward, M. (1992). Heterotypic protection of 
mice against chlamydial salpingitis and colonization of the lower genital tract with a human serovar F 
isolate of Chlamydia trachomatis by prior immunization with recombinant serovar L1 major outer-
membrane protein. J Gen Microbiol 138: 1707–1715. 
Valdivia, R.H. (2008). Chlamydia effector proteins and new insights into chlamydial cellular 
microbiology. Curr Opin Microbiol 11: 53–59. 
Valihrach, L., and Demnerova, K. (2012). Impact of normalization method on experimental outcome 
using RT-qPCR in Staphylococcus aureus. J Microbiol Methods 90: 214–216.  
Vandahl, B.B., Pedersen, A.S., Gevaert, K., Holm, A., Vandekerckhove, J., Christiansen, G., and 
Birkelund, S. (2002). The expression, processing and localization of polymorphic membrane proteins 
in Chlamydia pneumoniae strain CWL029. BMC Microbiol 2: 1–12. 
Vandahl, B.B., Birkelund, S., and Christiansen, G. (2004). Genome and proteome analysis of 
Chlamydia. Proteomics 4: 2831–42.  
Vandahl, B.B., Birkelund, S., Demol, H., Hoorelbeke, B., Christiansen, G., Vandekerckhove, J., and 
Gevaert, K. (2001). Proteome analysis of the Chlamydia pneumoniae elementary body. Electrophoresis 
1204–1223. 
Vandesompele, J., De Preter, K., Pattyn, F., Poppe, B., Van Roy, N., De Paepe, A., and Speleman, F. 
(2002). Accurate normalization of real-time quantitative RT-PCR data by geometric averaging of 
multiple internal control genes. Genome Biol 3: 1-12. 
Van Lent, S., Piet, J.R., Beeckman, D., van der Ende, A., Van Nieuwerburgh, F., Bavoil, P., et al. 
(2012). Full Genome Sequences of All Nine Chlamydia psittaci Genotype Reference Strains. J 
Bacteriol 194: 6930–1. 
Van Ooij, C., Kalman, L., van IJzendoorn, S., Nishijima, M., Hantada, K., Mostov, K., and Engel, J. 
(2000). Host-cell derived sphingolipids are required for the intracellular growth of Chlamydia 
trachomatis. Cell Microbiol 2: 627–638. 
Vanrompay, D., Butaye, P., Van Nerom, A., Ducatelle, R., and Haesebrouck, F. (1997). The 
References                                                                                                                  167 
prevalence of Chlamydia psittaci infections in Belgian commercial turkey poults. Vet Microbiol 54: 
85–93.  
Vanrompay, D., Charlier, G., Ducatelle, R., and Haesebrouck, F. (1996). Ultrastructural changes in 
avian Chlamydia psittaci serovar A-, B-, and D-infected Buffalo Green Monkey cells. Infect Immun 64: 
1265–71.  
Vanrompay, D., Ducatelle, R., and Haesebrouck, F. (1995a). Chlamydia psittaci Infections - a Review 
with Emphasis on Avian Chlamydiosis. Vet Microbiol 45: 93–119. 
Vanrompay, D., Mast, J., Ducatelle, R., Haesebrouck, F., and Goddeeris, B. (1995b). Chlamydia 
psittaci in turkeys: pathogenesis of infections in avian serovars A, B and D. Vet Microbiol 47: 245–56.  
Vasilevsky, S., Stojanov, M., Greub, G., Baud, D., et al. (2016). Chlamydial polymorphic membrane 
proteins : regulation , function and potential vaccine candidates. Virulence 5594: 11–22. 
Verdoodt, F., Willems, M., Dhondt, I., Houthoofd, W., Bert, W., and Vos, W. De (2012). Measuring S-
phase duration of adult stem cells in the flatworm Macrostomum lignano by double replication 
labelling and quantitative colocalization analysis. Cell Biol Int 36: 1251–1259. 
Verminnen, K., Van Loock, M., Hafez, H.M., Ducatelle, R., Haesebrouck, F., and Vanrompay, D. 
(2006). Evaluation of a recombinant enzyme-linked immunosorbent assay for detecting Chlamydophila 
psittaci antibodies in turkey sera. Vet Res 37: 623–32.  
Voigt, A., Schöfl, G., Heidrich, A., Sachse, K., and Saluz, H.P. (2011). Full-length de novo sequence 
of the Chlamydophila psittaci type strain, 6BC. J Bacteriol 193: 2662–2663. 
Voigt, A., Schöfl, G., and Saluz, H.P. (2012). The Chlamydia psittaci genome: a comparative analysis 
of intracellular pathogens. PLoS One 7: e35097.  
Voulhoux, R., Bos, M.P., Geurtsen, J., Mols, M., and Tommassen, J. (2003). Role of a highly 
conserved bacterial protein in outer membrane protein assembly. Science 299: 262–265.  
Wang, Y., Berg, E. a, Feng, X., Shen, L., Smith, T., Costello, C.E., and Zhang, Y. (2006). 
Identification of surface-exposed components of MOMP of Chlamydia trachomatis serovar F. Protein 
Sci 15: 122–34.  
Watson, M.W., Lambden, P.R., and Clarke, I.N. (1991). Genetic diversity and identification of human 
infection by amplification of the chlamydial 60-kilodalton cysteine-rich outer membrane protein gene. 
J Clin Microbiol 29: 1188–93.  
Watson, M.W., Lambden, P.R., Everson, J.S., and Clarke, I.N. (1994). Immunoreactivity of the 60 kDa 
cysteine-rich proteins of Chlamydia trachomatis, Chlamydia psittaci and Chlamydia pneumoniae 
expressed in Escherichia coli. Microbiology 140: 2003–11.  
Wehrl, W., Brinkmann, V., Jungblut, P.R., Meyer, T.F., and Szczepek, A.J. (2004). From the inside 
out-processing of the chlamydial autotransporter PmpD and its role in bacterial adhesion and activation 
of human host cells. Mol Microbiol 51: 319–34.  
Wheelhouse, N., Aitchison, K., Spalding, L., Livingstone, M., and Longbottom, D. (2009). 
Transcriptional analysis of in vitro expression patterns of Chlamydophila abortus polymorphic outer 
membrane proteins during the chlamydial developmental cycle. Vet Res 40: 47.  
Wheelhouse, N.M., Sait, M., Aitchison, K., Livingstone, M., Wright, F., McLean, K., et al. (2012a). 
Processing of Chlamydia abortus Polymorphic Membrane Protein 18D during the Chlamydial 
Developmental Cycle. PLoS One 7: e49190.  
168                                                                                                              References 
Wheelhouse, N.M., Sait, M., Wilson, K., Aitchison, K., McLean, K., Smith, D.G.E., and Longbottom, 
D. (2012b). Expression patterns of five polymorphic membrane proteins during the Chlamydia abortus 
developmental cycle. Vet Microbiol 160: 525–9. 
Woodman, P.G., and Futter, C.E. (2008). Multivesicular bodies: co-ordinated progression to maturity. 
Curr Opin Cell Biol 20: 408–414. 
Wylie, J.L., Hatch, G.M., and Mcclarty, G. (1997). Host cell phospholipids are trafficked to and then 
modified by Chlamydia trachomatis. J Bacteriol 179: 7233–7242. 
Wyrick, P.B. (2010). Chlamydia trachomatis Persistence In Vitro: An Overview. J Infect Dis 201: 88–
95. 
Yang, J. (1997). Prevention of Apoptosis by Bcl-2: Release of Cytochrome c from Mitochondria 
Blocked. Science (80- ) 275: 1129–1132.  
Yeung, Y., Nieves, E., Angeletti, R., and Stanley, E.R. (2008). Removal of detergent from protein 
digests for mass spectrometry analysis. Anal Biochem 382: 135–137. 
Yin, L., Kalmar, I.D., Lagae, S., Vandendriessche, S., Vanderhaeghen, W., Butaye, P., et al. (2013). 
Emerging Chlamydia psittaci infections in the chicken industry and pathology of Chlamydia psittaci 
genotype B and D strains in specific pathogen free chickens. Vet Microbiol 162: 740–749  
Yu, H., Karunakaran, K.P., Jiang, X., and Brunham, R.C. (2014). Evaluation of multisubunit 
recombinant polymorphic outer membrane protein T cell vaccine against Chlamydia muridarum 
genital infection in three strains of mice. Vaccine 6: 4672–4680. 
 Yuan, Y., Zhang, Y.X., Watkins, N.G., and Caldwell, H.D. (1989). Nucleotide and deduced amino 
acid sequences for the four variable domains of the major outer membrane proteins of the 15 
Chlamydia trachomatis serovars. Infect Immun 57: 1040–9.  
Yucel, N., Citak, S., and Bayhün, S. (2011). Antimicrobial resistance profile of Staphylococcus aureus 
isolated from clinical samples and foods of animal origin. Foodborne Pathog Dis 8: 427–31. 
Zhang, Y.X., Morrison, S.G., Caldwell, H.D., and Baehr, W. (1989). Cloning and sequence analysis of 
the major outer membrane protein genes of two Chlamydia psittaci strains. Infect Immun 57: 1621–5.  
Zhang, J., and Stephens, R.S. (1992). Mechanism of  C. trachomatis  attachment to eukaryotic host 
cells. Cell 69: 861–869. 
Zhang, Y., Stewart, S.J., and Caldwell, H.D. (1989). Protective Monoclonal Antibodies to  Chlamydia 
trachomatis  Serovar- and Serogroup-Specific Major Outer Membrane Protein Determinants. 
Microbiology 57: 636–638. 
Zhang, Y.X., Stewart, S., Joseph, T., Taylor, H.R., and Caldwell, H.D. (1987). Protective monoclonal 
antibodies recognize epitopes located on the major outer membrane protein of Chlamydia trachomatis. 
J Immunol 138: 575–81. 
Zhang, Y.X., Watkins, N.G., Stewart, S., and Caldwell, H.D. (1987). The low-molecular-mass, 
cysteine-rich outer membrane protein of Chlamydia trachomatis possesses both biovar- and species-
specific epitopes. Infect Immun 55: 2570–3.  
Zhao, W., Li, Y., Gao, P., Sun, Z., Sun, T., and Zhang, H. (2011). Validation of reference genes for 
real-time quantitative PCR studies in gene expression levels of Lactobacillus casei Zhang. J Ind 
Microbiol Biotechnol 38: 1279–1286. 
Zhou, K., Zhou, L., Lim Q.E., Zou, R., Stephanopoulos, G., and Too, H.-P. (2011). Novel reference 
References                                                                                                                  169 
genes for quantifying transcriptional responses of Escherichia coli to protein overexpression by 
quantitative PCR. BMC Mol Biol 12: 18.  
Zugel, U., and Kaufmann, S.H. (1999). Role of heat shock proteins in protection from and pathogenesis 
of infectious diseases. ClinMicrobiolRev 12: 19–39. 
 
 
 
 Dankwoord 
Ongelooflijk maar waar: we zijn aanbeland bij het laatste stukje van mijn doctoraat. 
Als ik er nu naar terugkijk, lijkt het een tijd die voorbij gevlogen is. Het was een tijd 
met heel veel mooie momenten en ervaringen, maar af en toe ging het ook wel wat 
moeilijker. Daarom wil ik heel graag alle collega’s, vrienden en familieleden 
bedanken die de voorbije jaren steeds paraat stonden om me te helpen, te steunen, om 
plezier te maken en te zorgen dat er voldoende ontspanning was.  
Mijn promotor, Prof. dr. Daisy Vanrompay wil ik bedanken omdat ze 5 jaar geleden 
vertrouwen in mij had en me de kans gaf om een doctoraat te beginnen in haar labo. 
Daisy, bedankt om mij te laten starten op het boeiende, uitdagende project van de 
Pmp eiwitten. Ik ben je heel dankbaar dat ik 8 maanden naar het labo van Prof. dr. 
Patrik Bavoil mocht gaan, want die ervaring is tot de dag van vandaag nog steeds de 
mooiste ervaring van m’n wetenschappelijke carrière. Verder wil ik je ook bedanken 
voor de vrijheid die ik steeds kreeg om nieuwe ideeën uit te werken, samen met mij 
naar mogelijke samenwerkingen met andere labo’s te zoeken, de electronen-
microscopie beelden samen te analyseren, mij naar verschillende internationale 
congressen te laten gaan en om mijn artikels en doctoraat te verbeteren.  
I would like to thank Prof. Dr. Patrik Bavoil and his wife Prof. Dr. Ru-ching Hsia. 
Patrik, I remember the first day in your lab (the 4th of September 2011) like it was 
yesterday. You were so friendly, asking if I had food and all the furniture I needed at 
Joshua’s place, otherwise you would drive me to a shop. You told me that you didn’t 
care at what time I would start working every day, but if I would be late, you asked 
me to send an email, as you would be worried otherwise. Your PhD students were like 
your children. The time in your lab is my best scientific experience up to now. I 
learned a lot during my stay in your lab, you corrected chapter IV of my thesis, but 
also very important to me, is that you were always available during the last 4 years, 
when I was back in Belgium. When we had a chance to meet, you always made some 
time to discuss my data and give me some new ideas to move on with my research. 
Also when I had a hard time, you told me you believed in me and that I should hang 
on and soon I would be able to finish the PhD. Thank you so much! Ru-ching, you did 
 all the electron-microscopy work and helped me with the analyses. Thank you for 
your support! 
Ik wil ook heel graag alle leden van mijn examencommissie (Prof. dr. ir. Monica 
Höfte, Prof. dr. Els Van Damme, dr. Yvonne Pannekoek, Prof. dr. Katleen 
Hermans, Prof. dr. Richard Ducatelle en Prof. dr. Andre Skirtach) bedanken om 
tijd vrij te maken om mijn doctoraatsthesis te lezen en voor het leveren van jullie 
constructieve opmerkingen. Dankzij jullie is de kwaliteit van mijn thesis er zeker op 
vooruit gegaan.  
Uiteraard wil ik heel graag mijn collega’s, de immuno’s, bedanken! In het begin was 
ik maar een maandje bij jullie, toen ik al voor 8 maanden naar Baltimore vertrok. 
Toch behoorde ik voor jullie al tot de groep en stuurden jullie me een postpakket met 
leuke boodschappen, dat was fantastisch! Ik geloofde zelfs dat Yin dat Chinees tekstje 
geschreven had, hilarisch! Ook wanneer ik terug in België was, hadden we een 
fantastische tijd samen. Altijd was er wel wat te vertellen, de middagpauze’s vlogen 
voorbij, iedereen stond paraat om elkaar te helpen. Ja, ik kan zeker zeggen dat mijn 
collega’s vrienden voor het leven zijn geworden! Annelien, als overburen hebben we 
jaren samen naar het werk gefietst, toen ik ziek was en ik gepland had om een staal te 
gaan nemen in het weekend stelde jij direct voor om in mijn plaats te gaan, als ik 
besloot 40 flessen ineens op te kweken stelde jij voor me te helpen bij het oogsten, en 
ik kan zo nog even doorgaan! Jij stond gewoon altijd paraat, voor een babbel, om te 
helpen, of met wat eten als ik laat thuis kwam, nooit was er iets teveel! Heel hard 
bedankt daarvoor! Stefanie, jij was de senior van het labo toen ik aan mijn doctoraat 
startte. Altijd mocht ik je lastigvallen met wat vraagjes. Bovendien was je mijn grote 
voorbeeld van de ‘plantrekker’. Je zorgde mee voor de fantastische sfeer en ik heb je 
dan ook echt wel gemist toen je een jaartje weg was voor je zwangerschap. Jammer 
dat je terugkomst van korte duur was, maar ik ben echt heel blij dat je jouw draai in 
het onderwijs gevonden hebt! Je bent gewoon een geboren lerares! Leentje, Kristien 
en Evelien, mijn drie bureaugenootjes. Ondanks dat ik niet tot de ‘varkens’groep 
behoorde, was ik toch heel welkom in jullie bureautje in de kelder. Elke dag kwam ik 
met plezier naar het werk! Toen jullie 1 voor 1 het bureautje (en immunoland) 
verlieten miste ik zeker jullie aanwezigheid! We hebben in ons bureautje wat 
afgelachen en gebabbeld. Ik zal het moment dat Evelien haar kleedje voor de trouw 
 van haar zus aan ons toonde nooit vergeten ☺. Jullie hebben me allemaal veel 
geholpen, Leentje o.a. met de microscoop, Kristien o.a. met de Pmps en Evelien o.a. 
met wat truckjes in Mendeley en excel. Maar ook al verschilden onze projecten zeer 
hard, we stonden altijd voor elkaar klaar! Merci voor de leuke tijd en de oppeppende 
gesprekken die ik af en toe eens nodig had! Julie, met jouw vrolijk karakter paste je 
perfect in ons immuno-team! Ik had je graag opgeleid als mede Pmp-onderzoeker, 
maar begreep jouw keuze om ons labo te verlaten volledig. Onderzoek doen 
combineren met tussen de koeien zitten, lijkt mij de ideale job voor jou en ik ben dan 
ook heel blij dat je zo’n job gevonden hebt! Katelijn, toen ik terugkwam uit 
Baltimore werkte je niet meer bij ons, maar gelukkig kwam je ons een tijdje later nog 
eens vergezellen voor een 6-tal maanden. Je was altijd heel vrolijk en als ik vraagjes 
had stond je altijd klaar! Cindy, bedankt voor de babbeltjes tussendoor. Ik wens je 
nog veel succes bij jouw doctoraat! Eamy, I’ll never forget our conversations about 
REsearch. Good luck with your defense! Anh and Tho, we had a nice time together in 
our lab. I want to thank you especially for the nice talks and your delicious food! Tho, 
I wish you good luck with your PhD! Joanna and Evelien you both joined the lab 
when I was finishing my PhD, but I’m sure we would get along very well. Evelien, 
veel success met je verdediging! Ine, ook jij kwam het labo versterken toen ik bijna 
begon te schrijven. Maar de donderdagen waren steeds heel aangenaam! Met jouw 
vrolijke, enthousiaste persoonlijkheid pas je zeker bij de immuno’s! 
Ook naast de immuno’s zijn er nog wat collega’s van de vakgroep die ik graag wil 
bedanken! Lander, jij bent degene die me op mijn eerste werkdag opving en zei dat 
mijn bureau niet op het 2de verdiep maar op het gelijkvloers of in de kelder zou zijn. 
In de jaren die volgden, kwam ik regelmatig wat vertellen aan jouw bureau. Bedankt 
om altijd zo goed te luisteren en me aan te moedigen! Je was ook een vaste afzetplaats 
voor mijn baksels ☺. Nog eens dubbel bedankt om me te helpen met mn vele 
doctoraatsvraagjes de laatste maanden! Annelies, het was een fantastische tijd toen jij 
er was! Als we elkaar tegenkwamen in de gang was het tijd voor een dikke knuffel en 
een babbeltje!!! Die heb ik zeker wel gemist toen jouw doctoraatsjaren er op zaten! 
Lore, jij werd mn nieuwe glyco-vriendinnetje toen Annelies het schip verliet. We 
hebben ook ettelijke knuffels gegeven en babbeltjes gedaan! Ik mis jouw vrolijke noot 
in de bureau nu al! Merci voor de leuke tijd en om altijd paraat te staan! Ik wens je 
nog heel veel succes bij het afronden van jouw doctoraat! Sofie, wij hebben ook wel 
 wat babbeltjes gedaan! Je hebt me ook veel geholpen met allerlei programma’s zoals 
Inkscape en Illustrator for Biological Sequences. Ik heb ze goed kunnen gebruiken 
voor mijn doctoraat, merci! Je bent er nu ook bijna vanaf, ik wens je nog veel succes 
met jouw verdediging! Katrien, jou leerde ik kennen toen je plots veel gebruik kwam 
maken van ons q-PCR toestel. Terwijl je stond te wachten deden we uiteraard een 
babbeltje! Bedankt om de eerste schrijfsels van mijn eerste artikel na te lezen en me 
zo op weg te zetten bij het wetenschappelijk schrijven!  
Ik wil ook Sofie en Fien bedanken voor alle administratieve hulp en bestellingen (ook 
Annelien wordt hiervoor bedankt!). Bij jullie langskomen was altijd een plezier, je 
werd altijd met de glimlach ontvangen en goed geholpen. Een welgemeende 
dankjewel! Geert, jij stond altijd klaar als er iets mis was met mn computer of als er 
een technisch mankement was in het labo, bedankt! Ik wil ook de andere collega’s 
van de vakgroep Moleculaire biotechnologie bedanken voor de aangename tijd! 
Winnok wil ik graag nog in het bijzonder bedanken voor zijn hulp met de microscoop! 
Naast alle fantastische collega’s wil ik ook nog graag mijn vrienden en familie 
bedanken. Jullie zorgden er allen samen voor dat ik mijn doctoraat op tijd en stond 
eens uit mijn hoofd kon zetten. Mijn doctoraat was voor de meesten van jullie totaal 
niet in jullie branche, toch vroegen jullie regelmatig hoe het er mee ging, luisterden 
jullie en steunden jullie mij! Eerst en vooral een dikke merci aan Lot en Elien. Vanaf 
het begin aan de universiteit waren wij onlosmakelijk verbonden. Op elk 
chemicafeestje waren we samen te vinden, tijdens de vakanties gingen we samen op 
reis, naar de Gentse feesten, naar het cactusfestival,… Na onze studententijd zijn we 
nog steeds beste vriendinnen. Ik wil jullie bedanken voor al jullie steun de voorbije 
jaren. Zowel tijdens de eerste bachelor als tijdens mn doctoraat had ik wel eens last 
van faalangst en jullie stonden steeds klaar om me moed in te spreken! Ik wil ook mn 
vrienden van Chemica bedanken voor de leuke tijd, met in het bijzonder Lien en 
Jolien. Bedankt ook aan mijn chirovrienden en in het bijzonder aan Liesbeth, 
Lieselot, Dorien, Annik en Camille! Bedankt aan mijn Gentloopt vriendjes en in het 
bijzonder aan Tine en Bianca! Ook mn kok- en bakschoolvriendjes zorgden voor de 
nodige ontspanning, bedankt voor de leuke avonden!  
Een heel speciaal woordje van dank gaat uit naar mijn moeke en vake. Jullie gaven 
mij alle kansen en steunden mij onvoorwaardelijk. Ik zag het af en toe niet meer zitten, 
 maar jullie geloofden altijd heel hard in mij! Jullie hebben wel wat afgezien tijdens de 
examenperiodes aan de universiteit, toen ik weer eens dacht dat ik het niet ging 
kunnen. Toch bleven jullie altijd zeggen dat het wel zou lukken, en zorgen jullie dat 
er een thee’tje en wat fruit klaarstond tijdens m’n pauzes. Het eten werd ook steevast 
klaargemaakt op het exacte moment dat ik een pauze plande. Jullie keken zelfs tv 
zonder geluid! Toen ik naar Amerika vertrok voor mijn doctoraat kwam moeke 3x op 
bezoek en zelfs vake, die nog nooit gevlogen had, kwam me bezoeken. Het was heel 
leuk om met jullie samen New York te ontdekken en ook gewoon om ’s avonds bij 
jullie thuis te komen. Ik weet met zekerheid dat wat ik ook beslis in mn leven, dat 
jullie altijd als een blok achter mij zullen staan en dat is fantastisch. Dankuwel!!! Ook 
mn grootouders moemoe en vava wil ik bedanken. Moemoe, jij verbeterde met veel 
plezier mn masterthesis. Daaruit concludeerde je dat werken met DNA toch wel heel 
veel werk is. Altijd waren jullie geïnteresseerd en vroegen jullie hoe het in Gent ging. 
Stijn, Dries en Jelle, mn drie grote broers, jullie hebben me ook de voorbije jaren 
onvoorwaardelijk gesteund. Stijn, merci om me te komen bezoeken in Baltimore en 
zonder problemen reed jij samen met moeke moeke en mij naar de Niagara 
watervallen in Canada. Jelle, ook jij kwam samen met Eve op bezoek bij mij. Ons 
tripje naar de Everglades en naar Six Flags was fantastisch! Dries, mijn verblijf in 
Terhagen was van korte duur, maar samen op het veld werken vorige zomer was heel 
rustgevend en heeft me veel deugd gedaan! Mattis, Maité, Amber, Anouk, Sam en 
Seppe, stuk voor stuk zijn jullie mijn hartendieven! Jullie vrolijke kinderlachjes en 
dikke knuffels zorgden de voorbije jaren meermaals voor de ontspanning die ik nodig 
had!  
Tot slot wil ik m’n vriend Bart heel hard bedanken. Ons eerste jaar was zeker geen 
gemakkelijk jaar. Toen we dan nog eens besloten om de deadline van mijn doctoraat 
te combineren met een stevige verbouwing, werd het helemaal hectisch. Gelukkig 
kwamen jouw mama en papa, die ik ook heel hard wil bedanken, veel helpen met de 
verbouwing! Maar beide deadlines zijn gehaald, nog even volhouden en we kunnen 
weer volop genieten! Bedankt voor jouw steun, jouw liefde, jouw levensvisie die je 
graag met me deelt,… Kort samengevat, bedankt om mij zo gelukkig te maken!   
 
 
  
 
 
 
 
 Curriculum vitae 
Personalia 
 
 Van Lent 
 Sarah 
 Bommelbekestraat 35 
 8000 Bruges, Belgium 
 +32479/501703 
 sarahvanlent@gmail.com 
 Belgian 
 21st June 1988 
 Drivers license category B 
Education 
2011 – 2016 PhD Applied Biological Sciences as a 
Research Assistant of the Research-
Foundation-Flanders (FWO – 
Vlaanderen), Ghent University 
2014 Laboratory animal sciences (FELASA C), 
Ghent University 
2013 Advanced Academic English: Writing 
Skills, Ghent University 
2013 Post-academic training: Statistics in R, 
Ghent University 
2012 qPCR experimental design and data-
analysis, Biogazelle 
2006-2011 Master of Science in Biochemistry and 
Biotechnology, magna cum laude 
2000-2006 Science-Maths, Sint-Norbertusinstituut 
Duffel 
Experience - Research skills 
 
PCR and Real-time PCR, Fluorescence and confocal microscopy, Cell and tissue culture, 
Bacterial culture, Cloning, Recombinant protein expression (in prokaryotic and eukaryotic 
expression systems) and purification (His-tag and GST-tag), SDS-PAGE and western blotting, 
ELISA, Animal experiments, Working in a BSL3 lab, Writing scientific papers and reports, 
Presentation skills.                                                                                                                
Thesis student: 2014-2015: Astrid Reymer: “Ontwikkeling van een SK-6 celcultuurmodel 
voor de studie van persistente Chlamydia suis infecties”. Masterproef voorgedragen tot het 
behalen van de graad Master in de bio-ingenieurswetenschappen: cel- en genbiotechnologie 
 Languages 
  
Dutch Native language 
English Fluent conversation and writing 
French Basic conversation and writing 
Computer skills 
 
• Microsoft Word, Excel and Powerpoint 
• qBasePlus (qPCR analysis) 
• Vector NTI (sequence database) 
• R (statistical software) 
• ImageJ (image processing) 
Publications 
Van Droogenbroeck C, Dossche L, Wauman T, Van Lent S, Phan TTT, Beeckman DS a & 
Vanrompay D (2011) Use of ovotransferrin as an antimicrobial in turkeys naturally 
infected with Chlamydia psittaci, avian metapneumovirus and Ornithobacterium 
rhinotracheale. Veterinary microbiology 153: 257–63  
Van Lent S, Piet JR, Beeckman D, Van der Ende A, Van Nieuwerburgh F, Bavoil P, Myers 
G, Vanrompay D & Pannekoek Y (2012) Full Genome Sequences of All Nine 
Chlamydia psittaci Genotype Reference Strains. Journal of bacteriology 194: 6930–1  
Van Lent S, Creasy HH, Myers G & Vanrompay D (2016) The Number, Organization, and 
Size of Polymorphic Membrane Protein Coding Sequences as well as the Most 
Conserved Pmp Protein Differ within and across Chlamydia Species. Molecular 
Microbiology and Biotechnology 26: 333-44. 
 
Conferences 
• Seventh Meeting of the European Society for Chlamydia Research. Amsterdam, 
Netherlands, 1 - 6 July 2012. Poster presentation 
“Genome sequences of all Chlamydia psittaci genotype reference strains”. 
• Sixth Biennal Chlamydia Basic Research Society Meeting. San Antonio, Texas, USA, 
19 – 23 March 2013. Poster presentation 
“Transcriptional analysis suggests a critical role of the polymorphic membrane 
proteins of Chlamydia psittaci in late differentiation and/or early infection”. 
• Tenth Annual Amsterdam Chlamydia Meeting. Amsterdam, Netherlands, 6 February 
2015. Oral presentation (won the price for best oral presentation). “Transcriptional 
and translational analysis of in vitro expression profiles of Chlamydia psittaci 
polymorphic membrane proteins”. 
• Seventh Biennal Chlamydia Basic Research Society Meeting. New Orleans, Los 
Angeles, USA, 29 March – 1 April 2015. Oral presentation 
“Variable immunogold labeling and subcellular location of polymorphic membrane 
proteins of two Chlamydia species”. 
 Experience Abroad 
Goal: Cloning and purifying one member of each subtype of the polymorphic membrane 
proteins (Pmp) of C. psittaci to obtain polyclonal antibodies. Determine the transcript profile 
of all pmp CDSs of C. psittaci by RT-qPCR.  
1st September 2011 – 1st May 2012.  
Host: Prof. dr. Patrik Bavoil, University of Maryland, School of dentistry, Department of 
Molecular Pathogenesis, Baltimore, USA 
Hobbies 
 
2006-2007: part of the chiro leadership team 
2007-2008: sportpraeses Chemica  
2008-2009: vice praeses Chemica 
Sport: running, snowboarding 
Interests: cooking and travelling 
 
